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Allostery is a form of signalling within biomolecules such that ligand binding to a
protein affects its activity at a second site. Allostery was described by early models
to be driven by structural changes in the protein. However, more recently there has
been increasing evidence that dynamics can contribute to or even drive allostery. The
protein studied in this thesis, the Catabolite Activator Protein (CAP), is an allosteric
protein homodimer that has been shown to exhibit negatively cooperative binding of the
ligand cyclic Adenosine Monophosphate (cAMP) to each of its monomers. Interestingly,
CAP is a protein whose allostery is believed to be driven by dynamics rather than a
conformational change.
In this thesis, a number of coarse grained models are employed to investigate this
dynamic allostery in CAP. One family of models, termed Super Coarse Grained (SCG)
models explore the global properties of the dynamics of the CAP dimer that cause it to
exhibit negatively cooperative allostery. It is shown through these models that changes
in protein interactions can provide a basis for changing cooperativity. A second family
of coarse grained models called Elastic Network Models (ENM) are studied. These
are used to show that adjusting the interactions between specific residues can affect
cooperative binding of cAMP to CAP.
A number of atomistic approaches are also used to study the cAMP-CAP system,
including Molecular Dynamics (MD) and Normal Mode Analysis (NMA). The efficacy
of using such approaches for studying the thermodynamics of the allostery in CAP is
investigated. The motion observed within the protein is also studied closely to identify
potential allosteric pathways.
X-ray crystallography and Isothermal Titration Calorimetry (ITC) are finally used
to investigate how accurately computational methods can describe the cooperative
binding of cAMP to CAP. They are also used to try and determine whether the al-
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Project Overview and Background
Proteins are biological molecules essential for life. Knowing their three dimension(al)
(3D) structure contributes to understanding how proteins function. Proteins consist
of amino acids joined by peptide bonds into a polypeptide chain. For most proteins,
these chains of amino acids are folded into complex 3D structures. It is understood
that proteins have evolved over time to perform specific functions dependent on these
structures [1], however it was not until the 1970s that the importance of thermal
fluctuations of proteins on their function was recognised [2].
This thesis explores the importance of structure and dynamics in a form of in-
tramolecular signalling common in proteins called allostery. An example protein, where
allostery is believed to occur without a global conformational change, the catabolite
activator protein (CAP) is investigated in detail.
1.1 Protein Structure
Amino acids, the building blocks of proteins follow a specific template, with a central
carbon atom (Cα) bonded to an amino group, a carboxyl group, a hydrogen atom and
a side chain. The α-carbons of adjacent amino acids are separated by three covalent
bonds arranged as Cα-C-N-Cα (see figure 1.1). The C-N bond for each amino acid is
unable to freely rotate, as electron sharing occurs between the carbonyl oxygen and
the amide nitrogen, forcing the Cα-C-N-Cα atoms into a planar conformation. The
rigid peptide bonds therefore limit to some extent the number of conformations that
can be adopted by the folded protein. Typically the torsional angles in the amino acids
3
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Figure 1.1: a) The basic structure of an amino acid showing the Cα atom and the amino acid
side chain, R, and b) the peptide bond between adjacent amino acids in a polypeptide chain.
The torsional angles φ and psi are displayed.
are labelled φ for C-N-Cα-C and ψ for N-Cα-C-N. The allowed values for φ and ψ are
limited as many values are prohibited by steric interference. Ramachandran plots are
a graphical representation that plots allowed values for φ and ψ and are useful for
validating a protein’s structure [3].
A protein’s 3D structure is the result of folding of the polypeptide chain to create
compact units with specific 3D structures, such as α-helices and β-sheets. Most proteins
exist with more than one unique spacial arrangement of their atoms. These unique
spacial arrangements, called conformations, exist at local minima on a complex multi-
dimensional potential energy surface. Usually separate conformations will exist for the
active and the inactive states of the protein [4].
The folded state of a protein is held together by disulphide bonds and many weaker
intermolecular interactions, such as hydrophobic interactions, hydrogen bonding and
ionic interactions. However, a protein’s stability can not be calculated by simply sum-
ming these interactions; there are other factors to take into account. Firstly, all of the
hydrogen bonds formed internally in the protein would include the breaking of a hy-
drogen bond between the protein and water prior to the protein folding. Secondly, the
presence of the protein in water disrupts the hydrogen bonding network of pure water,
causing the water to form a highly structured solvation shell around the protein. And
thirdly, the entropic penalty associated with ordering the water around the protein, is
worse for hydrophobic regions of the protein. Therefore, the protein folds in such a
manner that the hydrophobic groups are shielded from the solvent as much as possible
and the hydrophilic groups are found on the exterior. The gain in entropy from the
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Figure 1.2: The primary, secondary, tertiary and quaternary structures of proteins. The
primary structure is given by the ordering of the amino acids, the secondary is the struc-
tural elements such as an α-helix (shown) or a β-sheet. The tertiary structure gives the
3D arrangement of the protein monomer in space, while the quaternary structure is the 3D
structure of the entire protein complex. Figure adapted from [1].
release of the structured water when the intramolecular interactions in the protein are
formed compensates somewhat for the loss of conformational entropy associated with
folding the protein into a single conformation.
A protein’s structure is described over four levels. The primary structure of a
protein is given by the sequence of amino acids or residues in the polypeptide chain. The
secondary structure of a protein is the arrangement of local domains of the polypeptide
chain into structural elements, where the structure of the amino acids in these local
domains are spatially related to each other. The most common secondary structural
elements are α helices, β sheets and β turns. An α helix is a helical structure in which
the protein backbone is tightly wound around an axis drawn along the length of the
helix with the side chains pointing away from axis of the helix. A single turn of the
alpha helix extends approximately 5.4 A˚ along the length of the helical axis. The φ
and ψ values of the residues in an α helix are -60◦ and -45◦ to -50◦ respectively. When
the structure of the protein chain extend into a zigzag rather than a helical structure,
it forms a β strand. These β strands stack in either a parallel or antiparallel manner
to form β sheets. β turns connect two adjacent β strands in an antiparallel stacked
β sheet. The tertiary structure is given by the 3D arrangement of these structural
elements in space for the polypeptide chain. For a protein complex of two or more
polypeptide chains, the arrangement of these chains in 3D space is the quaternary
structure. A depiction of the four structure levels of a protein can be seen in figure 1.2.
The tertiary and quaternary structures of a protein can bring residues that seem
distant in the primary structure, close together in 3D space to form a functional region
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of the protein such as a catalytic or binding site. Proteins are able to exist with
more than one conformation, often having an active form and an inactive form. The
conversion of a protein from its inactive form to its active form can be triggered by an
event such as the binding of a small molecule.
Knowing a protein’s 3D structure is a very powerful tool for understanding its
biological function. However, predicting a protein’s tertiary or quaternary structure
from its primary structure is not yet possible. Currently the most powerful method is
homology modelling, which makes use of known structures of protein domains that have
similar sequences [5]. Typically homology modelling can work well with proteins that
have greater than 30% sequence identity, however, as structure is conserved more than
sequence, proteins that share no sequence similarity can share structural similarities.
This makes predicting the protein’s 3D structure such a difficult task.
Rather than calculating a protein’s structure computationally, since 1958 when
Kendrew solved the structure of Myoglobin [6], it has been possible to solve a protein’s
structure experimentally using X-ray crystallography. X-ray crystallography is able
to resolve the average positions of the heavy atoms in the protein, generating a 3D
static structure. Nuclear magnetic resonance (NMR) or electron microscopy (EM) can
now also be used to solve a protein’s crystal structure. The protein data bank (PDB)
[7, 8] is a database of the 3D structures of biomolecules derived predominantly from
crystallographic studies. At the time of writing, this contains over 100,000 structures.
Around 90,000 are derived from X-ray crystallography, 10,000 from NMR and 1000 by
EM and other methods. The protein data bank is a priceless tool for studying protein
structure and dynamics.
1.2 Protein Dynamics
A protein’s structure, however, is not static and the structure seen by X-ray crystallog-
raphy is a high precision average structure located at a minimum on the complicated
potential energy landscape. In reality thermal fluctuations of the protein allows it to
explore a multitude of other conformations in the surrounding conformational space.
It wasn’t until the 1970s that Weber [2] indicated that the thermal fluctuations can be
essential for protein function and Austin et al. [9] demonstrated this with Myoglobin,
showing that an ensemble of conformational substates can affect ligand binding.
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Over the last few decades a number of techniques have been used to study protein
dynamics. With X-ray crystallography, for example, it is possible to identify flexible
regions of proteins. However, it is often hard to gain useful dynamic information such
as timescales from this. NMR is also very sensitive to protein motions [10, 11] and
can resolve the dynamics of independent residues because of their distinct chemical
shifts. Isotopic labelling can also be used as a further set of tools to study dynamics in
specific residues or regions of the protein. NMR can also be performed with the protein
in solution, and at room temperature, closer to native conditions than is possible with
X-ray crystallography. The use of molecular dynamics (MD) to study protein dynamics
also quickly gained popularity since the first simulations of a simplified protein folding
process by Levitt and Warshel in 1975 [12].
The recent emphasis put on the importance dynamics on protein functionality is
evident in the increased number of studies of protein dynamics over the past 10 years. A
number of recent studies show the importance of dynamics in certain aspects in protein
function such as ligand recognition [13], protein folding [14], enzyme catalysis [15], ion
channel selectivity [16], and allosteric regulation [17, 18]. This new emphasis has led
to a model of protein evolution predicting that they have evolved on a dynamic basis,
alongside a structural basis, to fulfil their role within the cell [19].
Henzler-Wildman and Kern defined protein dynamics as any time-dependent change
in atomic coordinates [20]. This can of course refer to both equilibrium fluctuations,
or other non-equilibrium phenomena. The majority of biological processes, including
allostery (section 1.4), are regulated by equilibrium fluctuations. These range from
fast motions on the fs to ns timescale to slow motions on the microsecond to second
timescale. The fast motions indicate motions caused by local flexibility including bond
vibrations and side chain motions. The slow motions are the biologically important
collective motions of much larger amplitude such as large domain motions and motions
on the timescale of protein folding. Figure 1.3 displays a break-down of these motions.
This thesis primarily investigates slow collective protein motions. It can be argued
that these motions are biologically more important than the fast modes as they involve
large rearrangements felt over large distances, whereas the fast modes are localised so
are unlikely to cause long distance signalling such as that seen in allostery. Protein
motions on timescales less than 100 ps were argued in a review article by Daniel et
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Figure 1.3: The large spectrum of timescales observed in the thermal fluctuations of proteins.
(a) A schematic protein potential energy landscape along one conformational coordinate
showing barrier transitions between local minima corresponding to motions on three different
time scales. (b) Examples of motions observed across the spectrum of protein timescales and
the techniques used to study protein motion at corresponding timescales. Adapted from [20],
with extra information from [21]
al. [22] to be unnecessary for enzyme function. There is some disagreement between the
timescale of motions active in allostery [17,23–25]. However, the most likely answer is
that motion at most timescales contribute in some way to the signalling. Furthermore,
it has also been shown that a change in a protein’s backbone shape is not always
necessary for allosteric signalling [17]. This report will investigate further, allostery
that is driven by protein dynamics rather than a structural change.
1.3 Thermodynamics of Protein-Ligand Binding Events
The function of many proteins is dependent on the reversible binding of regulatory
molecules, termed ligands. Ligands can be anything as small as an ion, or can be as
large as deoxyribonucleic acid (DNA) or another protein. Proteins are able to interact
selectively with ligands, only binding one or a select few at specific binding sites. This
process is of utmost importance for a protein’s function and is critical to life itself.
The original view of protein-ligand binding was that the shape of the ligand was
complementary to the shape of the binding site of the protein. This theory introduced
in 1894 by Fischer [26] described the protein and the ligand as rigid structures and the
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a)
b)
Figure 1.4: Different models for protein-ligand binding. (a) The lock and key model, where
the ligand is the complementary geometric shape of the binding site. (b) The induced fit
model, where the shape of the binding site adapts upon binding to better fit the ligand.
ligand slotted into the protein like a key in a lock. This model was able to explain the
specificity of protein-ligand binding, but was unable to explain the stabilisation that
occurs upon binding.
However, proteins are flexible and in 1958 Koshland introduced the induced fit
model to accommodate this [27]. This model accepts that the binding of a ligand to
a protein is often coupled with a conformational change of the protein that induces
tighter binding of the ligand. In proteins with multiple subunits, the conformational
change upon binding of one subunit can then affect the conformation of the other
subunits. Figure 1.4 shows a graphical representation of these models.
As with any reversible chemical reaction, it is possible to describe the binding of a





where the binding event has an association constant, Ka. Ka can be calculated either
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Here Ka is a measure of the affinity of the ligand for the protein, with units of mol
−1
dm3 (or concentration−1). A higher value of Ka corresponds to a higher binding affinity
between ligand and protein.
It is also sometimes useful to consider the binding equilibrium from the standpoint
of the fraction of ligand binding sites on the protein that are occupied:
θ =
binding sites occupied
















The value of Ka can then be determined by plotting θ against the concentration of free
ligand, [L].
Often in biological circles the dissociation constant, Kd, is used to characterise
protein-ligand binding. The dissociation constant is the reciprocal of the association
constant, Kd = 1/Ka and given in concentration units. When looking at the dissocia-





The dissociation constant, Kd can be described as the molar concentration of ligand
needed for half of the available binding sites to be occupied (see figure 1.5).
From the association constant it is possible to calculate the molar Gibbs free energy
of binding,
∆G	 = −RT lnKac	, (1.3.7)
where R is the universal gas constant, T is the temperature (usually 298 K or 300 K)
and the standard reference concentration c	 = 1 mol dm−3.
As with any thermodynamic phenomenon, the Gibbs Free energy, ∆G, determines
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Figure 1.5: A Graphical representation of ligand binding, showing the fraction of occupied
ligand binding sites, θ, plotted against free ligand concentration, [L]. The dissociation con-
stant Kd (or 1/Ka) is equivalent to the value of [L] when half of the available ligand binding
sites are occupied (θ = 0.5)
how well the ligand binds to the protein. ∆G < 0 indicates a favourable binding event
and a ∆G > 0 indicates an unfavourable binding event. Where proteins are involved
the magnitude of ∆G is usually relatively small, as the ability for a protein to unbind a
ligand once it has performed its specific purpose is necessary for the protein to continue
to function. The Gibbs Free energy is composed of an enthalpic and an entropic part
∆G = ∆H − T∆S. (1.3.8)
The enthalpic contribution to the free energy, ∆H, is typically associated with
changes to structure upon binding that are described in the induced fit model. An en-
thalpically favourable reaction, where ∆H < 0, results from a net increase in favourable
interactions (such as hydrogen bonds or van der Waals interactions) due to the struc-
tural change. Changes in the protein dynamics tends to have a larger effect on the
entropy, with an entropically favourable binding event being one where −T∆S < 0.
The entropy of a system is a measure of how disordered it is, measuring the number
of ways the particles in the system can be arranged. If N is the total number of mi-
crostates available to a system and the ratio Pi = ni/N is the proportion of members
12 1.4. Allostery













Here the index i is summed over all accessible microstates. If the total number of
microstates that can be occupied by a system increases, the entropy increases. A
ligand binding to a protein usually decreases the flexibility of the protein, decreasing
the number of accessible microstates available to the system, which leads to a reduction
in the entropy of the system. The less common case of ligand-protein binding increasing
the flexibility of the protein causes a decrease in entropy using the same reasoning.
Enthalpy-entropy compensation can be observed during these binding events. Upon
binding, the increase in attractive interactions contributing to an enthalpy increase, is
compensated by a loss in entropy due to a reduction in the degrees of freedom of
the system. There are a number of methods available, such as isothermal titration
calorimetry (ITC) (see section 3.2), which can be used to determine the thermodynamic
parameters of protein-ligand binding.
1.4 Allostery
Allostery is a process where binding at one site of a protein affects the binding of
another ligand at a different site on the same protein. The cooperative binding in
these allosteric events can either promote or inhibit the binding of other ligands at
distant sites [28]. Being able to understand this process is, therefore, very important
for many areas of molecular biology. For example, an allosteric site of a protein can be
used as a target for drug design [29–31].
Homotropic allostery is when the second ligand binding to the protein is the same
as the allosteric modulator ligand that binds. When the allosteric modulator is dif-
ferent to the second ligand that binds, the interaction is called heterotropic allostery.
Proteins may have more than one modulator, so it is possible that they undergo both
homotropic and heterotropic allostery. The system studied in this report, CAP, is one
such protein. CAP undergoes homotropic allostery with the ligand cyclic adenosine
monophosphate (cAMP). The binding of the second cAMP modulator then activates
the protein, increasing its affinity for binding to DNA. The homotropic allostery in CAP
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will be discussed in more detail in section 1.5.5 and will be investigated throughout
the thesis.
1.4.1 Cooperative Binding
Allostery is thermodynamic in nature, the cooperativity driven by the free energy
difference between the individual binding events. If binding of one ligand makes the
binding of the second more energetically favourable, the allosteric effect is said to have
positive cooperativity. Negative cooperativity occurs when binding of the first ligand
causes the binding of the second to be less favourable.
In 1910 Archibald Hill developed a general approach to study cooperative binding
to multi-subunit proteins [32]. By extending the equilibrium of equation 1.3.1, it is


















Figure 1.6 shows how the graphical representation of ligand binding as seen in figure 1.5












= n log [L]− logKd. (1.4.14)
A Hill plot is then created by plotting log (θ/(1− θ)) against log [L]. Theoretically, this
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Figure 1.6: Binding curves describing noncooperative binding, positively cooperative binding
and negatively cooperative binding. Noncooperative binding occurs when the affinity for
binding does not change once an allosteric effector binds. Positively cooperative binding has
a sigmoidal shape curve, whereas negatively cooperative binding has a curve similar to a
protein with two classes of binding sites. Adapted from [33].
corresponds to perfectly cooperative binding. However, in practice the experimentally
determined gradient reflects the level of cooperativity between the binding sites rather
than the total number of binding sites (n). Thus, the gradient of the Hill plot, called
the Hill coefficient and denoted nH, reflects the degree of cooperativity. Values of nH
greater than one indicates positive cooperativity in the ligand binding, whereas values
of nH less than one implies that the ligand binding is negatively cooperative. If the
value of nH is equal to one, then the ligand binding is not cooperative. Figure 1.7
shows example Hill plot’s for the binding of oxygen to myoglobin and haemoglobin.
When reducing the complexity of cooperative binding of n ligands to homotropic
allostery with two consecutive binding events of equivalent ligands, L1 and L2, the
equilibrium becomes:







Here the rate constants for binding the first ligand (L1) and the second ligand (L2) can




























Figure 1.7: Hill plots for the binding of oxygen to myoglobin (blue line) and haemoglobin
(green line). Myoglobin exhibits no cooperativity with nH = 1 due to it having a single
binding site for oxygen. The maximum value of nH for hemoglobin is nH = 3 indicating
strong positive cooperativity, however with haemoglobin’s four oxygen binding sites, it is not
perfect cooperativity. In this plot, the partial pressure of oxygen, pO2, is used rather than
the free ligand concentration [L].
each binding event are then given as:
K1a =
[PL1] + [L2]





As with a single ligand binding event, the free energy change upon binding determines
whether the binding event is energetically favourable or not. In homotropic allostery,
the difference between the free energy of binding for two consecutive binding events,
∆∆G, determines the cooperativity of the allostery:
∆∆G = ∆G2 −∆G1. (1.4.17)
Here ∆G1 is the free energy for the first binding event and ∆G2 is the free energy
for the second binding event, so each of these can in turn be written as the difference
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between the free energy of the systems before and after each binding event:
∆∆G = (GP·2L − (GP·L +GL2)− (GP·L − (GP +GL1). (1.4.18)
Here P · 2L refers to the protein with the two equivalent ligands bound, P · L refers
to the protein with just one ligand bound and P refers to the free protein. These
are frequently denoted holo2, holo1 and apo respectively and are referred to as such
throughout this thesis. In homotropic allostery, the two ligands, L1 and L2 are the
same, meaning that equation 1.4.18 can be simplified to:
∆∆G = GP·2L − 2GP·L +GP. (1.4.19)
A slightly different notation is adopted for heterotropic allostery; a protein that is
not bound to the allosteric effector is called the apo-protein whereas a protein with
the allosteric effector bound is called the holo-protein. The allosteric free energy can
then be determined by finding the difference between the free energy of binding the
substrate to the apo-protein and the holo-protein;
∆∆G = ∆Gholo −∆Gapo. (1.4.20)
For both homotropic and heterotropic allostery, if ∆∆G is negative, the two bind-
ing events are positively cooperative, meaning that the second binding event is more
favourable than the first binding event. A ∆∆G greater than zero indicates negative
cooperativity.
Another way to measure the cooperativity of binding in homotropic allostery is






where a C value greater than 1 indicates positive cooperativity and a C value less




can be related to the allosteric free energy
difference by:





Early models of allosteric signalling [34,35], explained any allosteric effects in terms
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of conformational changes of the protein. These models are described in greater detail
in sections 1.4.2. However, the free energy of binding (∆G) has an entropic contribution
(∆S) as well as the enthalpic contribution (∆H) which should really be considered due
to the thermodynamic nature of allostery; ∆G = ∆H−T∆S. Therefore, more recently
it has been accepted that a change in the dynamics of a protein (primarily entropic)
can contribute to or even drive allostery in some cases (see section 1.4.3). It has been
observed experimentally that a change in the average backbone structure of a protein
is not always necessary for allostery to occur, instead it can be solely explained by a
change in the dynamics of the protein. It was Cooper and Dryden [36] who originally
proposed a model for allosteric signalling driven by the effect of dynamics. They derived
approximate expressions, allowing the magnitude of the allosteric effect to be measured
by changes in normal mode frequencies and mean-square atomic displacements.
1.4.2 Models for Cooperative Binding
Many models have been proposed describing cooperative binding in proteins. There are,
however, two very different models, inspired by the binding of oxygen to haemoglobin,
that are widely accepted by the field.
MWC Model
The first of these two models, usually called either the MWC, or concerted model, was
developed by Monod, Wyman and Changeaux in 1965 [34]. The MWC model assumes
that the allosteric protein comprises of at least two identical subunits in identical
conformations; each with one binding site. Each subunit exists in one of two states,
however the symmetry of the protein is conserved, so although large structural changes
may occur during the transition between states, all of the subunits must undergo the
changes simultaneously. In one state, the Ti state, the binding site has a low affinity
for ligand and in the other state, the Ri state, the binding site has a higher affinity for
the ligand. The index i denotes the number of ligands bound to the protein in each
state, however the protein’s affinity for the ligand stays constant regardless of the value
of i. This model assumes that there is an equilibrium between the two forms such that
at any moment there exists a mixture of proteins with all their subunits in one of the
two states (see figure 1.8). In the the absence of ligand the equilibrium between the
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Figure 1.8: The MWC and KNF models for allostery. Adapted from [4,33,35]
two states is characterised by the equilibrium constant, L =
[T0]
[R0]
. In this model L > 1,
meaning that most molecules are in the T0 state, and the protein has a low affinity for
ligand.
The model describes cooperativity by increasing the proportion of molecules in the
Ri state as ligands bind to the subunits of the protein; a shift in the equilibrium to
favour the R form more in accordance with Le Chaˆtelier’s principle. The association
constants for the binding of one ligand to the Ti and Ri states are designated KT and
KR respectively, staying constant regardless of how many ligands are bound to the






with 0 < c < 1 and smaller values of c corresponding to stronger positive cooperativity.
When one ligand binds, the equilibrium constant between the T1 and R1 states becomes






The simplicity of this model with only two parameters L and c, means that it is best
for describing homotropic positive allostery. It is unable to correctly model negative
allostery, however the original authors suggested that heterotropic allostery could be
modelled with the same mechanism, with the allosteric effector stabilising either the T
or R states for positive or negative allostery respectively.
At the time of writing the paper was a success; the failure of the model to describe
negatively cooperative homotropic allostery was not important, as no such systems had
been observed.
KNF Model
The second model was proposed by Koshland, Nemethy and Filmer in 1966 [35]; called
the KNF model or the sequential model. This model was devised for allosteric proteins
composed of two or more subunits.
In the sequential model, each of the subunits are able to exist in one of two con-
formations, W a weak binding form, or S a strong binding form. The binding of the
ligand to a subunit induces a structural change in that subunit to the S form. Coopera-
tivity in this model arises because the pair interactions between adjacent subunit pairs
change depending on the composition of the pairs. Such that the interactions between
W-W,W-S and S-S pairs are assumed to be different. In this model, the association





The transformation constant for a subunit from W to S when the neighbouring subunits





The interaction between the subunits are represented by the constants KWS and KSS
for W-S and S-S subunit pairs respectively. From these constants and the topology
of the interactions between the subunits, the fraction of occupied binding sites, θ can
be determined. The fact this model allows different topologies of interactions to be
modelled is an advantage over the MWC model, for example besides a square topology
seen in figure 1.8 where each subunit has two neighbours, tetrahedral topologies are
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allowed where subunits each have three neighbours.
The KNF model, unlike the MWC model creates the possibility of negative cooper-
ativity by destabilising latter binding events as well as positive allostery by stabilising
the latter binding events. However, the MWC model is mathematically much simpler
with only two parameters that need to be fitted in comparison to the four parameters
along with the interaction model that need to be fitted for the KNF model. Therefore,
due to its mathematical complexity, the KNF model has not experienced the same level
of popularity as the MWC model.
Ackers Model
The cooperative binding of O2 to haemoglobin, has been a popular system for modelling
allostery. Haemoglobin is a tetramer, containing two copies of α and β subunit pairs,
which themselves are very similar. Haemoglobin is therefore often modelled as a dimer
of α-β pairs. For this example, the MWC model was shown to be insufficient when
X-ray diffraction [37–39] and NMR studies [40,41] showed the conformation of subunits
changing independently upon binding, breaking the symmetry rule of the model. In
1992 Ackers et al. summarised that the cooperative binding of O2 to haemoglobin has
similarities to both the MWC model and the KNF model, but agrees completely with
neither. A number of other models for allostery have been proposed to try to model
this effect better than the MWC and KNF models; often drawing from themes in the
MWC and KNF models [42–46].
A popular model for haemoglobin was introduced by Ackers et al. in 1992 [47] and
is displayed in figure 1.9. In this model, it is assumed that the haemoglobin tetramer
is comprised of two subunits, each with an α and a β monomer. Each monomer
(regardless of whether it is an α or a β monomer) is in the t state when no ligand is
bound and undergoes a structural change in the tertiary structure to r upon binding
the ligand. The overall quaternary structure starts in the T state when no ligands are
bound and only changes from the T to the R state once a ligand is bound to at least
one of the binding sites on each α-β pair. Hence, this model draws themes from both





















Figure 1.9: A model for allostery developed by Acker et al.. In this model, the four subunits
of the tetramer are split into α− β pairs. Each of these subunits exists in either the t state
(depicted as a green circle) or the r state (depicted as a red square). The quaternary structure
of the tetramer has two states, the T state or the R state. The tetramer exists in the T state
when no ligands are bound and only transitions to the R state when a ligand binds to at
least one subunit of each of the α− β pairs.
1.4.3 Dynamic Allostery
All of the models of allostery previously described assume that allosteric signalling is
solely caused by conformational changes caused by one or more ligands binding to the
protein. Thermodynamically, this view is a solely enthalpic view, looking only at the
strengths of interactions in the allosteric systems. However, as has previously been
discussed, ligand binding also contains an entropic term, which can equally have a role
in allosteric binding. Weber first made this point in 1972 [2], stating that proteins
constantly fluctuate between a number of conformations and the structure observed
is only the average. The importance of these conformational fluctuations in allosteric
signalling have been studied with combinations of NMR and X-ray diffraction [48–51].
There is increasing evidence that allosteric cooperativity can be communicated between
distant sites on proteins through modulation of their dynamic properties, even in cases
with no structural change between the ligand bound (holo) and unbound (apo) forms
[36,52–59].
Cooper and Dryden view of Dynamic Allostery
It was Cooper and Dryden who first identified the potential of allostery without a
macromolecular conformational change in 1984 [36], introducing a model to describe
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this dynamic allostery. They investigated the potential importance of dynamics in
allosteric signalling by evaluating the thermodynamics of ligand binding. They hy-
pothesised that changes in the amplitude and frequency of macromolecular thermal
fluctuations could generate cooperative binding free energies amounting to several kJ
mol−1. They noted that this effect can involve the entire spectrum of dynamic be-
haviour from highly-correlated low frequency vibrational modes to the local anhar-
monic motion of individual atoms or residues. Protein motions over both timescales
had been demonstrated experimentally [60–63] and theoretically [64–69] shortly before.
This view of allostery is predominantly entropic; a stark change to the previous
models which explained allostery entirely by conformational changes, a phenomenon
that is predominantly enthalpic. In this new view, Cooper and Dryden suggested that
proteins may have evolved to take advantage of these thermal motions as well as their
mean conformational states. They started by looking at the thermodynamics of protein
binding, noting an almost universal decrease in heat capacity upon ligand binding [70],
which suggests a reduction in the thermal energy fluctuations.
They therefore opted to study the canonical partition functions of the molecular









where ∆ε1 = εP + εL − εPL1 is the difference in zero point energies, corresponding to
the energy of ligand binding at 0 K. ZP, ZL and ZPL1 are the partition functions for
the free protein, the free ligand and the protein-ligand complex respectively. In the
absence of significant changes in volume, the Gibbs free energy is then:
∆G1 = −kT lnKa






The same argument can be applied to subsequent binding events to find ∆G2 and so
on. The allosteric free energy difference is then returned as:
∆∆G = ∆G2 −∆G1







For homotropic allostery in the absence of structural change, ∆ε1 = ∆ε2 as the same
molecular contacts are involved at each site.
The partition function is separable into translational, rotational, vibrational, elec-
tronic and conformational states, so Cooper and Dryden investigated each contribution.
The electronic, rotational and translational contributions were disregarded straight
away. The electronic because at ambient temperatures there are no significant elec-
tronic excitations and the rotational and translational disregarded because the size of
the protein compared to the ligand means that the terms are very similar for differ-
ent ligated states, cancelling each other out. This leaves just the contribution due to
changes in the vibrational spectrum of the system and conformational changes in the
system.






and the free energy difference associated with a vibrational frequency shift νP → νPL1 →
νPL2 during sequential binding is
∆∆Gvib = −kT (ln q(νP) + ln q(νPL2)− 2 ln q(νPL1)) . (1.4.31)
If the only modes affected by the sequential binding are high frequency modes then the
quantum partition function is essentially unity, as hν >> kT , giving non cooperative
binding (∆∆Gvib = 0). They then showed that for a low frequency global mode of
motion the allosteric free energy difference becomes






within the classical limit. They showed that if a stiffening in the protein was induced
each time a ligand bound, ∆∆G would be negative, indicating positive cooperativity.
For example if each ligand binding event increases the normal mode frequencies by 10%,
a ∆∆G of around −0.01 kT would be observed per mode. Summing over the hundreds
of low-frequency normal modes proteins have, this effect can give rise to biologically
relevant free energy changes around the order of a few kJ mol−1.
As well as the small shifts in the frequencies of normal modes that could be caused
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by ligand binding, there is also the possibility that binding could freeze out entire
global modes involving collective domain motions or even convert them to higher fre-
quency modes. This effect was hypothesised for lysozyme [71] and later demonstrated
experimentally [62,72].
They then went on to study the hypothesis that the protein wanders in a haphazard
and none periodic fashion amongst a number of conformational states, as supported by
MD [68,69]. The probability distribution of these conformational states can be used to
determine the flexibility of a protein, with wider probability distributions corresponding
to more flexible proteins. Ligand binding can then either cause a shift in the mean
of this probability distribution, corresponding to a conformational change in the usual
sense, or it can cause a change in the overall shape of the distribution. In this case,
if a narrower distribution appears due to ligand binding, this represents a stiffening of
the protein without a global structural change.
They hypothesised that if these distributions of fluctuations in coordinates for each
atom were approximated as being Gaussian in shape with a width of σ. The atomic
partition function for a Gaussian distribution about a fixed mean position is propor-
tional to the width of the distribution, σ. Therefore for homotropic allostery with two
equivalent binding sites, the contribution from atom i to the allosteric free energy is:







assuming i and i′, equivalent sites from the two chains have no difference for the apo
and holo2 forms. The σn(i) represent the root-mean-square fluctuation (RMSF) at i
when n ligand molecules are bound to the protein. In this case, a shift in the RMSF
of the order of 1% per atom, which would be difficult to observe experimentally could
give rise to cooperativity free energy differences in the order of a few kT , which again
is an entirely entropic effect.
The article was unable to make an immediate impact on the views of allostery, partly
due to the lack of experimental techniques available to observe the changes in protein
structural fluctuations upon ligand binding. It wasn’t until 1993 that thermodynamic
fluctuations were shown experimentally by NMR to contribute to the cooperative free
energy of ligand binding [73]. Since then more examples of dynamic allostery, unable
to be explained by structural changes in the classical sense have emerged, including:
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allostery without a structural pathway [74–76], changes in cooperativity due to surface
mutations that do not affect structure [77], and allostery without a conformational
change [17]. This original article and the subsequent studies of dynamic allostery has
sparked debate over the mechanism for which these dynamic fluctuations are commu-
nicated between distant allosteric sites.
Mechanisms for signalling between allosteric sites
One hypothesis, by Hilser, describes a protein as an ensemble of conformational states
[78–80]. The statistical weights are computed for each of the conformational states
in the ensemble by Boltzmann weighting the free energy of the conformation. This
hypothesis investigates how a perturbation, such as ligand binding at distant sites
can affect the cooperative network within the protein. Ligand binding is viewed to
stabilise the state which has the highest affinity for the ligand, causing changes in
the dynamics, conformational entropy or the population’s mean conformation. This
ultimate redistribution of the ensemble affects binding of another ligand, which could
be identical to the first ligand for homotropic allostery or different for heterotropic
allostery.
A second perspective is that physically connected pathways of increased (or de-
creased) thermal motions, coupled along their trajectories, connect the allosteric sites
[81–83]. In this view there are a network of spatially distributed key residues which
have cooperative interactions as a pathway for allostery or other signalling events. The
exact nature of these cooperative interactions differ from case to case, but a number
of examples with this kind of signalling have been observed, for example in G protein-
coupled receptors [84,85], in the modulation of ligand binding in PDZ domains [86] and
in controlling the catalytic rate for a number of enzymes [21, 87–89]. Protein residues
which are functionally important, such as those in an allosteric pathway, have been
observed to have co-evolved throughout the long term evolution of a protein; whereas
the majority of amino acids evolve almost independently [90–95], strengthening the
argument for allosteric pathways.
In this thesis, the hypothesis that the global collective modes are important carriers
of the allosteric signal and can act without a change in conformation is investigated.
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1.5 Catabolite Activator Protein.
The catabolite activator protein (CAP), often referred to as the cAMP receptor protein
(CRP), is an extensively studied transcription factor native to certain strains of E. coli.
CAP that has been activated by the allosteric effector cAMP is a transcription activator
for genes involved in the catabolism of lactose. In its apo form (without the ligand
cAMP bound) it is inactive, but when two molecules of cAMP bind to the dimer
(cAMP2-CAP), a change in the protein’s structure renders it active. CAP also has an
intermediate form, where one cAMP is bound to one of the subunits, while the other
subunit remains un-liganded (cAMP1-CAP).
The allosteric regulation of CAP by the effector, cAMP is an example where the
cooperativity cannot be described solely by a conformational change. It was recently
shown that a truncated form of CAP exhibited negative cooperativity without a sub-
stantial change in conformation [17].
1.5.1 CAP’s role in Catabolite Repression
When bacteria have more than one food source, for example glucose and lactose, it is
more efficient for the bacteria to use the food source that is most quickly metabolisable
to get its energy and carbon. In this example, the bacteria would preferably metabolise
glucose than the lactose. This phenomenon (initially called the glucose effect) was first
described by Monod when he observed a two stage growth of E. coli with a mixture
of glucose and lactose as the food source [96]. The bacteria is able to do this by
suppressing the genes necessary for the catabolysis of lactose. This process has more
recently been named catabolite repression.
When the concentration of glucose in the cell is high, the concentration of cAMP
in the cell decreases. This is because the presence of glucose in the cell inhibits the
production of cAMP by specific mechanisms [97,98]. Firstly, glucose inhibits the intake
of inducer molecules, which are necessary for the induction of repressed genes. One
such inducer that is believed to be excluded from the cell by glucose is a dephosphory-
lated component (Factor III) of the phosphoenol pyruvate-dependent phototransferase
system (PTS). Factor III of PTS is an activator of adenylate cyclase, which in turn is
a catalyst for the synthesis of cAMP from adenosine triphosphate (ATP), thereby the
overall concentration of cAMP in the cell is reduced [99,100].
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This means that when glucose is available to the cell, the concentration of cAMP
is low and when it is not, the concentration of cAMP dramatically increases. When
cAMP then binds to CAP it activates the protein and increases its affinity for binding
to DNA to a very large extent.
CAP acts as a transcriptional activator, it is known to bind to a promoter of the
lac operon gene as well up to 200 other promoters [101,102]. The lac operon contains
genes for three proteins (β-galactosidase, β-galactoside permease and β-galactoside
transacetylase) necessary for the catabolism and transport of lactose. When CAP
binds to the DNA it is known to bend the chain by approximately 90◦ [103]. It forms
a complex with the ribonucleic acid (RNA) polymerase, thereby allowing it to bind to
the DNA and initiate transcription of the genes in the lac operon.
1.5.2 Structure of CAP
CAP, like many prokaryotic transcription factors, exists as a homodimer with two-fold
symmetry; each subunit consisting of 210 amino acids [104]. Each subunit in the CAP
dimer consists of two domains, a C-terminal DNA binding domain (DNABD) (residues
138 to 210) and an N-terminal ligand binding domain (LBD) (residues 1 to 137) to
which the allosteric effector, cAMP, binds. A hinge region (residues 134-138) connects
the first α-helix (D-helix) of the DNABD to the last α-helix (C-Helix) of the N-terminal
domain [105,106]. The two-domain structure can easily be seen by looking at the 1.48
A˚ resolution structure of the CAP-cAMP complex, obtained by X-ray crystallography
(see figure 1.10) [59,107].
The dimerisation of CAP can be accounted for by the LBD, which is predominantly
composed of β-sheets with an antiparallel β-roll structure from residues 19 to 99 and
a large α-helix on the dimer interface. The DNA binding domain consists of three
α-helices; two of which form a typical helix-turn-helix motif. The F-helix in this motif
binds to specific sequences of DNA when cAMP is present (see figure 1.10). The
orientation of this domain is believed to be affected by the binding of cAMP to the
LBD of the protein [18,108].
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Figure 1.10: 1.48 A˚ resolution structure of CAP (PDB code 4HZF) [59], showing α-helices
as coils and β-sheets as arrows. One monomer is coloured green and blue while the other
is coloured red and orange. The DNABDs (coloured blue and orange) and LBDs (coloured
green and red) are clearly two separate subunits. The DNA recognition (F) helix is labelled.
The cAMP ligands (with a stick representation) can be seen nested in the LBD.
Structure of cAMP2-CAP
Most structural information about CAP is for the cAMP2-CAP bound state. When in
this bound state, the hinge region separating the LBD and the DNABD sits between
residues 134 and 138 and the DNABD on both monomers are oriented so that the DNA
recognition F-helices point in the correct direction to bind to DNA [109]. The DNABDs
of each subunit were observed in different orientations relative to their respective LBD
in the original crystal structure by Steitz and Weber [110]. This demonstrates the
inherent flexibility of the hinge region and the ability of the DNABD to rotate around
this hinge to a certain extent.
Two cAMP molecules bind CAP in the anti-conformation at two equivalent sites in
the LBD, one for each monomer. They sit between the β-roll structure and the coiled-
coil at the dimer interface. The cAMP molecule forms a hydrogen bonding network
within the binding site, as shown in figure 1.11. Hydrogen bonds form between the
ribose and phosphate oxygens of cAMP and residues Gly72, Glu73 and Ser84. An
additional hydrogen bond, or potentially an ionic interaction occurs between one of
the phosphate oxygens of cAMP and Arg83. At the other end of cAMP the adenine
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Figure 1.11: The binding site of cAMP in CAP (PDB code 4HZF) with the hydrogen bonds
and ionic interactions between cAMP and CAP shown.
6-amino group forms one hydrogen bond with the OH of residue Thr128 in the large
C-helix of the same chain and another with the OH of Ser129 of the C-helix in the
opposite chain [110].
Structure of apo-CAP
A number of studies of apo-CAP have shown that in the absence of cAMP, CAP
undergoes a slight shortening of the C-helices in the LBDs and a lengthening of the D-
helices of the DNABD by a similar amount. This effect has been shown in X-ray [108]
and NMR structures [111] of CAP and earlier by NMR NOESY spectra [112]. The
structures of apo-CAP show a rigid rotation and translation of the DNABD when
compared to the cAMP2 structure. For example, Kalodimos et. al [111] used NMR to
predict a rotation of roughly 60◦ and translation of 7 A˚ of the DNA binding domain
compared to the cAMP2 CAP.
Steitz et. al [108], while not giving magnitudes of rotation and translation of the
DNA binding domain in apo-CAP relative to cAMP2-CAP, showed the DNABD in
a different orientation for a 2.3 A˚ resolution structure of a D138L apo-CAP mutant.
They also provided a low resolution (3.6 A˚) structure of apo-CAP, agreeing with the
large reorientation of the DNABD seen in the mutant. They observed little difference
between the internal structures of the DNABDs of the mutant and wild-type (WT); the
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main difference being slightly different orientations of the loops near the cAMP binding
site. However, the extent to which the DNABD transformed with respect to the LBD
was different between mutant and WT. The WT structure also contained three dimers
per asymmetric unit, all of which showed the DNABD in a slightly different orientation
with respect to the LBD. Figure 1.12 shows the structural change observed by Steitz
et al. [108].
The lack of agreement between the structures in these studies suggest that the
hinge region between the LBD and the DNABD is very flexible, allowing the DNABD
to rotate and translate to a number of different preferred orientations. The rotation
of the DNABD relative to that of cAMP2-CAP in both these instances mean that the
DNA-recognition helix are not in the correct position or orientation to fit into the major
groove of the DNA. Hence apo-CAP is inactive and does not regulate transcription.
Regardless of the large structural rearrangement of the DNABD, the LBD respon-
sible for the dimerisation of CAP and the cooperative binding of cAMP undergoes very
little structural change. The main structural change observed is the shortening of the
C-helices, which are stabilised in cAMP2-CAP by the hydrogen bonds between residues
THR127 and SER128 in the C-helices and cAMP [17,18,111].
Structure of cAMP1-CAP
No crystal structures for cAMP1-CAP are available. However, there is evidence that
the structure of the full CAP dimer does not undergo major changes from the apo
form upon binding one cAMP molecule, but changes on a larger scale on binding of the
second cAMP. Investigations using Raman spectroscopy have shown that the secondary
structures of apo-CAP and cAMP1-CAP in solution have no noticeable differences
[113, 114]. Whereas cAMP2-CAP shows a 7% decrease in α-helix content and a 5%
increase in β-sheet content when compared to the secondary structure of apo-CAP. In
addition to this, investigations into the hydrodynamic properties of CAP have shown
that the stokes radius of CAP decreases by a very small amount on the binding of
one cAMP and by 2% on binding of the second cAMP [115]. The lack of a change in
structure of CAP when the first ligand binds suggests that dynamics must hold a very
important role in the allosteric regulation of CAP.
A recent NMR study, by Popovych et al. [17], of the N-terminal CAP dimer with
1.5. Catabolite Activator Protein. 31
Figure 1.12: The structures of apo-CAP (left) and holo2-CAP (right), demonstrating the
structural change of CAP when cAMP binds. (A) The structures of full length CAP. (B) The
LBDs have been excluded in these representations to emphasise the differences in orientations
of the DNABDs; the DNA recognition helice for apo-CAP is not in the correct orientation
to bind specifically to DNA. (C) Representations of just the hinge regions of one monomer.
The location of the hinge region is different for apo-CAP to holo2-CAP. Taken from [108].
the DNABDs truncated (CAPN) showed that if a ligand bound to one subunit, then the
structure of the subunit with which the cAMP was bound changed, but the structure
of the unbound subunit remained the same as apo-CAPN. The binding of the second
cAMP ligand restored the symmetry of the CAPN dimer, with both subunits having
the same conformation as the liganded subunit in the cAMP1-CAP
N complex. They
were able to show this result using a 2D-NMR technique; only one set of resonances
were present for apo-CAPN and cAMP2-CAP
N, whereas two resonances were present
for the 2D-NMR spectrum of cAMP1-CAP
N, hence the structure was only changed for
the liganded subunit.
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1.5.3 CAP with Four cAMP Binding Sites
Contrary to the view that two ligands of cAMP bind to CAP, crystal structures of a
CAP-DNA complex with four cAMP molecules bound to each CAP have been pub-
lished [116]. In addition to the two cAMP molecules buried in the N-terminus domains
in the anti -conformation, they also contain an additional two syn-cAMP molecules
bound to the surface of the DNA binding domain.
Passner and Steitz [116] postulated that the three states of CAP in its homotropic
allostery were not apo-CAP, cAMP1-CAP and cAMP2-CAP. Instead they argued
that the intermediate structure could actually be cAMP2-CAP with the two cAMP
molecules bound in the buried sites of the N-terminus. They also argued that the fully
occupied CAP was cAMP4-CAP with the two anti -cAMP bound in the N-terminus
and the two syn-cAMP bound to the surface of the DNA binding domain. There is
however no compelling experimental evidence, except for this crystal structure, that
the activated form of CAP has four cAMP molecules bound. Most experimental evi-
dence in fact points to the stoichiometry of the cAMP-CAP complex being 1:1 for the
activated complex including structures of the CAP-DNA complex [103,117,118].
1.5.4 CAP binding to DNA
Crystal structures of CAP bound to DNA show that the F-helices in the CAP DNABDs
fit into the major grooves of the DNA binding domain. This binding constrains the
DNA, causing it to bend by approximately 90◦ [103, 117] allowing RNA polymerase
to bind to the DNA and initiate transcription. A number of X-ray structures of the
complex of CAP with DNA [103, 117, 118] and CAP with DNA and the C-terminal
domain of RNA polymerase [119] show no significant conformational change in CAP
from the cAMP2-CAP form when compared to the conformational change seen between
apo and holo2-CAP.
1.5.5 Dynamic Allostery in CAP
Unlike most observed allosteric systems, the homotropic cooperative binding of cAMP
to CAP is an example of negative cooperativity [17, 25]. This makes CAP an inter-
esting protein to study because in contrast to positively cooperative systems, negative
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Figure 1.13: A representation of the effect the sequential binding of cAMP to CAP has on
the structure and dynamics of CAPN. For apo-CAPN, motions on the µs to ms time scale
are suppressed. Binding of the first cAMP does not change the structure of the subunit to
which it is not bound, but does activate motions on this time scale. Binding of the second
cAMP, suppresses the motions on all the timescales. A change in backbone conformation is
indicated by a change in the shape of the monomer. Adapted from [17].
allostery allows intermediate states to be studied in the WT protein. This was shown
to be possible in a study of allostery in the N-terminal domain of CAP (CAPN) by
Kalodimos et al., which showed a strong negative cooperativity when binding cAMP
without a structural change [17]. The measured values of the cAMP association con-
stants to CAPN in this study were K1a = 25 × 106 M−1 and K2a = 2.5 × 106 M−1,
with ∆∆G = 11.8 kJ mol−1. ITC data showed that this negative cooperativity was
entirely entropically driven, with the enthalpic term alone corresponding to positive
cooperativity.
The structural and dynamical properties of the monomers in the dimeric CAPN
were studied using NMR. They observed that the structure of cAMP2-CAP
N and apo-
CAPN were symmetric and the structure of the ligated and un-ligated monomers of
cAMP1-CAP
N had structures similar to cAMP2-CAP
N and apo-CAPN respectively.
They observed that motions on the microsecond to millisecond timescale not observed
in apo-CAPN were activated in both monomers upon binding the first ligand. Upon
binding the second ligand, a tightening of the entire protein occurs, with motions
on the microsecond to millisecond and the picosecond to nanosecond timescale were
suppressed. Figure 1.13, demonstrates the changes in structure and dynamics observed
in the study.
As the binding of the first cAMP did not cause a change in the mean conformation
of the second ligand binding site they concluded that the negative allostery observed
in CAPN was driven by changes in protein dynamics upon ligand binding. There is
however, no such mechanistic description for how cooperative binding can occur in the
full-length protein.
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A number of experimental techniques , such as ITC, have been used to study the
thermodynamic parameters of the cooperative binding events in full-length CAP. These
have shown negative cooperativity in most instances although not to the extent seen
in CAPN [59, 120–124]. This weaker negative cooperativity unfortunately means that
studies isolating cAMP1-CAP are much less likely to be possible for full-length CAP
than for the truncated form. Interestingly, there is evidence that the cooperativity of
cAMP binding is dependent on the ionic strength of the solution. Takahashi et al. [120]
found that increasing the concentration of KCl switched the cooperativity from being
negative at low concentrations to being strongly positive at high concentrations.
Toncrova and McLeish recently developed a coarse grained model for allosteric
protein homodimers and applied this model to the cooperative binding in CAP [54,
55]. They modelled the motions in the protein homodimer as a single slow harmonic
breathing mode for each subunit. Each slow mode was also coupled to a number of
localised fast modes.
They assumed that the binding of a cAMP molecule scaled the spring constant of
the slow mode of local subunit by a factor, β, and the coupling between the subunits
by a different factor, α. Hence, binding of the second cAMP did the same for the
other subunit (meaning the spring constant coupling the two monomers was scaled by
α2). They were then able to show that the cooperativity of binding could be changed
from negative to positive by adjusting the spring constant of the breathing modes, the
coupling spring constant between the subunits and the factors by which the binding of
cAMP affects the spring constants. The theory behind this model is discussed further
in section 2.4
1.6 Outline of the Current Work
This thesis explores the hypothesis that changes to global low frequency fluctuations
of the protein carry an allosteric signal in CAP. This is approached with the fol-
lowing structure. Chapter 2 introduces the basic theory behind the computational
methods used, such as MD, normal mode analysis (NMA) and principal component
analysis (PCA). Likewise, chapter 3 explores the experimental techniques, ITC and X-
ray crystallography, used in this thesis to study protein structure and thermodynamic
properties.
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Chapter 4 explores this hypothesis by using a variety of coarse grained methods
in an attempt to reduce the complexity of the system and explore the possibility of
manipulating the allostery in CAP. Chapter 5, complements the previous chapter by
studying the allostery in CAP using atomistic modelling techniques such as MD to
validate the coarse grained models and investigate potential pathways for the allosteric
signalling. Chapter 6 is the experimental chapter with results and discussion from
experiments to support the computational results in the previous two chapters, inves-
tigating both the structure and thermodynamics of CAP during these allosteric events.
These chapters are followed by conclusions and closing remarks.
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A range of computational techniques are available for studying the dynamics of biomolecules.
The techniques used in this thesis range from atomistic modelling to coarse graining
the protein to reduce the degrees of freedom of the protein as much as possible. In this
chapter, these techniques are introduced and the theory behind them discussed.
2.1 Molecular Dynamics Background and Theory
MD is a very powerful tool for modelling atoms and molecules (in this case biomolecules)
and studying their movement [125]. To run any MD simulation, two things are neces-
sary. First a molecular model is needed: This consists of the coordinate positions of
the atoms in the system and information about which atoms are bonded to each other.
Secondly, a mathematical model of the interactions between atom pairs, termed a force
field, is needed (see 2.1.1).
For large biomolecules such as proteins, it is not possible to predict their tertiary and
quaternary structures using purely computational techniques, so the input coordinates
are taken from crystal structures that are determined experimentally.
Using the force field, it is then possible to calculate the force acting on each indi-
vidual atom (at any point in time and with any initial velocity) by the relationship:
Fi(t) = −∇riV, (2.1.1)
where Fi gives the total force acting on atom i, ri represents the atom’s Cartesian
coordinates and V is the potential energy of the system. Using Newton’s laws of
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From integration of the acceleration with respect to time, it is then possible to
calculate the velocities and positions of the atoms after discrete time steps (see 2.1.2).
Repeating this process allows one to build a trajectory, describing the positions, veloc-
ities and accelerations of the individual atoms in the system as a function of time.
2.1.1 Force Fields
As mentioned above, a force field is a potential energy function characterising the
pairwise interactions of the atoms in the system. There are two main types of force
fields used in MD simulations. These are all atom (AA) force fields, which treat every
atom individually; and united atom (UA) force fields, which group non-polar hydrogen
atoms with the heavier atom to which they are bonded, treating this group as a single
“united atom”. [126,127]
A typical force field, such as the one in equation 2.1.3 (the AMBER force field) is
made up of four terms, the first three terms being bonded terms and the fourth being
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The first term in the potential function describes bond lengths as harmonic springs
with spring constant Kr and a deviation from the equilibrium bond length (r0) of
(r − r0). The bond angles are also described by a harmonic function (second term)
with Kθ representing the bending force constant and (θ − θ0) giving the deviation of
the bond angle from the equilibrium angle, θ0. The third term gives the potential
energy associated with the dihedral angles in the system. Here, vn/2 is the force
constant, φ is the dihedral angle and δ gives the phase angle. The fourth term in
the potential function contains both a Lennard-Jones potential modelling the Van der
Waals interaction and the electrostatic term given by Coulomb’s law. In this term,
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Aij and Bij are parameters in the Lennard-Jones potential that describe the strength
and repulsion between pairs of non-bonded atoms, qi and qj are the partial electronic
charges of atoms i and j, and Rij is their interatomic distance.
Other terms can sometimes be added to the force field, to model hydrogen bonding
in the system, polarisation terms or implicit water (see sections 2.1.10 and 2.1.11).
2.1.2 Molecular Dynamics Integrators
For a molecular dynamics simulation, a potential function, V (ri) (section 2.1.1) deter-
mines the interactions between the particles of an N particle system with coordinates,
ri. The force acting on atom i is then given as [128]:
Fi = −∂V (ri)
∂ri
. (2.1.4)
This force can be used with Newton’s equations of motion for a system of N particles
(equation 2.1.2) along with initial conditions to solve the acceleration, r¨i(t), of particle
i. Subsequently, the velocity, r˙i(t), and the future position, ri(t+ δt), of particle i can
be calculated by solving these coupled ordinary differential equations.
Solving these ordinary differential equations is achieved through finite difference
methods. The molecular dynamics integrator defines the form and method of the finite
difference equations used. For an integrator to be successful, a number of conditions
need to be met. Firstly, at the limit of the step size, ∆t→ 0, the integrator should re-
produce the original differential equations and should reproduce the analytical solution
to a tolerable accuracy at more reasonable time steps. It should also be efficient, so
larger time steps can be used and computational time can be reduced. The algorithm
for an integrator also needs to be time reversible to mirror Newton’s equations. Finally,
the volume in phase space and the total energy of the system need to be conserved
throughout the simulation.
Verlet Algorithm
The Verlet algorithm [129] returns the position of atom i, at time t+ ∆t by summing
the Taylor expansions of r(t−∆t) and r(t+ ∆t) at time t and rearranging, to give:
ri(t+ ∆t) = 2 ri(t)− ri(t−∆t) +m−1i Fi(t)(∆t)2 (2.1.5)
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Therefore, for each step, the position, ri(t), and force, F(t), at time t and position
ri(t−∆t) at time t−∆t, are needed to calculate the position ri(t+∆t), at time t+∆t.






This algorithm encounters a problem at t = 0, where the position at −∆t is required.
The solution to this problem is either to use a Taylor expansion about r(t), or to use
a different algorithm for the first time step.
Leapfrog Algorithm
The leapfrog algorithm is algebraically equivalent to the Verlet algorithm, however it
makes adjustments to how some of the quantities are calculated [128]. This algorithm












step velocities are subsequently used to calculate the positions at the next full time































The AMBER simulation package [130] uses an algorithm similar to the leapfrog
algorithm, however it is more complicated due to the use of bond length constraints,
thermostats and barostats.
2.1.3 Energy Minimisation
The crystal structure of a protein taken from the PDB can safely be assumed to be at
a local free energy minimum. However, the size of hydrogen atoms and their ability to
diffract X-rays is normally not sufficiently large for their positions to be resolved. The
positions of the hydrogens are therefore included by a computer program that adds
them using typical bond length and angles for amino acid residues. This can lead to a
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few bad contacts between atoms appearing close together in the resulting 3D structure.
When combined with a knowledge that the force field used (although parametrised by
experimental data) does not model all of the interactions completely accurately, one
can safely assume the starting protein structure will not be in a local minimum of the
force field. This creates a need to minimise the energy of a starting protein structure
prior to the an MD simulation to remove any high energy contacts, which would have
lead to failure of the simulation.
A number of algorithms can be employed to perform the energy minimisation such
as a steepest descent algorithm, a conjugate gradient algorithm [131] or the L-BFGS
algorithm [132]. A minimisation can either be run for a chosen number of steps or until
the force acting on an atom is less than a chosen tolerance for all atoms in the system.
Steepest Descent
Steepest descent minimisation works on the principle that a function, V (x), decreases
fastest at a point a in the direction of the negative gradient of V , −∇V (a). So a path
to a local minimum can be found by the algorithm:
xn+1 = xn − γn∇V (xn), n >= 0 (2.1.9)
for small enough values of γn, such that V (xn) >= V (xn+1). The value of γn is variable
upon each iteration, so eventually convergence to the local minimum will be achieved.
One limitation of steepest descent minimisation is that convergence can be slow
when ∇V is very small, for example when the system is close to a local minimum.
Conjugate Gradient
The conjugate gradient method is an iterative method for solving systems of linear
equations that is frequently used to minimise functions [131]. With the conjugate
gradient method it is possible to minimise a system with an N × N sparse system
matrix in a maximum N steps when there are no rounding errors. This method starts
with an initial estimate, x0, of the minimum. Successive new estimates, x0, x1, x2... of
the minimum are made, such that each estimate xi is closer to the minimum than xi+1.
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Figure 2.1: Graphical representation of periodic boundary conditions in a two dimensional
system. The illustration shows a snapshot of the whole system and the movement of the red
particle during the next time step. A (yellow) cut-off radius is shown around the red particle
in the blue central box. This particle interacts with any particle whose centre of mass falls
within this radius, whether it is in the same box or across the periodic boundary. [128]
L-BFGS Minimisation
The limited memory Broyden-Fletcher-Goldfarb-Shanno algorithm (L-BFGS) is a quasi-
Newton method for minimisation of a multivariable function. L-BFGS implicitly ap-
proximates the inverse Hessian matrix, using vectors. It then uses this Hessian ap-
proximation to steer the search through variable space for the local minimum. The
L-BFGS method stores the positions and gradients calculated for a number of previous
steps, which are used to implicitly guide the implicit inverse Hessian search of variable
space.
2.1.4 Periodic Boundary Conditions
Periodic boundary conditions are used for molecular dynamics simulations of proteins
that use explicit water. For periodic boundary conditions, the simulation box is sur-
rounded by images of itself; particles near one face of the box interact with particles
near the opposite face of the box. Also, if a particle leaves the simulation box at one
side, it will instantaneously enter the box at the opposite side, keeping the number of
particles in the simulation box constant (Figure 2.1)
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The reason for using periodic boundary conditions is to ensure the atoms at the
edge of the box undergo the same interactions as those in the centre of the box and
that the particles in the box do not run off into the space surrounding it.
The word ’box’ has been used to describe the shape of the repeating unit for the
periodic boundary conditions. It can in fact be any shape that can tessellate perfectly
in three dimensions such as a cube or a truncated octahedron.
2.1.5 Ensembles
There are a number of thermodynamic ensembles that can be used to derive the prop-
erties of thermodynamic systems in equilibrium [133]. Without temperature and pres-
sure regulation, molecular dynamics simulations would naturally be performed in the
microcanonical ensemble (NV E) of microstates, assuming no loss of precision. This
ensemble has a constant number of particles (N), constant volume (V ) and constant
system energy (E). However, this ensemble does not match the conditions that most
experiments are performed in, so instead MD simulations can be performed in a num-
ber of different ensembles which better match experimental conditions using devices
such as temperature and pressure regulation (described in sections 2.1.6 and 2.1.7 re-
spectively).
One such ensemble is the canonical ensemble (NV T ), which has a constant number
of particles (N), constant volume (V ) and constant temperature (T ). The characteristic
state function for this ensemble is the Helmholtz free energy, A = −kBT lnZ(N, V, T ),
where Z(N, V, T ) is the canonical partition function. In this thesis, this ensemble is
used during the temperature equilibration stage of the molecular dynamics simulations.
The volume is kept constant by not allowing the volume of the periodic box to change,
whereas the temperature is controlled by using a weak coupling thermostat as described
in 2.1.6.
Another ensemble is the isothermal-isobaric (Gibbs) ensemble (NPT ), where both
the pressure and temperature have specified average values and the number of particles
is fixed; the volume of the system is allowed to fluctuate. The characteristic state
function for this ensemble is the Gibbs free energy, G = −kBT lnZ(N,P, T ). For this
thesis this ensemble is used for all production run MD simulations.
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2.1.6 Thermostat
To regulate the temperature of MD simulations a thermostat is needed. Thermostat
algorithms are modifications to the Newtonian MD scheme which scale the velocities
of the molecules in the system so that the average kinetic energy of the system matches
that of the system at a target temperature [133]. Thermostat algorithms modify New-
ton’s second law (equation 2.1.2) to
r¨i(t) = m
−1
i Fi(t)− γ(t)r˙i(t), (2.1.10)
introducing a pseudo friction coefficient γ(t). A positive value of γ(t) indicates heat
being drawn from the system into the heat bath, whereas a negative value indicates heat
flowing in the opposite direction. This thermostat, however does not take the stochastic
nature of thermal fluctuations into account so should not be used in a stochastic MD
simulation.
The thermostat used in the MD simulations presented in this thesis, the Langevin
thermostat, makes a few changes to equation 2.1.10, which becomes
r¨i(t) = m
−1
i Fi(t)− γi(t)r˙i(t) +m−1i Ri(t). (2.1.11)
In the Langevin Thermostat algorithm the atomic friction coefficient, γi(t) is positive
definite, hence it draws heat from the system. A stochastic force, Ri is introduced,
giving heat to the system. This stochastic force is uncorrelated with the previous




= 2 miγikBT0, (2.1.12)
where T0 is the target temperature for the simulation. The stochastic force is also
independent for each atom, Cartesian coordinate axis and time step.
2.1.7 Barostat
In constant pressure simulations such as the NPT ensemble, a barostat is needed to
regulate the pressure. This barostat adjusts the volume of the unit cell at each time-
step to make the observed pressure of the system approach the target pressure. The
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barostat used is a weak coupling barostat, called the Berendsen barostat [134]. The




(Ek − Ξ), (2.1.13)






rij · Fij. (2.1.14)
Here rij = ri− rj and Fij is the force from particle i acting on particle j. The barostat
scales the distances between particles, rij, which in turn scales the internal virial and
the pressure of the system.
2.1.8 TIP3P water model
TIP3P is a model to explicitly express water in molecular dynamics simulations [135,
136]. Three point water models, such as TIP3P, represent water as a rigid molecule
with fixed bond lengths and angles. Each water molecule has three interaction sites,
corresponding to each of the three atoms in a water molecule. The potential function














where i and j are the charged sites on m and n. As with the force field in equation
2.1.3, A and B are the Lennard-Jones parameters, qi are the partial charges and rij
is the distance between charged sites. The distance between oxygen atoms of any two
molecules of water is also given as rOO. For TIP3P water these parameters are given
in table 2.1 along with the geometry used for a water molecule.
Using rigid water molecules such as TIP3P speeds up MD simulations as bonded
terms do not need to be calculated. Using a three point water molecule such as TIP3P
also benefits from a reduction in the calculation time when compared to 4-site (TIP4P)
or 5-site (TIP5P) water models. These reductions in calculation time are significant
when a large number of water molecules are simulated, such as in biomolecular simu-
lations. Hence, the TIP3P water model was used for the simulations in this study.
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Parameter Value
r(OH) / A˚ 0.9572
∠HOH / deg 104.52
A× 10−3 / kcal A˚12 mol−1 582.0
B / kcal A˚6 mol−1 595.0
q(O) -0.834
q(H) 0.417
Table 2.1: Geometry and parameters used for the TIP3P water model.
2.1.9 SHAKE Bond Length Constraints
SHAKE is an algorithm used in MD to constrain the length of certain bonds during
the simulation [137]. Using SHAKE during MD simulations allows longer time steps
to be used as the size of the time step is determined by the fastest motion in the
system, which in an unconstrained simulation is bond stretching. Using longer time
steps in turn increases the total time a simulation can be run for. For the molecular
dynamics simulations in this thesis, SHAKE bond length constraints are used for all
bonds involving hydrogen, therefore a timestep of 2 fs is employed.
2.1.10 Poisson-Boltzmann Implicit Solvent Model
Poisson-Boltzmann (PB) solvents are frequently used to model the effect solvation
has on the electrostatic interactions and have been shown to reliably reproduce the
energetics and conformations of a variety of systems compared to explicit solvents
[130, 138]. PB implicit solvent models describe all solvent and dissolved salt as a
continuum, while representing the solute as a dielectric body with a shape defined by
the coordinates and cavity radii of its atoms [139]. An electrostatic field in the solvent
and the solute region is created by point charges at the atomic positions of the solute
and is computed by solving the PB equation [140,141]:
∇ · [ε(r)∇φ(r)] = −4 piρ(r)− 4 piλ(r)
∑
i
zici exp (−ziφ(r)/kBT ) . (2.1.16)
Here, ε represents the position dependent dielectric constant, φ(r) the electrostatic
potential, ρ(r) the solute charge, zi the charge of ion type i, ci the bulk number of
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ion type i and λ(r) the Stern layer masking function, determining the accessibility of
position r to the ions in solution. In assisted model building with energy refinement
(AMBER) the PB equation is solved using a finite difference approach on a numerical
grid.






qi (φsol(ri)− φvac(ri)) , (2.1.17)
where φsol and φvac are the electrostatic potentials of the solute partial charges (qi) in
implicit solvent and in vacuum respectively.
2.1.11 Generalised-Born Implicit Solvent Model
Due to the computational cost of solving equation 2.1.16 for the PB implicit solvent
model, often an approximation called the Generalised-Born (GB) implicit solvent model
is used [130,142,143]. This method models the atoms in the protein as spheres of radius
Ri (the effective Born Radii). The dielectric constant inside these spheres is 1 and the
dielectric constant outside matches that of the target solvent (80 for water at 300
K). For the GB model to be successful the effective Born radii need to be accurately
estimated [142].















Here the Ri and Rj are the effective Born radii of atoms i and j and rij the distance
between them. The Debye-Huckel screening parameter, κ, introduces the electrostatic
screening effects of salt [144], while fGB is a smooth function, which makes the GB








although it can be defined in other ways [142,145].
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2.1.12 Nonpolar implicit solvent models
The nonpolar (NP) component of the free energy of solvation is often estimated using
the solvent accessible surface area (SASA) [146,147]. This model yields a nonpolar free
energy of:
∆Gnp = γ · SASA + c, (2.1.20)
where γ is the surface tension coefficient and c is the free energy of solvation for a point
solute (i.e. when SASA=0).
Recently, a few studies have shown that the NP solvation free energy is better
approximated by splitting it into an attractive and a repulsive part [130, 148, 149],
∆Gatt and ∆Grep, such that;
∆Gnp = ∆Gatt + ∆Grep. (2.1.21)
In one such model, proposed by Tan et al. the repulsive contribution is modelled with
SASA
∆Grep = γ · SASA + c (2.1.22)
and the attractive contribution can be approximated by the van der Waals attractive
interaction between the solvent (v) and solute (u):
∆Gatt ≈ 〈Uuvatt〉 (2.1.23)
as was first observed by Chandler et al. [150, 151]. The solute-solvent van der Waals






Here, ρaw(raw) is a solvent distribution function around solute atom a, raw is the solvent
distance and Vatt(raw) is the attractive van der Waals potential. The sum is over all of
the solute atoms, Ns, and the integration is over the volume occupied by the solvent.
Equation 2.1.24 is often simplified further, by approximating ρaw(raw) as a constant
density distribution.
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2.2 Normal Mode Analysis
A normal mode of vibration of a protein involves an oscillation of the atoms in the
protein. In a normal mode, all of the atoms vibrate at the same frequency and in
phase. For proteins the normal modes that are believed to be most important for
protein function are the low frequency vibrations, which cause the largest deviations
in the protein structure and have the largest contributions to the heat capacity and
entropy.
NMA is a technique that can often probe the large structural rearrangements of
proteins better than MD, due to its ability to identify motions on slow time-scales. It
is less computationally expensive in terms of CPU time than MD, but more costly in
terms of the memory required.
NMA finds the normal modes of a protein at a local minimum on its potential
energy surface. In NMA, a couple of approximations are made; firstly that the protein
cannot cross energy barriers to another local minimum and secondly that the shape of
the energy well can be approximated as a harmonic potential.
In NMA the conformation of a system containing N particles is described as a
3N -dimensional position vector,
q = (x1, y1, z1, ..., xN , yN , zN)
T . (2.2.25)
The harmonic approximation looks at small displacements of the particles from their
equilibrium conformation, q0, where the net force acting on all N particles in the
system is zero.
Consider first the Taylor expansion of the potential energy V (q) about a minimum.
[152–154]



















(qi − q0i )(qj − q0j ) + ... (2.2.26)
Here, i and j represent N 3D coordinates for the particles. The potential energy
function used can be any potential energy function, such as the one used in MD (see
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equation 2.1.3), as long as it is at a minimum. By definition, at a local minimum, the
first derivative of the potential is equal to zero, so this term in the expansion of the
potential disappears. The first term of the Taylor expansion can also be set to zero by
studying the potential relative to this minimum potential. If we say the displacement

















Where H is the 3N × 3N Hessian matrix given by the Laplacian of the potential,
∇2V (q), containing the force constants between neighbouring particles. The velocities
of the particles are then given by:
q˙i = dqi/dt = d(∆qi)/dt = ˙(∆qi). (2.2.28)
It is possible to solve the equations of motion of the system by looking at the kinetic














Here mij gives the elements of the N ×N diagonal matrix, M, containing the masses
of the particles; each mass repeated three times due to its three Cartesian coordinates.





















M ¨(∆q) + H∆q = 0. (2.2.31)
The modes of motion for the system, represented by uk, are 3N-dimensional vectors
2.2. Normal Mode Analysis 53
that are solutions to equation 2.2.31:
uk = ak exp(−iωkt). (2.2.32)
Where for each mode of motion, ωk is the angular frequency and ak is a complex vector








which can be expressed in matrix form as
HU = MUΛ (2.2.35)
where U is the 3N × 3N matrix. Each column is a solution, uk, and Λ is the diagonal
matrix with the diagonal elements λk = ω
2
k. Converting the solutions of the equation
of motion uk into mass-weighted coordinates (by mass-weighting the Hessian (H˜ =
M−1/2HM−1/2)) is then possible, giving the solutions u˜k = M1/2uk, which are the
normal modes of the system. Each u˜k is the eigenvector for normal mode k (where
k = 1, ..., 3N) and each λk is the frequency of the normal mode squared.
For systems where every particle has the same mass, m, the mass matrix, M,
becomes the identity matrix multiplied by m. So in this case, the eigenvector for the
normal mode is scaled by the square root of m, such that u˜ =
√
mu.
2.2.1 Atomistic Normal Mode Analysis
Atomistic normal mode analysis uses an AA force field, as is seen in equation 2.1.3 as
the potential for which a harmonic approximation is found. In this case, the particles
mentioned in section 2.2 are the atoms of the protein, so if the protein has N atoms
the Hessian matrix created from its potential is of size 3N × 3N . NMA needs to be
performed at a local minimum, and the tolerance for it being performed away from
this minimum is very low (the maximum force acting on any atom shouldn’t exceed
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around 0.001 kJ mol−1 nm−1) [155]. Therefore, before it can be performed a rigorous
L-BFGS minimisation (see 2.1.3) is performed to obtain a local energy minimum for
the force field used [132].
A draw-back for using atomistic NMA is that it can be computationally expensive
in terms of memory. The memory needed to perform a fully atomistic normal mode
analysis is proportional to N2 for a macromolecule with N atoms. To reduce the
amount of memory needed for normal mode calculations, force fields where bond lengths
and bond angles have been fixed can be used [65]. Elastic network models were later
introduced, reducing the memory needed further [156].
2.2.2 Elastic Network Model Background and Theory
An elastic network model (ENM) is a simplified model for computing the normal modes
of a macromolecule. The simplicity of ENMs means that computational cost is greatly
reduced; hence the normal modes of much larger molecules can be computed.
The first ENMs, inspired by the work of Tirion [156], modelled the protein’s struc-
ture as a network of point masses connected by simple Hookean spring potentials for
point mass pairs separated by a distance less than a specified cut-off rc. Tirion no-
ticed that using this potential, the low frequency normal modes were insensitive to
small changes in protein structure, therefore it was safe to assume that the experimen-
tal crystal structure was a local minimum. This removed the need for minimisation,
which is necessary for fully atomistic normal mode analysis.
The simplest ENMs, such as the Gaussian network model (GNM) and the anisotropic
network model (ANM) use one point mass per amino acid located at the position of
the Cα atoms and use the same spring constant between all connected amino acid
pairs [157–160]. There are ENMs that use more complex potentials however, such as
Hinsen’s model, which uses distance dependent spring constants [161,162].
2.2.3 Gaussian Network Model
In the GNM it is assumed that the position of the point masses undergo Gaussian
distributed fluctuations around the equilibrium position, [157,158] inspired by Flory’s
theory of polymer networks [163]. The potential used in the GNM is given by






















nodes i and j. Rij is the instantaneous distance vector between the position vectors, Ri
and Rj and ∆Rij is the difference between the equilibrium and instantaneous distance
vectors between node pair i and j. Also, γij is the spring constant between nodes i and
j, but this is usually treated as a constant γ between all node pairs that are within the
specific cutoff distance Rc.
For the GNM the fluctuations of the Cα positions and their cross-correlations are
controlled by the N ×N Kirchoff or connectivity matrix, Γij, defined as
Γij =

−1 for i 6= j, and Rij < Rc
0 for i 6= j, and Rij > Rc
−∑k,k 6=i Γik for i = j.
(2.2.37)
Here, the Kirchoff matrix multiplied by γ is the counterpart of the Hessian matrix, so
diagonalisation gives N eigenvalues and eigenvectors. In this instance the eigenvectors
are one dimensional distance vectors meaning it is not possible to obtain information
describing the 3-dimensional directionality of motion using the GNM. However, they
still provide very useful information about the normal modes of macromolecules. For
example, the inverse of the Kirchoff matrix can be used to see the correlation between
fluctuations ∆ri and ∆rj







A web server called El Nemo that allows a user to submit protein coordinates in a
PDB file and runs the GNM on the protein is available [164].
2.2.4 Anisotropic Network Model
The anisotropic network model succeeded the Gaussian network model, incorporating
3D directions of the fluctuations of proteins [159, 160]. The ANM, like the GNM,
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usually uses the positions of the Cα atoms as the positions of the nodes in the network





(Rij −R0ij)2 Rij ≤ RC
0 Rij > RC
. (2.2.39)
In this case, the instantaneous distance vector, Rij, is in one of the three directions
in the 3D space such that the position of every node is described by three distance
vectors. This is of course the same for the equilibrium position, R0ij, and the difference
between the two, ∆R0ij. The spring constant between pairs of nodes, γij, is usually
treated as a universal spring constant, γ, for all node pairs. The Hessian matrix, H,
for a system of N nodes is then made up of N ×N off diagonal 3× 3 sub-matrices of
H, which take the form




































As illustrated in section 2.2, the equations of motion for this Hessian are solved to
calculate the normal modes.
A web server utilising the anisotropic network model is available [165]. A user can
submit a PDB file containing a protein’s coordinates to this server and the server will
run the ANM on the protein.
The elastic network model used in this study has the same potential function as
the ANM, however the Hessian matrix is mass-weighted before diagonalisation, using
the mass of the residue as the Cα mass [156].
2.2.5 Rotational-Translational Block Model
The rotational-translational block (RTB) method for normal mode analysis treats a
protein as a sequence of nb rigid-body blocks of consecutive amino acids. The rigid-
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body blocks can be made of one, or a few consecutive residues [166]. Each block is
allowed six degrees of freedom, three rotational and three translational when calculating
the normal modes.
To do this the 3N × 3N Hessian matrix, H, is projected into a 6nb × 6nb Hessian,




where P is a 3N × 6nb matrix, whose columns contain the vectors associated with the
local translations and rotations of each block. The eigenvectors, U, associated with
the normal modes are then given by:
U = PUb. (2.2.43)
Here, the rows of Ub are the eigenvectors of the projected Hessian, Hb. The frequencies
of the modes are the eigenvalues of Hb.
2.3 Principal Component Analysis
Principal component analysis (PCA) is a technique applied in the post-processing of an
extended MD trajectory [167–170]. This method, originally proposed by Karplus and
Kushick [167], allows one to study functionally important modes of motion, without
the need to make the assumption that the system is harmonic. These important modes
are found for a macromolecule of N atoms through diagonalisation of the 3N × 3N
covariance matrix, defined as
σij = 〈(qi − 〈qi〉) (qj − 〈qj〉)〉
σ =
〈
(q− 〈q〉) (q− 〈q〉)T
〉
, (2.3.44)
where q is the 3N -dimensional vector describing the macromolecule’s atomistic coor-
dinates. 〈 〉 denotes an average over time, such that 〈q〉 is the average coordinates for
all the snapshots in the MD trajectory. The covariance matrix is mass-weighted using
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the mass matrix [171,172], M,
σ˜ = M1/2σM1/2, (2.3.45)
which ultimately gives a more accurate description of the modes. The same analysis
with a non-mass-weighted covariance is called Quasiharmonic analysis. σ˜ is a symmet-






Again, the full motion of the system is approximated to a harmonic motion, with
eigenvectors, u, that describe the principal modes of motion for the system. The
eigenvalues 〈Q2ii〉 are the classical variances for the resulting new coordinates, Qi. Here,
larger eigenvalues correspond to larger fluctuations in the systems structure. Depending
on the methodology used, the first six modes can be rotational and translational modes,
as is the case for NMA. If this is the case, they are ignored when calculating the entropy.
It is possible to determine the frequency, ωi, of mode i by extending the harmonic
















Here, Pi represents the momentum of the mode. Thermodynamic averages of function,
X of Qi and Pi can be computed by the equation:
〈X(Qi, Pi)〉 =
∫ ∫






















Treating the system as a harmonic oscillator, however, does not take into account
that some of the motions observed in a molecular dynamics simulation may be caused
by random diffusion. Methods for identifying whether modes are a consequence of
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random diffusion are discussed in section 2.5 along with other methods for analysing
normal modes from PCA and NMA.
2.4 Super Coarse Graining Proteins Background
and Theory
The secondary structures of proteins such as α-helices and β-sheets often create regions
of greater rigidity (than the rest of the protein), connected by short residue chains that
create, what can be described as a hinge. Hawkins and McLeish suggested a coarse-
grained (CG) model, treating these rigid bodies as solid objects coupled together by
Hookean springs. This is mathematically equivalent to representing the protein as a
small number of point masses coupled by springs. Therefore, it is a simple model of the
protein undergoing coupled oscillations [56, 57]. Toncrova and McLeish later applied
this method to protein homodimers, taking CAP as the example system [54,55].
These CG models (termed super coarse grained (SCG) models) assume that the
minimum energy of the system occurs when none of the elements of the system undergo
any displacement, x = 0. A force (or elasticity) matrix, K, is then built for the system
of coupled oscillators, whose elements are related to the spring constants in the CG
model.
The energy of the CG model (regardless of the exact model) can then be expressed





x˙TMx˙− xTKx) . (2.4.50)
Here x is the vector showing the displacement of the rigid domains from equilibrium
and x˙ is the velocity vector. M is the inertia matrix. For the model of ligand binding,
it is assumed that the changes in mass are negligible, so the term containing the inertia
matrix is ignored.
By comparing this Lagrangian to the one in section 2.2, one can see that the
elasticity matrix is analogous to the Hessian matrix for the system. Therefore the
slow vibrational modes can be solved in the same way as described in section 2.2,
ignoring the mass-weighting of the system. The free energy and entropy of the system
can then either be computed as described below.
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Figure 2.2: The CAP CG model devised by Toncrova and McLeish [54, 55]. In this picture,
the crosses represent the CAP monomers as hinged rods and the fine jagged lines represent
the springs connecting the rods. k is the internal spring constant of each subunit and kc is
the coupling spring constant between the subunits and (x1, x2) represents the displacement
of the two monomers. The binding of cAMP to a monomer scales kc by α and k for the
bound monomer by β. Taken from [54].
It is possible to calculate the partition function, Z, for the system using the theorem







where n is the number of coordinates in the system and |K| is the determinant of K.
The conformational free energy is then
Gconf = −kBT lnZ = 1
2
kBT ln |K|+ C (2.4.52)




− 2Gcholo1 +Gcapo. (2.4.53)
Where Gcholo2 , G
c
holo1
and Gcapo represent the conformational free energy for a doubly









Toncrova and McLeish, applied a CG model to the allostery of CAP [54,55]. They
modelled each subunit of the CAP dimer as solid rods, connected by springs with spring
constant k, to make a ‘scissor’ domain. The two subunits were fixed in space at their
hinge and were also coupled together by a spring constant kc and the displacement
2.5. Analysis of Normal Modes and Principal Components 61
of the rods from equilibrium is given by the vector x = (x1, x2) (see figure 2.2). The
elasticity matrix, K, is then built by looking at the springs that displacements along
the directions in x are coupled to, and is given as:
K =
 k + kc −kc
−kc k + kc
 . (2.4.55)
One pitfall of this model is that it allows only 2 degrees of freedom, because it allows no
change in the centre of mass of the monomers. This results in only 2 normal modes; one
in phase motion where both scissors open simultaneously and one out of phase motion,
where one scissor opens while the other closes. Another weakness is that it models each
monomer of CAP as a single scissor domain, however the flexibility between the LBD
and the DNABD suggests that a model with two scissor domains to each monomer
would perhaps model CAP more accurately. This new model would therefore imply
that the model by Toncrova and McLeish models just the LBDs of CAP.
The work in chapter 4 of this thesis, will expand on the work by Toncrova and
McLeish, tackling some of the issues with the model mentioned above.
2.5 Analysis of Normal Modes and Principal Com-
ponents
The modes of motion of a protein as calculated by techniques such as NMA and PCA
are characterised by a set of eigenvectors, which define the shapes of the normal modes
and a set of eigenvalues, which contain information about the frequency of the motion
in the case of NMA or the magnitude of the motion in the case of PCA. There are
a number of techniques for analysing the shape of the normal modes of motion. The
techniques used in this thesis are described in this section.
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2.5.1 B-factors
It is possible to calculate the B-factor (Bi) of an atom i in a system from its normal









Where u2i (v) is the normal mode vector and ωv is the frequency of the normal mode.
The sum is performed over a set of normal modes, usually less than the total number, as
the higher frequency modes contribute much less to the B-factor than the low frequency
modes.
2.5.2 Cross Correlation
The cross correlation, Cij, shows whether or not atoms i and j move in similar directions









A value of Cij = 1 signifies that the motion of atoms i and j is perfectly correlated,
whereas Cij = −1 signifies perfectly anti-correlated motion. The cross correlation is
therefore useful for identifying regions of the protein that undergoes correlated motion.
When two different modes, u(v) and v(v), calculated by different methods are being





This is most useful when the atoms i = j, so the similarities in the motion of individual
atoms can be compared between different modes. This is how this analysis is performed
in this thesis.
2.5. Analysis of Normal Modes and Principal Components 63
2.5.3 Overlaps
The overlap between two normal modes, Iv1v2 , is a measure of the extent of similarities
between two normal modes, v1 and v2:
Iv1v2 =




An overlap of 1 indicates that the motion for normal mode v1 is identical to the motion
for normal mode v2, whereas a value of 0 indicates that the motion is completely
different (or orthogonal). As the eigenvectors calculated by NMA and PCA form an
orthonormal basis, the overlap of an eigenvector with another from the same set of
normal modes will always equal 1 if v1 = v2 or 0 if v1 6= v2. Therefore the overlap is
mainly useful for comparing normal modes from two different systems (with the same
number of atoms included in the eigenvector) or from two different analyses.
2.5.4 Subspace Overlaps
When comparing multiple sets of eigenvectors, looking at the individual overlaps of
modes separately can become overwhelming. The subspace overlap quantifies the sim-
ilarities between the subspaces spanned by two sets of n orthonormal vectors, u and













with a subspace overlap of 1 corresponding to u and v occupying the same subspace.
It is also possible to quantify the extent to which a single eigenvector W exists









This is useful for seeing the extent to which the differences between two PDB structures
can be accounted for by a subset of the normal modes or principal components.
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2.5.5 Normalised Subspace Overlaps
In principal component analysis, when looking at the principal components from two
simulations of the same system, the overlap of the fluctuations can provide a measure
for the convergence of the sampled space [174]. It is possible to perform this analysis
in terms of covariance matrices. The normalised subspace overlap, snorm, between two






where trA denotes the trace of covariance matrix A. The normalised overlap, snorm, is
1 iff the two matrices are identical and 0 if the subspaces sampled by the two matrices
are orthogonal.
This method has a couple of advantages over the subspace overlap (section 2.5.4)
of the first nA and nB eigenvectors of matrix A and B. Firstly by using the covari-
ance matrices, all of the eigenvectors are included in the calculation. Secondly, the
normalised subspace overlap, by using the covariance matrices includes the informa-
tion contained in the eigenvalues. The subspace overlap on the other hand ignores
the eigenvalues, meaning that differences between eigenvectors with large eigenvalues
reduce the overlap by the same amount as the same differences between eigenvectors
with small eigenvectors.
2.5.6 Cosine Content of Principal Components
In PCA, the principal component (PC) of the eigenvector, ui, with index i is defined
as the projection (pi(t)) of the MD trajectory onto the eigenvector. Where:
pi(t) = ui · (x(t)− x¯(t)). (2.5.63)
Here x(t) indicates the positional vector of the system at time t and x¯(t) indicates the
average orientation.
The shape of the PCs contains information about whether good sampling has been
achieved in the MD simulation. Hess showed in a study of the PCs of a potential-
less Brownian motion simulation that the shape of the PCs of random diffusion are
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cosine shaped with the number of periods equal to half the index of the principal
component [174,175]. Therefore cosine shaped PCs in protein simulations are indicative
that the the motion captured by the PCA for that specific mode is caused by diffusive
motion rather than the motion of a protein trapped within an energy well. The cosine
content, ci, is a measure of how much a PC resembles a cosine, and hence how much












Here the integral is over the length, T , of the simulation used to calculate the covariance
matrix. A cosine content of 1 indicates that the PC is a perfect cosine, so a cosine
content in the region of 1 would indicate that the PC is driven by random diffusion.
The fluctuation of the cosine content can be large between different PCs from the same
PCA, so a low value of the average cosine content can not be used as an indicator of
good sampling. However, it can be said that if the first PC strongly resembles a cosine,
the sampling in the simulation is far from converged [174].
2.6 Entropy and Free Energy of Normal Modes
Using statistical mechanics it is possible to calculate an estimate to the conformational
free energy and conformational entropy of a system using the frequency of vibrations
such as the normal modes. For this method, the partition function, ζk, for normal














When looking at one mole of the system, the total partition function, Ztot, is the
product of the partition functions, ζtot, for all the molecules, such that
Ztot = (ζtot)
NA
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The conformational free energy, Econf, of a system with internal energy, U , and
entropy, S, is given by
Econf = U − TSconf (2.6.67)
and can be calculated for a mole of the system from the total partition function with
Econf = −NAkBT ln(ζtot) = −kBT ln(Ztot) (2.6.68)




− kB ln(Ztot). (2.6.69)
With the internal energy given by




Here U(0) is the zero point energy of the system. Some generalisations are frequently
used when calculating the conformational entropy for the system these are discussed
along with the methods for calculating the entropies in 2.6.1 and 2.6.2
Equation 1.4.19 in section 1.4 shows the allosteric free energy for homotropic al-
lostery. The same relationship applies for the entropy, giving an allosteric entropy
of:
∆∆S = Sholo2 − 2Sholo1 + Sapo. (2.6.71)
If this value is positive, the allostery of the system has positive entropic cooperativity
and if it is negative, it exhibits negative entropic cooperativity.
To get a more accurate picture of the cooperativity of the binding events, however,
one should consider the Gibbs free energy difference, ∆∆G (see 1.4.19), which takes into
account the enthalpic contribution to binding as well as other entropic contributions.
The cooperativity of binding can also be measured with the cooperativity constant,
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where ks are the effective spring constants of the system, taken as the product of the










eα − 1 − ln
[
1− e−α]) , (2.6.73)
where α = ~ω
kBT
.
For a harmonic system of N atoms in Cartesian coordinates, the system has 3N nor-

















where ωi is the frequency of normal mode i. This harmonic entropy provides an upper
bound to the conformational entropy of the system, such that Sho > S.
2.6.2 Schlitter Method
Starting from the entropy of a one-dimensional oscillator (equation 2.6.73), Schlitter










with e = exp(1); showing that S ′ > Sho. For this method, every degree of freedom
is treated as a quantum harmonic oscillator, with the equipartition theory (equation















where Q is the classical variance.
In a multidimensional system, the Schlitter method becomes a way of calculating
a maximum entropy estimate for a macromolecule directly from the covariance matrix
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[171]. The eigenvalues, 〈Q2ii〉, of the covariance matrix, σ˜, as calculated by equation
































Taking the product of the diagonal elements of a diagonalised matrix is equivalent
to finding the determinant of that matrix, which itself will not have changed upon













Like the classical method, this approximation only holds for ~ω << kBT , so it fails
for the high frequency motions. However, these high frequency motions contribute
least to the entropy, meaning that the Schlitter approximation is likely to be good
approximation for the entropy.
The Schlitter method has been used to calculate the absolute entropy of ideal
gases and Lennard-Jones Fluids [176] and entropy of cooperative ligand binding in
DNA [177,178], with sufficient agreement to experiment or analytical methods.
2.7 MM/PBSA
Molecular mechanics/Poisson Boltzmann surface area method (MM/PBSA) is a method
for calculating the free energy of protein ligand-binding events [179, 180]. In this
method, the free energy of a complex system is estimated using a set of structures, typ-
ically collected from a molecular dynamics simulation. These structures are stripped
of any solvent and counter-ions and the solvated free energy for the system, G¯solvated,
calculated by:
G¯solvated = E¯MM + G¯PBSA − TSMM. (2.7.79)
Here, E¯MM is the average molecular mechanical energy, ∆G¯PBSA is the solvation free
energy determined by the implicit PB model (section 2.1.10) and a non-polar model
(section 2.1.12). The entropy is often determined using either NMA (section 2.2) or
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Figure 2.3: Thermodynamic cycle for calculating the binding free energy of a protein-ligand
complex. Systems are shown in blue boxes if they are solvated, or white boxes if they are in
vacuum. The free energy of binding is shown in red. Adapted from [180]
PCA (section 2.3).
The free energy of binding of a solvated protein-ligand complex can be determined
by subtracting the solvated free energies of the protein (∆G¯aposolvated) and the ligand





solvated − (∆G¯aposolvated + ∆G¯ligandsolvated), (2.7.80)
Where ∆G¯solbind is the average free energy of binding in solvent. This process is shown
as a thermodynamic cycle in figure 2.3. To determine the allosteric free energy, the
difference between the free energy of binding for the two consecutive binding events is
calculated (see section 1.4).
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Chapter 3
Experimental Techniques used to
study Protein Structure and
Dynamics
While using computer modelling can be useful for studying the dynamics and ther-
modynamics of cooperative binding in proteins, without experimental validation no
confidence can be put in the computational results. This section looks at a couple
of experimental techniques, X-ray crystallography (section 3.1) and ITC (section 3.2),
used to validate the computational studies in this thesis.
3.1 X-ray Crystallography
X-ray crystallography is the most important tool for the determination of a macro-
molecule’s structure. It also provides useful information about the macromolecules
dynamics with the B-factors, however it does not provide any information about the
timescale of the motion observed. This section looks at X-ray crystallography as a
method for studying protein structure and dynamics, looking at some of the challenges
that need to be overcome and theory used.
3.1.1 The Crystal Lattice
In a crystal, the molecules are arranged in a lattice, a construct of regular periodic
units, repeated in three dimensions. These periodic units contain a motif, which in
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Figure 3.1: 2-dimensional representations of two sets of lattice “planes” and their Miller
indices for a 2-dimensional lattice with dimensions a and b. The Miller indices (h k) of the
sets of lattice “planes” are (1 1) for the blue lines and (3 -1) for the green lines. Adapted
from [181].
the case of protein crystallography, consists of one or more protein subunits, water
molecules and often other molecules from the crystallisation cocktail. The periodic
unit and its constituent motif is called the unit cell (see section 3.1.3).
The lattice has a set of lattice planes, which intersect the lattice in a periodic and
distinct manner. Each set of lattice planes can be defined by its Miller indices, hkl,
a set of integers indicating the reciprocal of the number of intercepts a set of lattice
planes have with the unit cell. Figure 3.1 shows 2-dimensional representations of two
sets of lattice planes and their Miller indices. The interplanar distance vector dhkl,
is the distance vector between two adjacent planes from the same set of planes with
Miller indices hkl.
3.1.2 Protein Crystallisation
For a protein to crystallise, the free energy of crystallisation;
∆Gc = ∆Hc − T∆Sc (3.1.1)
needs to be less than zero, therefore the entropy lost from the removal of the rotational
and translational degrees of freedom needs to be overcome (around -30 to -100 kJ
mol−1 at 300 K). The enthalpic contribution to the crystallisation free energy, ∆Hc
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is favourable, but not to the extent that is needed to overcome the entropic penalty
as there are generally very few contacts between the protein molecules in a crystal.
The value of ∆Hc is typically either moderately negative such as for lysozyme (-70
kJ mol−1) [182] or insignificant such as for ferritin, apoferritin and lumazine synthase
(around 0 kJ mol−1) [183–185]. Therefore, another factor must contribute to the free
energy of crystallisation for it to occur. This is the entropy gained upon releasing
structured water from the surface of the protein upon crystallisation. Typically between
5 and 30 ordered water molecules are released from the surface of the protein upon
crystallisation, which contributes between 30 and 200 kJ mol−1 at 300 K [181,186].
Taking all of these contributions of the free energy of crystallisation, into account:
∆Gc = ∆Hc − T (∆Sprotein + ∆Ssolvent), (3.1.2)
which has are two large entropy terms of opposite sign with a small difference between
their magnitude. Therefore fairly small changes to each of these entropy terms can
have drastic effects on the overall entropy change and hence whether or not the protein
crystallises.
A negative ∆Gc, although necessary for crystallisation, is not the only condition
that need to be met for crystallisation to occur. The kinetic barriers associated with
nucleation and self assembly also need to be traversed. Phase transitions necessary
for crystallisation such as these are initiated by “critical events” which are kinetically
driven and hard to predict for complex systems such as protein solutions. Neverthe-
less, all established physical principles of phase formation are applicable to protein
crystallisation, as has been shown by atomic force microscopy (AFM) [181].
The nucleation phase transition occurs when the protein solution becomes super-
saturated. At this point the protein solution is metastable, so will eventually separate
into protein plus a saturated solution. If the conditions are correct, and provided a
nucleation event occurs, the protein will separate out into the form of a crystal. The
solubility phase diagram for a protein solution can be seen in figure 3.2.
There are two types of nucleation events that can occur in protein crystallisation.
For the first, homogeneous nucleation, proteins in the solution occasionally collide and
form favourable interactions that overcome the entropy lost from the removal of degrees
of freedom. These small groups of proteins, or nuclei, can either be broken apart by



























Figure 3.2: An Idealised solubility phase diagram for a protein solution. Below the solubility
line there is a stable single phase protein-precipitant solution. The higher the precipitant con-
centration, the lower the protein concentration that can be achieved and vice versa. Above
the decomposition line, the solution spontaneously decomposes to two phases. Between the
solubility line and the decomposition line is the metastable region where the protein solution
is supersaturated. It is in this region that crystallisation happens given nucleation occurs.
Homogeneous nucleation tends need higher levels of supersaturation than heterogeneous nu-
cleation. Adapted from [181].
collisions with other molecules or go on to form a larger nuclei. These events occur
continuously in the supersaturated solution, with the probability of forming a larger
and more stable nuclei increasing with degree of supersaturation. Once a nucleus has
reached a critical size, the fluctuations in the solution cease to break it up, at which
point additional collisions with other protein molecules are energetically favourable and
crystallisation occurs. The second type of nucleation event is heterogeneous nucleation,
which occurs at a surface of the supersaturated solution. Heterogeneous nucleation
can be exploited with seeding techniques, where nucleation is artificially induced by
using previously formed crystals or crystal fragments as a starting point to grow larger
crystals. For spontaneous homogeneous nucleation to occur, generally a greater extent
of supersaturation is needed than for heterogeneous nucleation.
To achieve protein solution supersaturation, high purity protein is needed at a
sufficient concentration. Typically this has been noted to be around 10 mg/ml, however
there are examples of crystallisation at much lower concentrations [181, 187]. Protein
solution supersaturation can then be achieved in a number of ways, such as by the
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a) b) 
Figure 3.3: Two Vapour diffusion techniques: a) hanging drop vapour diffusion is a common
method used for manual setups. The drop of protein crystallisation cocktail (purple) is
typically made of 1 µl pure protein solution and 1 µl crystallisation solution from the reservoir
(blue). b) Sitting drop vapour diffusion has been optimised for robotic automation, with
droplets of the protein crystallisation solution typically 100 nl + 100 nl. Both methods work
on the principle that the water vapour diffuses from the protein droplet to the reservoir.
Adapted from [181].
addition of precipitant to the protein solution, removal of water by vapour diffusion,
solvent exchange or a change of pH, among others.
The method used to reach supersaturation in this thesis was vapour diffusion. Two
common vapour diffusion methods are sitting drop vapour diffusion and hanging drop
vapour diffusion, which are summarised in figure 3.3. Both of these methods work on
the principal that there is a drop of protein solution separate from a reservoir of precip-
itant solution in a closed system. The drop typically contains half the concentration of
the precipitant in comparison to the reservoir, resulting in water vapour diffusing from
the drop containing the protein solution to the well. This increases both the protein and
the precipitant concentration, causing the solution to become supersaturated. Ideally,
the protein solution gets supersaturated to the extent that homogeneous nucleation
occurs. An idealised phase diagram showing the path of a successful vapour-diffusion
experiment can be seen in figure 3.4.
3.1.3 Crystallisation Cocktail
The phase diagrams shown earlier are a highly idealised picture of the crystallisation
problem, and in reality finding the correct conditions for crystallisation is a multidimen-
sional problem, with a number of variables controlling whether or not crystallisation

























Figure 3.4: Idealised Phase diagram showing the path of a successful vapour diffusion crys-
tallisation trial. The starting droplet (denoted S) has half the precipitant concentration of
the solution in the reservoir, causing water vapour to diffuse from the droplet to the reservoir.
The loss of water causes a rise in the protein and precipitant concentrations in the droplet,
pushing the system into the metastable region of the phase diagram where spontaneous nu-
cleation occurs (1). As the crystal grows (2, 3) the protein concentration in the solution
reduces until the crystals reach equilibrium with the saturated solution (4), where they cease
to grow. Adapted from [181].
will occur. Therefore a number of different things go into the crystallisation cocktail
to try to cause the protein to crystallise.
One of these variables that contributes to whether crystallisation occurs is the
precipitant used. Salts and organic compounds can both be used as precipitants. The
most commonly used organic precipitant is polyethylene glycol (PEG), which was first
introduced as a precipitant in the 1970s [188]. PEGs work by competing for the water
molecules around the protein, thereby forcing the protein molecules to interact with
each other.
Salts work in a different way; the charged ions in the salt interact with the charged
residues on the surface of proteins, affecting the solubility of proteins in a complicated
manner. Small quantities of salts actually increase the solubility of a protein, this is
called the salting in effect. Larger quantities, however, do reduce the solubility; the
desired effect of a precipitant.
Another control of crystallisation is the pH used; this is controlled by the buffer
used for the crystallisation cocktail. A protein’s minimum solubility can be found at
3.1. X-ray Crystallography 77
its isoelectric point (pI) (where it has zero net charge) however evidence from the PDB
shows no direct correlation between the pI and crystallisation pH, in fact the average
pH of crystallisation is around 7.4 [181, 189, 190]. This lack of correlation between pH
and pI implies that in many cases a net charge on the protein can increase a protein’s
likelihood of crystallising.
Finally, additives can be added to the crystallisation cocktail; often this is done in
the process of optimising crystallisation. Additives are often added to crystallisation
cocktails to tackle problems such as small crystals, poor morphology, weak diffraction
patterns or poor reproducibility of results. An additive can essentially be anything
that improves crystallisation, therefore there are a lot of mechanisms for how different
additives work. Additives are an important strategy for optimising crystallisation, as
is investigated in the study by McPherson and Cudney in a study that looks at the
effects of different additives on crystallisation [191].
3.1.4 Crystallisation Screens
To try and solve the multivariable problem of finding the correct conditions that crys-
tallisation occurs, crystallisation screens are used. Initial a priori knowledge about
a protein, allows us to delete detrimental factors from the screen such as pH values
that would denature the protein and excessive precipitant concentrations. Despite this
knowledge, the crystallisation space is still extremely vast, so crystallisation screens
are used.
There are a number of different types of screens that can be used in protein crys-
tallography, such as footprint screens [192] and oversampled sparse screens [193]. The
type of screen used in this thesis is a grid screen, which can commonly be found in
the 24 well or 96 well format. Grid screens frequently vary two different variables in
the crystallisation space, such as pH and PEG size (pH/PEG) or salt cation and PEG
concentration (cation/[PEG]), but can technically be any two different variables from
the crystallisation space. If a screen is successful, protein crystals form which can then
be used for X-ray diffraction to solve the crystal structure.
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3.1.5 X-ray Diffraction
In the classical description, X-ray diffraction is a result of the electrons in the atoms
of the protein interacting with the X-rays causing them to scatter. Electrons interact
with the electric field vector of an X-ray, causing it to oscillate with the same frequency
as the X-ray. For the elastic Thompson scattering, utilised in X-ray crystallography
the oscillating electron then emits radiation at the same frequency as the incoming
wave. This is called a scattering event and can be described by a scattering vector
S = s1 − s0, (3.1.3)
where s0 is the incoming wave vector and s1 is the wave vector of the scattered wave.
Wave vectors are vectors of length 1/λ in the propagation direction of the wave. The
direction of the scattered electrons is not isotropic, but determined by the polarisation
of the incoming radiation.
Scattering of X-rays by an Atom
When the X-ray diffracting electrons are in atoms, they move around the nucleus in
orbits defined by their probability distributions. Therefore the amplitude of a scattered
wave depends on the electron density, ρ(r), of the atom. Each of the electrons in the
atom are excited by the electric field vector of the X-ray causing them to scatter partial
waves. These partial waves recombine to create the outgoing wave.
When looking at the scattering of two separate volume elements of the electron
density, O at the origin, and P which is separated from O by the vector r, the path
difference between partial waves scattered by O and P is:
∆p = λr · s1 − λr · s0 = (s1 − s0) · rλ = S · rλ. (3.1.4)
The multiplication factor of λ is present because the wave vectors s0 and s1 are in units





∆p = 2piS · r (3.1.5)











Figure 3.5: X-ray scattering by electrons in an atom. The figure shows two partial waves
being scattered by two volume elements, O (at the origin) and P in the electron density, ρ(r),
of an atom. The path difference between the two partial waves is given by the difference
between s1 · r and s0 · r. This translates to a phase difference between the two waves of
∆p = 2piS · rλ. Figure adapted from [181].
Depending on the positions of the volume elements within the electron density of
the atom, constructive or destructive interference can occur between the partial waves.
The scattering of the whole atom can then be described by the atomic scattering factor,





ρ(r) exp(2pii Sr) dr. (3.1.6)
This is the Fourier transform of the electron density of the atom. For macromolecular





















which is denoted f 0s to indicate that it is wavelength independent. The ai, bi and c
are the Cromer Mann coefficients for each atom, which are listed in the International
Tables for Crystallography [194].
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Scattering of X-rays by a Molecule
In a molecule, the partial waves scattered by neighbouring atoms interfere, leading to
a modulating scattering function. This scattering function is a superposition of all




f 0S,j · exp(iφ) (3.1.8)
where φ = 2piSrj is the relative phase of each contribution. In a single protein molecule,
as there is no periodicity, this function is a continuous decaying complex function with
an irregularly structured modulation to it. In practice, the scattering off individual
molecules is too small to detect, whereas the arrangement of many molecules in a
crystallographic lattice allows amplification to occur through constructive interference
[181]. The amplification factor is proportional to the number of repeats in the crystal.
Scattering of X-rays by a Crystal
A simple interpretation of X-ray diffraction in a crystallographic lattice introduced by
Sir William Lawrence Bragg, treats the X-ray diffraction as reflection on the lattice
plane of a crystal. Using this interpretation, the Bragg equation:
nλ = 2dhkl sin θ (3.1.9)
relates the scattering angle, θ, to the interplanar distance for the set of lattice planes
hkl. This equation works on the principal that the path difference between two inter-
fering partial waves is a multiple (n) of the wavelength (λ) of the wave for maximum
constructive interference to occur. As a consequence of this, the scattered X-rays only
interfere constructively if the unit cells are correctly aligned, thus scattering ceases to
occur in directions that do not correspond to integer hkl values.
Looking again at the scattering factor for unit cell direction a only for simplicity,





FcellS · exp(2pii uSa) (3.1.10)
where FcellS is the scattering factor for all of the atoms in the unit cell. The phase
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difference between unit cells is 2piSa, therefore summing over all the unit cells, the
scattered wave becomes extinct through destructive interference when Sa is not an
integer. As a consequence of this, no scattering occurs for none integer values of
Sa, and scattering peaks sharpen around integer values. Thus, these integer values
correspond to the h indices from the reciprocal lattice. At these peaks, the scattering
function for the a direction becomes F aS = u · FcellS .
Extending this to the three unit cell directions, the scattering function at the peaks
for N unit cell repeats is F crystS = N · FcellS Therefore, the expression for molecular
scattering can be used to describe crystal scattering, summing over all of the atoms in




f 0S,j · exp(2pii Srj) (3.1.11)
This equation can be made general by first expressing the real space lattice vector rj
for each atom, j in terms of fractional coordinates:
rj = A · xj = (axj + byj + czj) (3.1.12)
Therefore by applying the relationships S · a = h,S · b = k and S · c = l (the Laue
equations), it follows that:
Srj = Saxj + Sbyj + Sczj = hxj + kyj + lzj = hxj (3.1.13)
The total scattering from the crystal in lattice direction h or the structure factor of
reflection h is therefore proportional to the sum of all of the scattering contributions




f 0S,j · exp(2pii hxj) (3.1.14)
It is therefore possible to compute the scattering function for the diffracted X-ray
corresponding to the reflection in the lattice planes with reciprocal Miller index hkl.
When collecting the diffraction data, the structure factor amplitude, Fh, of a diffraction
peak in direction h is reconstructed from the intensity of the reflection, Ih by:
Fh = k · k′ · I1/2h . (3.1.15)
































Figure 3.6: Constructing the Ewald sphere and the significance of the reciprocal lattice on
diffraction conditions. a) Sketching a scattering event as a reflection on a set of lattice planes
and encircling with an Ewald sphere of radius 1/λ, it can be seen that S = (2 sin θ)/λ. b)
Drawing the reciprocal lattice with origin displayed as an unfilled circle (◦) it is possible to
see that for diffraction to occur for lattice plane hkl, the condition S = d∗hkl needs to be met.
For this crystal orientation, the diffraction conditions are met for the 1¯01 and 1¯01¯ lattice
planes. Rotation of the crystal and therefore the simultaneous rotation of the reciprocal
lattice, changes which lattice points intersect the Ewald sphere. Adapted from [181].
where k and k′ are correction terms.
A convenient way to visualise the geometric conditions necessary for X-ray diffrac-
tion to occur is an Ewald sphere (see figure 3.6). This method takes advantage of
the reciprocal lattice. Each set of lattice planes in real space with Miller indices hkl




hkl is reciprocal to the









for the case where n = 1. Placing a scattering diagram into an Ewald sphere with
radius 1/λ with the origin of the reciprocal lattice at the point where the incoming
beam direction exits the sphere shows the connection between the reciprocal lattice
and the diffraction direction. Any reciprocal lattice point that lies on the Ewald sphere
fulfils the diffraction condition d∗hkl = (2 sin θ)/λ and it also follows that Shkl = d
∗
hkl.
The symmetry of the diffraction pattern reflects the symmetry of the crystal structure.
By closer inspection of figure 3.6, a shorter wavelength leads to a larger Ewald
sphere. This corresponds to there being more reflections at lower angles, which can be
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useful as the size of the detector is finite.
Debeye Waller Factor and B-factors
The structure factor described in the previous section assumes that the atom positions
are fixed. However, in reality atoms vibrate around a mean position and the average
positions of atoms can be different in different unit cells. These two effects are generally
indistinguishable from a single data set in protein crystallography, but can be described









Where Biso is the isotropic B-factor, which is related to the mean square displacement







For proteins, the B-factors of individual atoms depend on the static disorder of the
atom, its dynamic behaviour and the overall dynamic behaviour of the protein. Residues
in an inflexible region of the protein will have much lower B-factors than residues in
flexible regions of the protein. These flexible regions do not diffract as well as the
inflexible regions.
3.1.6 Phase Problem
Recall from 3.1.5 that the complex structure factor is the Fourier transform of the
electron density. Fourier transforms (FT) are reversible, so it follows that:
FT−1 [FT (ρ(r))] = ρ(r) (3.1.19)
Therefore performing a Fourier transform on the complex structure factor in reciprocal






F(h) · exp(2piihx). (3.1.20)
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In this instance, the Fourier transform is expressed as a discrete sum as there are finite
reflections measured. Therefore, if the structure factors are known for each reflection
it is possible to calculate the electron densities and hence the structure of the protein.
Unfortunately as only the intensity, Ih, of the reflections is known, with Ih ∝ F 2h,
the magnitude of the structure factor. The phase information from the structure factor
is missing which contains most of the structural information. By using the relationship:
Fh = Fh · exp(iαh), (3.1.21)













F (h) exp(2piihx + iαh) (3.1.23)
The problem is now how to obtain the phases αh.
Until 1934 and the introduction of the Patterson function [195], the only way to
solve the phase problem was by trial and error. The Patterson function P (u) is defined




ρ(r)ρ(r + u)dr, (3.1.24)
where the integral is over the whole unit cell in real space (R). The Patterson function
has a large value at u when both ρ(r) and ρ(r + u) have large values. Therefore the
Patterson function has maxima where the distance vector u corresponds to interatomic
distances.
To obtain the Patterson function for a particular crystal, a Fourier transform is




F 2h exp(−2piihu) (3.1.25)
For a relatively small number of atoms, the position of the atoms can be determined
from the maxima in the Patterson function. For larger molecules such as proteins,
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however, this soon becomes an impossible task due to there being N(N − 1) peaks in
the Patterson function and many of the Patterson peaks are unresolvable from each
other; even at high resolutions.
Regardless, Patterson functions are still used in certain steps of a number of num-
ber of methods, such as multiple isomorphous replacement (MIR), single wavelength
anomalous dispersion (SAD), multiple wavelength anomalous dispersion (MAD) or a
combination of these methods. In these methods it is used in conjunction with “direct
methods” to locate the position of the heavy atoms. The technique used in this thesis,
however is molecular replacement, so only this method will be described in greater
detail.
Molecular Replacement
Molecular replacement is a technique that uses a model that is structurally similar to
a molecule in the target crystal structure to try solve the phase problem. This idea
behind this technique is that it places the model structure in the correct place and
orientation within the unknown unit cell. This makes the problem a 6-dimensional
problem, with 3 rotation dimensions and 3 translation dimensions.
The solution to this problem can be solved by looking closer at the Patterson
function. The peaks on the Patterson function can be split into intramolecular peaks
and intermolecular peaks. As the intramolecular peaks are not affected by the position
of the molecules within the unit cell, just their orientation, the Patterson function
for the model molecules can be rotationally fit to the experimental function before a
translational fit is used to determine the positions of the molecules within the unit cell.
In general, the peaks of the Patterson function closest to the origin are more likely to
correspond to the intramolecular vectors, so the rotation function can be fitted with
these peaks only.
In this thesis, the maximum likelihood rotational and translational functions are
used to fit the molecular model to the experimental data [196,197]. Maximum likelihood
methods works on the principal that the best model is the one that is most consistent
with the data and is defined as the probability that the data would be observed given
the model (p(data;model)). In crystallography, the data are the individual reflection
intensities, which are assumed to be independent. In this case, the joint probability of
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the data is the product of the individual probability distributions. To avoid numerical
problems of working with extensive data sets, the log of the likelihood is used, which





An overview of the algorithms used in the maximum likelihood method for molecular
replacement can be found at [196].
3.1.7 Model Building and Refinement
Model building is the construction of an atomic structure model of the macromolecule
that fits into the electron density. This process is alternated with global restrained
reciprocal space refinement of the atomistic positions and B-factors of the model.
The model building step is performed in real space using computational visualisation
of electron density maps to fit the model. There are two types of electron density
maps frequently used in model building, the combined electron density map (2Fobs −
Fcalc) exp(iφcalc) and the basic difference map (Fobs − Fcalc) exp(iφcalc). The (2Fobs −
Fcalc)exp(iφcalc) map is used as it displays regions of electron density where atoms are
missing from the model at normal density levels. Fobs exp(iφcalc) density maps, on
the other hand only recreate half (or less) of the density for unmodelled regions. The
combined map is therefore preferred for model building, whereas the difference map is
preferred for model correction as it displays regions where the model is incorrect.
Models originating from molecular replacement, as is the case in this thesis have
a number of challenges to overcome during the refinement stage of solving the crystal
structure. The initial phases used to determine the electron density originate solely
from the model, so can be incorrect or even missing in regions. This causes the model
phases to be biased, leading to the electron density maps to reconstruct the model’s
electron density. The model will also be incomplete and contain large errors, which
need to be accounted for when building the model. To minimise the model bias and
take into account other errors, maps constructed from the Fourier coefficients (2mFobs−
DFcalc) · exp(iφcalc) for acentric reflections and mFobs · exp(iφcalc) for centric reflections
are used [198]. The coefficient m is the figure of merit, which takes into account
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Figure 3.7: Flow chart showing the model building and refinement process. Initial electron
density map is produced from the observed diffraction data and either the molecular replace-
ment phases or experimental phase information. Model building then occurs in real space,
which is alternated with reciprocal space refinement which minimises the differences between
the observed and the calculated structure factor amplitudes. This cycle is contained within
the red box. The reciprocal space refinement is restrained using prior knowledge. Adapted
from [181]
the completeness of the model, while D is the Luzzati function, derived from σA; an
estimate of the error in the coordinates of the model.
While building and modifying the model, other properties of proteins are checked,
such as whether there are any disallowed backbone torsions (by observing the Ra-
machandran plot), unlikely side chain rotamers or improbable bond lengths and angles.
Local geometry errors after real space model building are corrected during the global
reciprocal space refinement by optimising the fit between observed and calculated struc-
ture factor amplitudes. In this stage, the parameters describing the structural model,
such as the atomic coordinates and the B-factors are refined against the experimen-
tal data, minimising the difference between the observed structure factor amplitudes
and the calculated model structure factor amplitudes using maximum likelihood meth-
ods [197, 199]. A flow diagram of the model building and refinement process can be
seen in figure 3.7.
The quality of the model in comparison to the diffraction data is quantified by the
R-value. This is the global linear residual between the observed and calculated scaled
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structure factor amplitudes Fobs and Fcalc defined as:
R =
∑
h |Fobs − Fcalc|∑
h Fobs
. (3.1.27)
During the model building and refinement, a small amount of the data is discarded
(typically 5%) and is not included in calculating the R-value. This neglected “free”
data is used to calculate a free R-value, Rfree, which helps determine if the model is
being over fit with too many parameters [200]. The corresponding R-value calculated
using all data except the free data is denoted Rwork. A large difference between Rwork
and Rfree gives a rough indication that too many parameters are being used in the
model.
As a result of their often not being enough experimental data being used in the
refinement relative to the number of parameters, prior knowledge about proteins is
used. This helps prevent nonsensical models caused by over-fitting the data. This prior
knowledge can be in the form of chemical information, such as the amino acids found
in proteins or structural information such as knowledge about interatomic distances
and backbone dihedral angles.
The prior knowledge is imposed upon the model in the form of constraints and re-
straints. Constraints reduce the number of refinement parameters by exploiting known
geometric relationships, such as using rigid models for certain chemical groups, such
as phenyl groups. Restraints also improve the data to parameter ratio, this time by
acting as additional observations. Variables such as bond lengths and bond angles are
restrained to values determined experimentally. The functional form of the standard







(bcalc(j) − bi(j))2. (3.1.28)
Here bcalc(j) represents the restrained geometric parameter, such as the bond length or
bond angle, as calculated from the model and bi(j) is the ideal value of this geometric
parameter. σ2b represents the variance in the ideal value of the geometric parame-
ter. bi(j) and σ
2
b are determined experimentally [201, 202] and are typically kept in a
dictionary of restraints that is utilised by automated refinement programs [199].
It is also possible to restrain the B-factors during the refinement. The B-factors are
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related to the displacement undertaken by the atoms, therefore it is not usually possible
to distinguish partially occupied static conformations from dynamic fluctuations in
atomic positions. It can also be seen that there is a correlation between the fluctuations
of adjacent atoms (if one atom is static, the adjacent covalently bonded atoms cannot
move around too much) making this a sensible restraint to use. The form of the
restraint is again harmonic, restraining the B-factor of a target atom, Btarget(n) to the





Here wB(n) is the weight of the restraint, which is dependent on the position of the atom
in the macromolecule. For example, the B-factors of long side chains on the surface
diverge much quicker than those of adjacent backbone atoms, therefore they require
stronger weights.
After the reciprocal space refinement round, the electron density map is recalculated
using the phases from the new model. The iterative cycling of real space model building
and reciprocal space refinement is continued until their is enough confidence in the
crystal structure observed.
The crystal structure and B-factors contain a lot of information about the structure
and the dynamics of the biomolecule; it is a technique that is unrivalled in that respect.
It however does not contain information about the thermodynamics of protein-ligand
binding; information that is very useful when studying an allosteric system. For this
purpose a technique called ITC was used, a technique that is unrivalled for measuring
the thermodynamics of reversible reactions between biomolecules.
3.2 Isothermal Titration Calorimetry
ITC allows the determination of the binding affinity, Ka, enthalpy, ∆H, and stoi-
chiometry, n, of a protein-ligand binding event. From these values it is then possible to
determine the Gibbs free energy, ∆G and entropy, ∆S of the reaction [203]. It is useful
for reactions with multiple binding events such as allostery because different binding
models can be used to investigate successive binding events.
Titration calorimetry first described as a method for determining K and ∆H in the
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1960s and was originally used to study weak acid-base equilibria and metal ion com-
plexation reactions [204–207]. At this time, the technique was limited by the sensitivity
of the instruments to measure K values less than around 105 M−1. Calorimetric bind-
ing studies were first used to study biological systems [208] in the late 1970s. 10 years
later MicroCal created the first commercially available titration calorimeter [209]. The
basic principles and design of a modern titration calorimeter have not changed much
since these first machines.
In the calorimeter there are two cells, a reference cell containing water and a sample
cell containing both typically containing around 250 µl of protein solution (in the case
of MicroCal ITC200 [210]). These cells are kept at exactly the same temperature, any
changes are detected and the cells then returned to the same temperature. These cells
are set to the desired experimental temperature, which is typically 25 ◦C.
A series of 2 µl aliquots of ligand solution are injected into the protein solution.
If the ligand binds to the protein, very small heat changes occur, which are detected
and measured. In the case of an exothermic reaction, the binding event causes a small
increase in temperature of the sample cell, whereas in an endothermic reaction a small
decrease in the sample cell temperature occurs. The heat change of the binding event,
i, is related to the enthalpy of binding through the relationship [211]
qi = V ·∆H ·∆[LB]i. (3.2.30)
Here q is the change in heat due to the reaction, V is the volume of the sample
cell and ∆H is the enthalpy change of the binding event and ∆[LBi ] is the change
in concentration of the bound ligand between the (i − 1)th and ith injection. The
magnitude of the heat change decreases after each consecutive ligand injection as the
concentration of free protein reduces until the sample cell contains an excess of ligand
to protein binding sites where the protein is saturated. Upon saturation, a small heat
change caused by mixing and mechanical factors is present, which is subtracted from
the rest of the experiment.
As we saw in chapter 1, the protein-ligand binding equilibrium for a binding site, j
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where Kj is the affinity constant for binding site j and [L
F] is the concentration of free
ligand. The total ligand concentration can now be expressed as:




In the simplest case with only one binding site, this allows the concentration of bound
ligand to be expressed as:




so equation 3.2.30 becomes:









With only the total concentration of ligand ([LT]) being known in the experiment, this
equation needs to be rewritten in terms of the free ligand concentration, which can be
determined after each injection from the total protein and ligand concentrations by the
equation [203,212]:
[LF] =




Modern ITC instruments operate on the heat compensation principal, so the signal
measured is the amount of power needed to maintain a constant temperature difference
between the sample cell and the reference. This is initially plotted against time, with
each injection event causing a peak in the plot. The area under each peak is then
integrated to return the heat released or absorbed and plotted against the molar ratio
of ligand to protein. The resulting isotherm can be fitted to the binding model to
directly return the association constant of binding, Ka, the stoichiometry and the
enthalpy. Figure 3.8 shows a schematic of a typical ITC data set and the resulting
isotherm for a simple 1:1 binding reaction with only one binding event per protein.
The free energy of ligand binding event i can then be determined from the associ-
















Figure 3.8: A schematic of a typical ITC experiment for an exothermic binding of ligand
to single binding site protein. a) Shows the power output by the ITC machine to keep the
temperature of the reference and sample cell the same. Each injection of ligand causes a
spike in this graph. b) The area under the peaks of a) is plot against the molar ratio. The
enthalpy and stoichiometry of the binding are determined by linear values on the graph and
Ka is determined by fitting the curve to the binding model [213].
ation constant;
∆Gi = −RT lnKi
and the entropy from the difference between the free energy and the enthalpy;
∆Gi = ∆Hi − T∆Si.
ITC is therefore, an ideal technique to study protein binding events, such as cooper-
ative binding; allowing the investigation of the enthalpic and entropic contributions
separately.
Part III




Coarse-Grained Models of CAP
The earliest examples of allosteric signalling were interpreted as being caused by
changes in structure, which gave rise to the classic MWC and KNF (chapter 1) [34,35].
The allosteric signalling in CAP, however has been hypothesised to be driven by dynam-
ics rather than by a structural change [59, 111]. The models discussed in this chapter
focus on the modification of the thermal fluctuations upon ligand binding, and investi-
gate how this can contribute to cooperative binding. They are coarse grained; reducing
the degrees of freedom of the problem and averaging the many local interactions in the
system into simpler CG potentials. This allows for the study of longer timescales and
the study of large protein systems much quicker than atomic simulations would allow.
With the slow global modes of motion contributing most to dynamic allostery, these
CG models may be able to calculate these relevent motions to a sufficient accuracy.
The first models discussed in this chapter are CG models of CAP, which reduce
the problem of allosteric signalling to as few parameters as possible. These models are
termed SCG models throughout this thesis. They could be described as dynamic ana-
logues to the static conformation based MWC and KNF allostery models [34,35]. These
models look at how global properties of the protein, such as the average interactions
within a domain or across domains can affect allosteric signalling.
A second model, the elastic network model is briefly discussed, which represents
the protein structure as a network of Cα atoms and the interactions between residues
as Hookean springs [156, 158]. This model allows mutations to be made by modifying




4.1.1 Super Coarse Grained Models of CAP
Toncrova and McLeish’s CG model for the allostery of CAP [54,55] was motivated by
the NMR experiments of Popovych et al. [17] on the N-terminal domain of CAP. Their
model, however, did not allow any motion between the two monomers of CAP and
they did not extend their model to the full untruncated form of CAP with a DNABD
as well as the LBD. This section therefore looks at three new CG models of increasing
complexity.
The first models only the LBDs again, this time allowing for motion between the
center of masses of the two monomers with an additional degree of freedom describing
the motion in the protein as three one-dimensional vector coefficients, x1, x2 and x3.
This model will be referred to as the truncated monomer model (TMM) in this thesis.
The second model includes the DNABDs as well as the LBDs, however it does not
allow motion between the center of masses of the monomers. The protein motion in
this model is described by four motion vector coefficients x1, x2, x3 and x4, where x1
and x2 correspond to motion within the two LBDs and x3 and x4 correspond to motion
within the two DNABDs. This model will be referred to as the static monomer model
(SMM).
The third and final model combines the improvements of both of the previously
described models, including the DNABDs and allowing the center of masses of each
domain to move. The motion in this model is described by seven one-dimensional
vector coefficients x1 to x7. This model (first seen in [59] and developed alongside Dr.
Tom Rodgers) will be referred to as the mobile monomer model (MMM). These last two
models distinguish the LBDs and the DNABDs by labelling them the X-domains and
Y-domains respectively. See figure 4.1 for a graphical representation of these models
and how the vector coefficient describe the motion in the model.
The TMM discussed above has two spring constants controlling the interactions
within the protein dimer; kx, the internal spring constant of each monomer and kxx,
the coupling spring constant between the two monomers. As with the previous model
by Toncrova and McLeish [54, 55], binding of one molecule of cAMP causes scaling of
the spring constant, kx, of the bound monomer by β to become βkx and the coupling
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Figure 4.1: Super Coarse Grained models of CAP. (a) Model of the ligand binding (X)
domains of CAP, where the center of mass of the monomers are allowed to move. (b) Model
of the full length CAP, with the ligand binding (X) domain and the DNA binding (Y) domain.
In this model the center of mass of each domain is technically fixed (represented by a red
circle in the figure), as each scissor domain opens and closes symmetrically. (c) The final
model allows the center of mass of each domain to move by adding three extra degrees of
freedom.
spring constant, kxx, to be scaled by α to become αkxx. Binding the second molecule
of cAMP to the second monomer again causes the internal spring constant to scale to
βkx and the coupling spring constant to scale to α
2kxx.
Along with the extra domains, the other two new models naturally introduce a
couple of extra spring constants controlling the interactions within the homodimer.
These are ky, the internal spring constant of the Y domain (DNABD) and kxy, the
spring constant between the X domain (LBD) and the Y domain of the same monomer.
When binding occurs to a monomer, as well as the changes to spring constants that
occur for the X domain only model, the spring constant kxy for the bound monomer
is also scaled by γ. These models, as well as the changes in spring constants upon
binding cAMP can be seen in figure 4.2.
Two more springs could have also potentially been added to the models, which
would have been the spring between the DNABDs of opposite monomers and the spring
from the LBD of one monomer to the DNABD of the other monomer. These springs
were excluded from the models for a few reasons. Firstly from visual inspection of the
holo2-CAP structure, it was decided that these spring constants would be negligible
in comparison to the other spring constants in the model. This was later found to be
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Figure 4.2: cAMP binding in the SCG models of CAP. (a) For the TMM, each binding event
scales the internal spring constant of the bound monomer kx by β and the coupling spring
constant kxx by α. (b) In addition to this scaling, the SMM and MMM scale the spring
constant kxy of the bound monomer by γ.
described in 4.1.2. And finally, leaving out these spring constants in the calculation
of ∆∆G returns a slightly less complex term, with fewer variables, keeping a more
manageable analytical solution. These spring constants could easily be reincorporated
into the model if other proteins were being modelled, where these interactions were
significant enough to include.
The elasticity matrices for each model were determined with the following method.







where ∆xi represents the change from equilibrium length of the spring with constant





As an example, this process is shown here in greater detail for the SMM. The potential
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energy of this system is given as:
V (x) = kx(x1 − (−x1))2 + kx(x2 − (−x2))2 + kxx(x1 − (−x2))2
+ ky(x3 − (−x3))2 + ky(x4 − (−x4))2 + kxy(x1 − x3)2




disappears in this model because each spring has an equivalent spring that is
displaced by the same amount at the other end of the scissor. Rearranging 4.1.3 gives:
V (x) = x21(4kx + kxx + kxy) + x
2
2(4kx + kxx + kxy)
+ x23(4ky + kxy) + x
2
4(4ky + kxy) + 2x1x2(kxx)
+ 2x1x3(−kxy) + 2x2x4(−kxy)
(4.1.4)
which can be written in matrix format as:
V (x) = xT

4kx + kxx + kxy kxx −kxy 0
kxx 4kx + kxx + kxy 0 −kxy
−kxy 0 4ky + kxy 0
0 −kxy 0 4ky + kxy
x (4.1.5)
Hence, the elasticity matrix can be determined. The same process was used to deter-
mine the elasticity matrices of the other models in this thesis.
The elasticity matrices were then evaluated in Maple, using equation 2.4.54 in sec-
tion 2.4, allowing ∆∆Gconf to be calculated for each model. As there are few parameters
for each model, the parameter space of the models can be explored to see under what
conditions cooperative binding occurs. Plots of the models’ free energy surfaces were
then created using the python module matplotlib.
4.1.2 Rotational Translational Block (RTB) Model
The RTB model splits the protein into rigid blocks that undergo rotational and trans-
lational motion (as described in section 2.2.5). The RTB model analysis was performed
by Dr. Tom Rodgers and has previously been published in [59].
The blocks were determined using the hingefind plugin of VMD [214] on the lowest
energy modes determined by principal component analysis from MD simulations of WT
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CAP and corresponded to one block for each LBD and one block for each DNABD.
See chapter 5 for MD protocol and results.
The resulting matrix from the RTB reduction contained 3 dimensional spring con-
stants between blocks, which were averaged to create one dimensional spring constants
for the SCG models. These spring constants determine the position of WT-CAP on the
free energy surfaces of the SCG models and are; kx = 57.36, kxx = 113.38, kxy = 21.73,
ky = 16.66 kJ mol
−1 A˚2, α = 1.30, β = 0.56 and γ = 0.90.
4.1.3 Elastic Network Model
Elastic network simulations were performed using in-house code, called Durham dy-
namic protein toolbox (DDPT), written by Dr Tom Rodgers in Fortran. The ENM
calculations and analysis in this section were performed by Dr. Tom Rodgers and were
first published in [59].
The nodes of the ENM were all Cα atoms, which were connected with springs if
their inter-node distance was within a cutoff radius of 8 A˚ (see figure 4.3). CAMP
was included in the model where appropriate by representing each heavy atom as an
additional node in the model. For WT-CAP, all spring constants were set to a constant
value of 1 kcal mol−1 A˚−2 (4.19 kJ mol−1 A˚−2). Point mutations in the protein were
modelled by adjusting the spring constants for all of the springs attached to the chosen
mutated residue.
The allosteric free energy was calculated by summing the first n none zero normal
modes, where n was determined by examining where the value of Ka2/Ka1 converged.
To construct the ENM for CAP that is shown in this thesis, the PDB entry with
the identification number 4HZF was used. The ENM calculations and analysis were
performed by Tom Rodgers [59].
4.2 Results and Discussion
4.2.1 Super Coarse Graining CAP
Three models were discussed in section 4.1.1. They will all be evaluated and discussed
in this section. Initially, the TMM will be investigated, by first working through the
model to investigate which regions of parameter space exhibit cooperative binding
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Figure 4.3: Network of springs for the elastic network of apo-CAP superimposed on the
cartoon representation of CAP. All Cα atoms within 8 A˚ of each other were attached by
springs, represented as black lines. The PDB code for the structure used is 1G6N [59,107].
and explore what this could imply to allostery in protein homodimers. The region of
parameter space that WT-CAP exists in (as fitted by the RTB model) will then be
explored in greater detail. Next the SMM and MMM will be investigated. However,
due to the added complication of added parameters, it becomes infeasible to investigate
the entire parameter space as is done for the TMM, so only the parameter space
surrounding the position of WT-CAP is studied in detail.
Truncated Monomer Model
The elasticity matrix for apo-CAP for the TMM is:
K0 =

2kx + kxx kx kxx
kx kx + kxx kx
kxx kx 2kx + kxx
 (4.2.6)










xx) + C (4.2.7)
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Where C is a constant, which is the same for apo-CAP, holo1-CAP and holo2-CAP,
assuming that there were no additional effects on binding. The free energy of holo1-



















4k2xx) + C (4.2.9)


















As there are only 4 parameters in this model, it becomes possible to explore what
parameter combinations lead to positive or negative cooperativity. The model is easier







where positive cooperativity is observed when c > 1, negative cooperativity is observed
when c < 1 and no cooperativity is observed when c = 1. Of course |K1|2 is always
greater than zero for all real systems, so it can be seen that:
|K1|2 − |K0||K2| > 0 Returns positive cooperativity
|K1|2 − |K0||K2| < 0 Returns negative cooperativity
|K1|2 − |K0||K2| = 0 Returns no cooperativity
(4.2.12)
Therefore the term, Ξ = |K1|2 − |K0||K2|, gives information about the sign of
cooperative binding within parameter space; however information about the magnitude
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of the cooperativity is lost. For this model:




−(8k2xkxx + 4kxk2xx)(8β2k2xα2kxx + 4βkxα4k2xx) (4.2.13)
= 4α2k2xk
3
xx(−2α2βkxx + α2β2kxx + α2kxx
+8αβkx + 8αβ










xx is always positive, so removing this term from Ξ does not affect the
sign of the cooperativity determined. It is therefore possible to look at:
Ξ˜ = α2kxx(β − 1)2 − 8βkx(α− 1)(α− β) (4.2.16)
to determine regions of cooperative binding. In this expression, α2kxx(β − 1)2 > 0 for
all α and β, therefore it is evident that positive cooperativity is observed when:
α2kx(β − 1)2 > 8βkx(α− 1)(α− β),
negative cooperativity is observed when:
α2kxx(β − 1)2 < 8βkx(α− 1)(α− β),
and of course non-cooperative binding is observed when:
α2kxx(β − 1)2 = 8βkx(α− 1)(α− β). (4.2.17)
By taking into account that all of the constants are greater than or equal to zero for
all real systems, a few simple observations about the cooperativity of the system can
be made. It is evident that when α = 1, the right hand term from equation 4.2.17
disappears, so only positive cooperativity can be observed. Furthermore, when β = 1,
the left hand term disappears, and the right hand term becomes 8βkx(α−1)2, which is
always positive. Hence negative allostery is always observed in this instance. If α = β,
the right hand term becomes zero, meaning that positive allostery is observed.
It is also evident that scaling both kxx and kx by the same amount cannot change the
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Figure 4.4: Plots of equation 4.2.18; the surface showing the values of kxx/kx where no
cooperative binding (positive or negative) occurs. The surface is split into two regions, a)
β < 1, the interactions within a monomer decrease upon ligand binding. b) β > 1, the
interactions within a monomer increase upon binding. a) is rotated 180◦ with respect to b)
to improve the viewing angles of both surfaces. Regions of the surface below a value of 10−2
or above 102 are truncated to these values, as values this large are unlikely to be observed in
proteins.
nature of cooperative binding, it likely only scales the magnitude of the cooperative
binding. However, the denominator of equation 4.2.11 would have to be taken into
account to see the true scaling of cooperativity upon altering kxx and kx. It is therefore




8 β(α− 1)(α− β)
α2(β − 1)2 (4.2.18)
and plot a surface which shows the values of kxx/kx that exhibit no cooperativity for
given values of α and β (see figure 4.4). Any values of kxx/kx that lie below the surface
lead to negative cooperativity for the given values of α and β. The reverse is true for
values of kxx/kx below the surface. The ratio kxx/kx is examined simply to avoid the
singularity that appears when α = β in the case of kx/kxx.
A plot like figure 4.4 is useful as it theoretically allows us to see what changes in
the interactions of a protein can be made to change its cooperativity. It is possible
to examine which regions of the α and β space exhibit cooperative binding for given
values of kxx/kx. For example there are regions of positive cooperativity for any values
of kxx and kx when β < α < 1 and when 1 < α < β.
Perhaps a clearer visual of regions in the global parameter space that exhibit positive
or negative cooperativity can be created by taking slices through the plot of the surface
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Figure 4.5: Regions of α−β space that exhibit cooperative binding for given values of kxx/kx.
Red regions represent regions of positive cooperativity (kxx/kx > (8β(α−1)(α−β))/(α2(β−
1)2) and blue regions represent regions of negative cooperativity. The position of WT-CAP
in α, β space, as calculated for the 4 scissor model is plotted on each diagram as a white
circle. The kxx/kx value of WT-CAP is plotted in the fourth axis (kxx/kx = 1.98), showing
WT-CAP to be negatively cooperative.
of zero cooperativity at distinct values of kxx/kx and colouring all positively cooperative
regions red and all negatively cooperative regions blue. This has been done in figure
4.5, while also showing the position of WT-CAP as determined by the RTB model
(shown in section 4.1.2). Strictly speaking, the parameters determined for WT-CAP,
place it on the slice of the plot where kxx/kx = 1.98, but is shown on all slices to
demonstrate the effect of altering kxx/kx on allostery.
It is evident that in this model, WT-CAP sits in a region of negative cooperativity
near the boundary where cAMP binding becomes positively cooperative. In the model,
WT-CAP can be pushed into a positively cooperative regime either by decreasing the
value of β (or strongly increasing β), decreasing the value of α or increasing kxx/kx
(by increasing kxx or decreasing kx). As is discussed in 4.2.2 a V132A mutation would
probably have the effect of reducing kxx, pushing the system further into negative
cooperativity and a V132A mutation would probably increase kxx, which creates a
positively cooperative system. This trend is seen in experiment (see 6.3.3).
Figure 4.6 shows the free energy surface in the kx − kxx parameter space when
α = 1.3 and β = 0.56; the values fitted by the RTB model for WT-CAP. Again this
shows WT-CAP to be in a position of high sensitivity, where the negative cooperativity
of CAP is sensitive to small changes in kx and kxx.
Of course with all of these models, one should also take into account that in a
system as complicated as a protein, adjusting one interaction strength may lead to
changes in the strength of the other interactions. In the worst case, playing with these
interactions could inadvertently remove a protein’s ability to bind a ligand, so caution
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Figure 4.6: Plot of cooperative free energy as a function of the reduced two dimensional
parameter space of the internal and coupling spring constants for the TMM. All other pa-
rameters for the model are set to WT values.
should be used. Also, the model investigated here is the truncated form of CAP, but
as will be discussed later, the region of parameter space surrounding WT-CAP for this
model is similar to the more complex full length CAP models.
Static Monomer Model
The elasticity matrix of apo-CAP for the SMM is:
K0 =

4kx + kxx + kxy kxx −kxy 0
kxx 4kx + kxx + kxy 0 −kxy
−kxy 0 4ky + kxy 0
0 −kxy 0 4ky + kxy
 (4.2.19)
In this instance, the extra parameters kxy and γ complicate the term for ∆∆G, making
it unfeasible to perform a similar analysis to that performed for the previous model.
However, the free energy surface in the parameter space surrounding WT-CAP can be
investigated again (figure 4.7).
In this model, WT-CAP is again shown to be at a negatively cooperative, sensitive
point in the parameter space, where increasing kxx or decreasing kx can push the
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Figure 4.7: Plot of cooperative free energy as a function of the reduced two dimensional
parameter space of the internal and coupling spring constants for a) the static monomer
model and b) the mobile monomer model. The position of WT-CAP ( ) is plotted on both
plots and the positions of mutants that increase ( ) or decrease ( ) the value of kxx are plotted
on b). All other parameters for the models are set to WT values.
allostery into positive cooperativity. This free energy landscape and its similarities to
the landscapes of the other models is discussed below.
Mobile Monomer Model
The elasticity matrix of apo-CAP for the MMM is:
K0 =




















kxy 0 kxy + 2 ky 2 ky 0 0
−kxy 0 0 2 ky kxy + 2 ky 0 0
0 0 −kxy 0 0 kxy + 2 ky 2 ky
0 − 1
2
kxy 0 0 0 2 ky kxy + 2 ky

(4.2.20)
The reduced 2D (kx − kxx) parameter space for this model is plotted in figure 4.7.
This shows that the allosteric free energy surface in this region of parameter space for
this model is very similar to that of the SMM. This would imply that the simpler SMM
is able to model this region of parameter space as well as the MMM. The plot of the
MMM allosteric free energy surface shows the positions of WT-CAP, a mutant that
increases kxx (the interactions between the two monomers) and a mutant that decreases
kxx. A mutation that decreases kxx makes the system more negatively cooperative,
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Figure 4.8: Comparison of the two dimensional parameter space for the three SCG models.
The other parameters are set to WT values.
whereas a mutation that increases kxx makes the system less negatively cooperative,
or positively cooperative if kxx is increased enough. This effect could be recreated
experimentally by mutating a residue on the interface between the two monomers (and
is done later in this thesis by mutating residue V132).
Super Coarse Graining Discussion
The shape of the free energy surfaces for SMM and MMM are nearly identical around
the vicinity of WT-CAP. This would perhaps be expected due to the similarity between
the models. What is perhaps surprising is that for the truncated model, the allosteric
free energy is actually less (324 J mol−1) than the full length SMM (443 J mol−1) and
MMM (418 J mol−1). This is the opposite to what has been demonstrated by ITC
experiments, where truncated CAP has been seen to exhibit much stronger negative
cooperativity than full-length CAP [17, 59]. The disagreement of the model with ex-
perimental data could be due to the fitting of the WT parameters being performed on
full-length CAP; it is unlikely that they would be the same for truncated CAP. As has
previously been discussed, WT-CAP is in a position on the allosteric landscape that
is very sensitive to small changes in some of the parameters. The magnitude of the
negative cooperativity can be increased by raising the internal interaction strengths of
the monomers (kx), decreasing the intermonomer coupling strength (kxx) or increasing
the gain in interactions between monomers upon binding cAMP (α). With the removal
of such a large domain, it is quite likely that there will be significant changes to these
parameters.
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Figure 4.9: Comparison of changes in the parameter space upon changing one parameter.
With all other parameters set to WT values, this figure explores the changes to the free
energy landscape of the MMM, upon changing one of the parameters from the WT value.
The top row shows how the free energy landscape is altered when decreasing the parameter
indicated from WT value and the second row shows how it is altered when increasing the
parameters.
What is also very interesting is that in the immediate vicinity of WT-CAP, the free
energy landscape of the TMM is similar to those from the full-length CAP models.
This is because CAP is nearing the region where kx and kxx are much greater than kxy
and ky, meaning that these springs dominate the free energy of the system. In addition
to this, looking at the parameters responsible for the interactions of the DNABD (γ,
kxy and ky), it is evident that the effect that these parameters have on the allosteric
free energy surface is almost insignificant when compared to the effect of α, β, kx and
kxx (see figure 4.9).
Observing the allosteric free energy surfaces brings up the question as to why CAP
would evolve to be on such a sensitive region of parameter space, where small changes
to the interactions within the protein can make significant changes to the allosteric
free energy. This would imply that mutations in the LBD can strongly affect the
cooperative binding of cAMP. One argument for why CAP could have evolved in such
a way is that in this region it is more sensitive to mutations, meaning that any changes
in the environment that would change the cooperativity of cAMP to CAP would more
likely be changed back to the desired cooperativity through a mutation. A mutation
in the DNABD on the other hand may also have the undesired effect of removing the
protein’s ability to bind DNA, so would have no benefit of being mutated in a change
of environment.
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These SCG models do not take into account the fast modes of motion. However,
as was shown by Cooper and Dryden [36] (discussed in section 1.4.3), the slow, global
modes of motion are the significant contributions to the allosteric free energy. This
hopefully means they are sufficient for modelling allosteric signalling transferred by
thermal fluctuations. There have been previous models that include local fast modes
[54], capturing the effect that the contributed to cooperative binding by coupling to
the global slow motions. They contributed to the allosteric free energy by affecting the
amplitude of the slow modes, but did not significantly alter the shape of the allosteric
free energy landscape.
SCG models such as the ones discussed in this thesis are useful to investigate what
global properties of the protein homodimer can cause cooperative ligand binding. They
can also be used to investigate what changes to the interaction strengths within the
system can be made to manipulate the cooperativity of ligand binding. However, the
models cannot be used alone without advanced biochemical knowledge and thorough
structural investigation to determine mutations that can be made to cause the changes
to the models’ parameters and hence manipulate allostery.
4.2.2 Elastic Network Model
The elastic network model on the other hand is able to explicitly mutate chosen residues
in the protein by adjusting the spring constants for the springs connected to the mu-
tated residue. This was performed for CAP by Dr. Tom Rodgers and the results in
this section were first published in [59].
As previously explained, this model returns the normal modes of motion of the
protein with a simple harmonic potential function. These normal modes were used
to determine the free energy of the system and hence the allosteric free energy was
determined by finding the differences between these free energies using equation 1.4.19.
To verify that the motion observed by the ENM was not an artefact of coarse
graining the system, the B-factors determined from this method were compared to the
B-factors from the original PDB and the B-factors determined with fully atomistic
MD solutions (figure 4.10a). The experimental B-factors represent a combination of
the static and dynamic disorder in the crystal, so represent a reasonable approximation
of the local motions observed in the protein. The motions of the protein in a crystal
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Figure 4.10: Validation of the ENM methodology. a) The plot of the B-factor against amino
acid number for the ENM, molecular dynamics and the X-ray structure. The ENM and
atomistic MD show good B-factor agreement with each other and qualitative agreement with
the crystallographic B-factors. b) The plot of the normal mode frequency against the mode
number as calculated by the ENM and by PCA show good agreement (from [59]).
are hindered due to the crystal packing, therefore the motion observed in crystallised
proteins is typically less than the motion that would be observed in solution. Hence
these B-factors are generally lower than B-factors that would be observed in solution.
There was good agreement between the ENM B-factors, the atomistic B-factors from
MD and the crystallographic B-factors when taking into account the reduced motion
in a crystal. The ENM and MD, being unhindered show larger B-factor amplitudes in
the chain termini and flexible loop regions such as residues 150-175 than the hindered
crystallographic B-factors.
The frequency mode structure of the normal modes observed with ENM were veri-
fied by comparison to the structure of the normal mode frequencies observed by prin-
cipal component analysis of a fully atomistic MD simulation (figure 4.10b). The dis-
tribution of mode frequencies from ENM agreed well with the vibrational frequencies
derived from PCA, showing that the total predicted motion using the ENM is similar
to other methods of analysis and is not a feature of the coarse graining in the model.
Free energies of each bound state of CAP were calculated using the frequencies
of the normal modes and the full harmonic solution for the given system. The ENM
was able to correctly identify the negative cooperativity of CAP with an allosteric free
energy of ∆∆G = 749 J mol−1; a value consistent with experimental results (chapter
6) [59, 120–122].
The effect of mutating the side chains of amino acids at sites distant from the
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Figure 4.11: a) A map for the global control space of allostery in CAP calculated from the
ENM. The map plots the change in cooperativity coefficient (Ka2/Ka1) due to the dimen-
sionless change in the spring constant (kR/k) for the mutated residue with the amino acid
number shown. Red corresponds to an increase in Ka2/Ka1 (stronger negative cooperativ-
ity), whereas blue corresponds to a decrease in Ka2/Ka1 (weaker negative cooperativity or
positive cooperativity). The secondary structural elements of CAP are represented above the
plot, with purple bars representing α-helices and yellow arrows representing β-sheets. b) The
global map demonstrating the effect of loosening mutations (kR/k=0.25) mapped onto the
real-space coordinates of WT-CAP. The mutation sites investigated both experimentally and
through molecular dynamics simulations are indicated (From [59]).
binding site of cAMP alters the hydrophobic or electrostatic forces between the mutated
residue and its neighbouring residues. As previously mentioned, this is modelled in
the ENM by changing the relative spring constant of the mutated residue such that
kR/k 6= 1, with kR/k > 1 corresponding to a tightening of local interactions and
kR/k < 1 corresponding to a loosening of local interactions. It is assumed that a
structural change would not be caused by this mutation. The ENM was then used to
observe how these mutations affected the normal modes of the protein, which in turn
would alter the cooperativity of cAMP binding.
The change in allosteric free energy (∆∆G) or the ratio of association constants
(Ka2/Ka1) as a function of altering the amino acid sequence (one residue at a time)
can therefore be viewed as a quantitative map of the contribution of the normal modes
to cooperativity. A map such as this could theoretically be constructed experimen-
tally by mutating each residue individually, however it is much more convenient to
perform this computationally. A scanning mutagenesis was therefore performed using
the ENM, changing the effective elastic potential of all springs extending from the mu-
tated residue, one residue at a time. The increase and decrease in the spring constants
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simulated the strengthening and weakening of side chain interactions.
A colour coded map showing the effect that these mutations has on the cooperativity
of cAMP binding in CAP is plotted by residue number (a) and in real space (b) in
figure 4.11. The global map (a) exhibits large regions where the cooperative binding
of cAMP is sensitive to changes in the strength of the side chain interactions. It
is evident from (b) that many of these control regions are at sites distant from the
cAMP binding site, such as residues 130 to 137 at the dimer interface and some are
distant both from the binding sites and the dimer interface, such as residues 150 to 162
in the DNABD. These regions appear to control the cooperativity of cAMP binding
without directly interacting with the ligand binding site or contributing to a spatially
recognisable dynamic pathway. The study by Cann et al. also displayed evidence that
these amino acids that make larger changes to the cooperativity of cAMP binding are
more likely to be conserved in nature [59].
4.2.3 Overall Discussion
The ENM shows some consistency with the SCG models. The mutations in the ENM
that would weaken the interactions between the monomers, for example the residues
on the central alpha helix, appear in general to increase the negative cooperativity of
the system. This even occurs in regions along the alpha helix that are distant from
the cAMP binding site, so would not be directly affected by the presence of cAMP or
lack thereof. These weakening mutations are equivalent to the reduction of the spring
constant kxx in the SCG models, which also increased the magnitude of the negative
cooperativity observed.
Beyond this, it is more difficult to see similarities between this model and the SCG
model. Mutations that would weaken the interactions within the monomer, which
would lead to a reduction in kx in the SCG models, appear to cause changes to the
cooperativity in CAP in either direction. However, the majority do appear to push the
protein more towards positive cooperativity, which is what was predicted by all of the
SCG models. The regions where weakening mutations do not push the cooperativity
towards positive cooperativity are generally near the cAMP binding site, which could
cause changes to the interactions with cAMP. As the SCG models do not model the
mutant as additional particles in the model in the way that the ENM does, there are
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less likely to be similarities between the two types of models for mutations in this region
of the protein.
The consistency between the ENM and the SCG SMM and MMM also appears to
break down when mutations of the ENM are made in the DNABD. The ENM suggests
that a number of weakening mutations within this domain appear to push the system
toward positive cooperativity, whereas the SMM and MMM would suggest that these
mutations would make very little difference to the cooperativity of cAMP binding.
Assuming the accuracy of the ENM (which is tested in chapter 6), this would suggest
either that the DNABDs have been incorrectly modelled in the SCG model, or that
the TMM, which would model the changes in the DNABD as changes to kx is a better
model for full length than the more complex models. One should also note that the
position of the mutations that reduce the negative cooperativity are all distant from the
DNA recognition helix, so if these mutations were made, they are unlikely to directly
remove the protein’s ability to bind DNA.
A number of residues were chosen to mutate experimentally and computationally
using MD to test the ENM. The experiments aim to show that the changes to cooper-
ativity observed by the ENM can also be seen without a change in the conformation of
the protein backbone. The MD simulations aim to see if the changes in cooperativity
can also be captured by atomistic detail simulations and also to investigate whether
the ENM and SCG models are sufficient models for describing the allostery in CAP.
For example, it will investigate if more subtle effects such as enthalpy-entropy compen-
sation contribute to the allosteric signalling in CAP; the models in this chapter really
only capture the contributions from the configurational entropy.
The mutants investigated experimentally were V132A, V132L, V140A, V140L,
H160L and Q108A. V132A and V132L were chosen as loosening and tightening muta-
tions respectively, acting by altering the strength of the local hydrophobic interactions.
With the ENM V132A was predicted to make CAP more negatively cooperative and
V132L predicted to push CAP toward positive cooperativity. The V140A, V140L and
Q108A mutations were chosen as they were predicted by the ENM to not make a change
to the cooperativity regardless as to whether mutations at these sites increased or de-
creased the local interactions. H160L was chosen as it was a surface mutation, distant
from the interface between monomers that would remove local electrostatic interac-
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tions, and was predicted to push the system towards positive cooperativity. Chapter
6 contains the experimental investigation of these mutants.
The mutants investigated using MD were V132A, V132L, V140A, V140L and
H160L; chosen for the reasons given above. The results from these MD investigations
are included in chapters 5 and 6.
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Chapter 5
Atomistic Studies of Dynamic
Allostery in CAP
5.1 Methods
5.1.1 Molecular Dynamics Simulations
Molecular dynamics simulations were performed using the AMBER molecular dynamics
package [130]. A number of different force fields were used in this thesis, which were
ff99SB [215], ff99SB-ILDN [216], ff99SBnmr [217], ff03 [218] and ff12SB. The force field
used for each simulation is outlined in the corresponding results sections of this chapter.
A number of simulations were run for apo-CAP, holo1-CAP and holo2-CAP, for the
WT, V132A, V132L, V140A, V140L and H160L variants of CAP. CAP variants were
made by mutating the WT structure with Coot [219,220].
Partial charges for cAMP were either AM1-BCC charges [221], determined using
Antechamber [222] or B3LYP/6-311G** charges [223,224], determined using Gaussian
09 [225]. The charge model used for each simulation is discussed in greater detail
in 5.2.2. The general amber force field (GAFF) was used for the other force field
parameters of cAMP.
The initial starting structures for each system were the vacuum energy minimised
structures that were used for normal mode analysis as outlined in section 5.1.2. The
force field was added to each system using LEaP from the AMBER tools package [130],
using the default protonation for the side chains as determined by LEaP. Next, more
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water was added to the already present crystallographic water of the systems, bring
the total to 10297 water molecules. The water molecules used the TIP3P force field.
The net charge of CAP was neutral, so when the negatively charged cAMP molecule
was present in the simulations, a neutralising Na+ ion was included for each cAMP
molecule.
Periodic boundary conditions were employed using a periodic truncated octahedron.
The energy was minimised in two stages; firstly the protein was held with restraints
while the water was energy minimised, then the restraints were removed and the entire
system energy minimised (using the configuration files in appendix A).
The temperature of each system was then raised to 300 K over a 20 ps period
and density equilibration was performed over the next 20 ps by switching on pressure
coupling using the thermostat and barostat described in section 2.1. The systems were
then simulated for up to 300 ns, with up to 100 ns of the simulation being kept as the
equilibration time. As the simulation times differ for each system, they are included in
section 5.2, where the results are shown and discussed.
For each of the simulations, a time step of 2 fs was used. The lengths of all bonds
containing hydrogen were constrained using the SHAKE algorithm. A short range-
cutoff of 10 A˚ was used for non-bonded forces, with the long range portion of the
electrostatic Coulomb interactions represented by an Ewald summation.
Simulations were performed using the AMBER 11 or AMBER 12 MD packages
[130]. The AMBER 12 simulations used the GPU accelerated code for all simulations
except energy minimisation and equilibration [226, 227]. All MD input files can be
found in appendix A. The version of AMBER used for each simulation is explicitly
stated in section 5.2 when the results for them are discussed.
5.1.2 Normal Mode Analysis
NMA was performed with the ff99SB-ILDN force field (5.1.1) using Groningen machine
for chemical simulations (GROMACS) [155] (see 2.2). NMAs were performed both on
the initial starting crystal structure (4HZF) and snapshots from the MD simulation.
The more stringent L-BFGS was used to minimise the energy of the system until the
maximum force acting on any atom in the system was less than the tolerance of 0.0005
kJ mol−1 nm−1. A sodium ion was added for each cAMP molecule present in a system,
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to keep the charge of the system neutral. This was to ensure the structure is truly at a
minimum of the free energy surface. No cut-off was used for non-bonded interactions
for both the energy minimisation and the NMA.
The GROMACS configuration files used to perform the NMAs can be found in
appendix B.
NMA on X-ray structure
Starting by minimising the energy of the WT holo2-CAP crystal structure in vacuum;
the WT holo1-CAP structure was then created by deleting one cAMP molecule from
the structure and re-minimising. This step was then repeated to obtain the structure
for apo-CAP. These structures were used as the minimum energy structures in NMA
and were mutated using crystallographic object-oriented toolkit (Coot) [219] to create
starting structures for the variants, which were in turn energy minimised before NMA.
Normal mode analyses were then performed on the three bound states of each of
the CAP variants.
NMA on MD snapshots
Snapshots from the MD simulations with the ff99SB-ILDN force field were taken every
4 ns for each of the CAP variants. These structures were then stripped of water and
re-imaged to ensure the two monomers were not split across the periodic boundary.
The systems were then energy minimised before performing a NMA.
5.1.3 Principal Component Analysis
PCA was performed on windows of the MD simulations described in 5.1.1 using com-
mand prompt process trajectory (CPPTRAJ) from the AMBER Tools package [228,
229] and analysed using the same program and in house software called DDPT [172]
(see 2.3). Windows with a 20 ns duration were used after an initial equilibration period
of 100 ns. 20 ns windows were chosen as a compromise of windows estimated to be long
enough to capture global motions of the protein, while allowing a number of windows
to be used to allow statistically significant averaging.
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5.1.4 MM/PBSA Calculations
MM/PBSA calculations were performed on the MD-simulations of all of the systems
using the ff99SB-ILDN force field using the MMPBSA.py scripts available in AMBER
tools [130, 180] (see 2.7). The MM/PBSA contribution to the free energy was deter-
mined for apo, holo1 and holo2-CAP for each of the simulated variants, as well as
cAMP. These were then used to help calculate ∆G1, ∆G2 and ∆∆G. The calculations
were performed on the systems after 100 ns equilibration time, using 2000 frames over
the 200 ns of remaining simulation. A 20 ns simulation of cAMP in a box of water
(with 2000 frames and a 4 ns equilibration time) was used for the calculation performed
on the ligand alone.
For the PB portion of the calculation, an internal dielectric constant of 1 was
used for the protein and a dielectric constant of 80 was used for the solvent. A salt
concentration of 300 mM was used to try match the experimental conditions in chapter
6 as closely as possible. The radius of the solvent probe used was 1.4 A˚. For the SASA
portion of the calculation, when the entire nonpolar contribution was modelled with
the SASA model, a surface tension coefficient, γ, of 0.00542 kcal mol−1 A˚2 and a cavity
offset, c, of -1.008 kcal mol−1 were used. When only the repulsive part of the nonpolar
contribution to the free energy was modelled by the SASA model, a surface tension
coefficient, γ, of 0.0378 kcal mol−1 A˚2 and a cavity offset, c, of -0.5692 kcal mol−1
were used (see 2.1.12). In this case, the attractive portion was determined by an
approximation to the van der Waals attractive forces [148].
5.2 Results and Discussion
5.2.1 Investigating the Protonation State of cAMP
The ligand cAMP has a number of protonation states that are all prospective states
to model cAMP in this thesis. This section investigates which protonation state is the
most sensible to study for further simulations.
Observing cAMP in the crystal structure of CAP (4HZF), it is apparent that it
forms a number of hydrogen bonds and electrostatic interactions with the protein as
shown in figure 5.1. The side chain carboxylate oxygens of Glu73 can both separately
form hydrogen bonds as acceptors with a central oxygen in cAMP, however it is unlikely
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Figure 5.1: cAMP binding site, showing the hydrogen bonds present between cAMP and
CAP (PDB ID 4HZF). Hydrogen atoms are not present in the PDB structure, so they are
omitted for clarity.
that they would form hydrogen bonds simultaneously. The same oxygen in cAMP can
also form a hydrogen bond with the donor nitrogen in the backbone of residue Gly72.
The side chain oxygen atoms of Thr128 from the same chain and Ser129 from the
opposite chain are both hydrogen bond acceptors from the amino-nitrogen in cAMP.
The backbone nitrogen of Ser84 is a hydrogen bond donor to one of the oxygen atoms
in the phosphate group of cAMP. A side chain nitrogen of residue Arg83 also either
acts as a hydrogen bond donor for a hydrogen bond with oxygen of the phosphate
group of cAMP or forms an electrostatic interaction with the same atom, depending
on whether the oxygen is protonated or not.
A number of structural models for cAMP are proposed, to be included in the further
simulations of this study. These models are shown in figure 5.2, and will be referred to
as (a),(b),(c) and (d), their labels in the figure from this point. The first two of these
models (figure 5.2a,b) can be distinguished from the others by an additional hydrogen
bonded to one of the oxygen atoms in the phosphate group of cAMP, with the hydrogen
in (b) bonded to the other oxygen to the one in (a). Model (c) removes this hydrogen,
giving an overall charge of -1 to cAMP. Model (d) is a zwitterionic form of cAMP, with
an additional hydrogen bonded to the amino-nitrogen at the opposite end of cAMP.
The structures displayed in figure 5.2 are the electronic energy minimised structures of
cAMP using B3LYP/6-311G** [223,224] within the Gaussian09 package [225].
To investigate which model to use for the future simulations, firstly the structures
were energy minimised using B3LYP/6-311G** to calculate their minimum electronic
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Figure 5.2: B3LYP/6-311G** cAMP energy minimised structures, determined using Gaussian
[223–225]. The phosphate groups of (a) and (b) are protonated, each with the hydrogen on a
different oxygen. For (c), the phosphate group is deprotonated, giving cAMP a charge of -1.
(d) is a zwitterionic form of cAMP, with a deprotonated phosphate group and a protonated
amino group at the opposite end of cAMP.
energies in vacuum and in a variety of solvents modelled implicitly with the polarisable
continuum model [230]. These are shown in table 5.1. From this table it is evident that
the electronic energy of form (a) and (b) is significantly lower than the electronic energy
of form (d). For this reason, model (d) is not investigated further in this study. The
electronic energy of these three forms cannot be directly compared to the electronic
energy of the (c) form due to the loss of a proton in this form, so the (c) form is studied
further alongside the (a) and (b) forms.
Next, the binding of cAMP models (a),(b) and (c) to the binding sites in WT-CAP
was investigated by running 200 ns molecular dynamics simulations of holo2-CAP with
each of the three models of cAMP. The hydrogen bonding network in the binding site
was then investigated for each model of cAMP. Table 5.2 shows the occupancy of the
hydrogen bonds in the hydrogen bonding network identified in figure 5.1. Here the
occupancy is calculated by defining the chosen hydrogen bond as being formed when
the distance between the two heavy atoms in the hydrogen bond is less than 3.5 A˚ and
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a b c d
Vacuum 0.00 -3.51 1345.93 264.99
Water 0.00 -7.62 1158.61 56.58
Methanol 0.00 -7.37 1161.95 61.46
Toluene 0.00 -4.44 1244.82 164.90
Table 5.1: The Electronic Energies of the different models of cAMP in vacuum, water,
methanol and toluene. The energies are minimised in Gaussian 09 and are given in kJ
mol−1 relative to model (a).
H-Bond Donor H-Bond Acceptor Occupancy / %
Residue Atom Hydrogen Residue Atom a b c
Gly72A H N cAMPA O






2P 0 0 100
Ser84A H N cAMPA O
1P 83 49* 100
Ser84A Hγ Oγ cAMPA O












 78 76 67
cAMPA H
10 N6 Thr128A O
1
γ 96 98 84
cAMPA H
11 N6 Ser129B Oγ 92 94 90
Table 5.2: Occupancy of the hydrogen bonds for the three models of cAMP identified in
figure 5.2. The occupancy values shown are the average values across the two chains. *The
(b) form of cAMP forms a partially occupied hydrogen bond (49%) between O2P in cAMP
(rather than O1P).
the heavy atom-hydrogen-heavy atom angle is greater than 120◦.
From this table it is evident that certain hydrogen bonds in the cAMP hydrogen
bond network with CAP do not form properly for cAMP models (a) and (b). Model
(b) also manages to rearrange within the binding site so that the other oxygen from
cAMP’s phosphate group forms a hydrogen bond with residue Ser84. This leaves cAMP
in a rather constrained orientation that does not agree with the crystal structures. A
number of other hydrogen bonds are lost entirely for models (a) and (b). Model (c) is
the only model that manages to correctly form the hydrogen bonding network seen in
the crystal structures for the duration of the MD simulation. Images of cAMP binding
using the three different models can be seen in figure 5.3. As can be seen in this figure,
when either model (a) or model (b) are used to represent cAMP, the residue Arg83,
rearranges, so that it no longer forms the correct hydrogen bonds with cAMP, instead
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Figure 5.3: Snapshots of the binding of cAMP to CAP using three different models of cAMP.
For models (a) and (b), the interaction between cAMP and Arg83 is incorrect, and for model
(b), the hydrogen bond between Ser84 and cAMP does not form either. The location of these
interactions, or the location of where the interactions are missing from are highlighted with
red circles. It is only for model (c) that all of these interactions are present.
creating interactions with other parts of CAP because the hydrogen on the phosphate
group of cAMP creates too many steric clashes in this region of the binding site. From
the crystal structures available it is obvious that the Arginine does not rearrange in
the binding site. Therefore, further simulations in this thesis use model (c) of cAMP.
5.2.2 AMBER Force Field
A number of AMBER force fields are available for running simulations in the AMBER
MD package; this section investigates which one is the most suitable for simulating
CAP. Some of the more recent are the ff99SB, ff99SB-ILDN, ff99SBnmr, ff03 and the
ff12SB force fields. For the reason that ff99SBnmr is not easily ported into GROMACS
and some of AMBER’s tools are not optimised for use with this force field, it was not
used for the production simulations in this study. Furthermore, the ff03 force field
was not used, as although it was shown in a study to perform similarly well to ff99SB,
it was shown to over stabilise alpha helices [215]. A later study has also shown that
the ff99SB based force fields also perform better when calculating binding energies,
using the MM/PBSA method on longer simulations, as is performed in this thesis [231]
(section 5.2.8). The recent ff12SB force field was not used for the variant simulations
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Figure 5.4: RMSD of simulations of apo-CAP against the first frame of the simulation using
different AMBER force fields: a) ff99SB b) ff99SB-ILDN c) ff99SBnmr d) ff03 e) ff12SB
as this force field was added to the available AMBER force fields when most of this
study had been performed.
The force fields ff99SB-ILDN was chosen to use for the majority of the other sim-
ulations shown in later sections of this chapter based on these conclusions from the
literature. ff99SB-ILDN was chosen rather than ff99SB as it contains a few improve-
ments to side chain torsional parameters over ff99SB for a small number of residues.
Initially, a number of 200 ns simulations were performed to look at the effect of the
force field on the stability of the simulation. These simulations were performed using
the PDB with ID code 1G6N, removing the cAMP molecules to make an apo-CAP
system. The AMBER 11 CPU code was used for all simulations except the ff12SB
force field, which used AMBER 12 GPU code, the release of AMBER that this force
field became available.
Figure 5.4 shows the root-mean-square deviation (RMSD) of simulations of apo-
CAP using the different AMBER force fields. This figure suggests that all of the sim-
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ulations tend to converge within the first 100 ns of the simulation, with the structure
in the simulations settling at around an RMSD of 3-5 A˚ from the starting structure.
The simulations using ff99SB seems to have a change in the RMSD after 100 ns into
the simulation. This could indicate a move to another minimum in the global confor-
mation landscape, however as the change is only small it is only a minor change in the
conformation. From visual inspection of the simulation, this can be confirmed to be
the case. The other simulations all appear to converge in terms of the RMSD.
Of these force fields, the ff99SB and ff99SB-ILDN force fields were used to check
the effect of the force field on the binding site of cAMP by simulating holo2-CAP for
200 ns with the same conditions described above for apo-CAP. Later in the study, the
ff12SB force field was added to this analysis and is included in this section
The first check to see the efficacy of each force field to model the cAMP binding sites
was to study the hydrogen bonds between cAMP and the protein. The hydrogen bonds
studied are the same as in section 5.2.1 and using the same method. The occupancy
of each of the hydrogen bonds are displayed in table 5.3.
It is evident from this table that both the ff99SB and ff99SB-ILDN force fields
perform well when recreating the hydrogen bonds between cAMP and CAP, with the
occupancy of most of the hydrogen bonds being close to 100% occupied for most of
the hydrogen bonds observed in the crystal structures. They both seem to represent
the cAMP hydrogen bonding network equally well, which is not surprising as the two
force fields are closely related.
The third force field, ff12SB does not form all of the hydrogen bonds to sufficient
occupancy, with a number of hydrogen bonds having a lower occupancy. In this case,
it is due to one chain having almost fully formed hydrogen bonds at all times and the
other chain losing a few hydrogen bonds for parts of the simulation. For example, the
hydrogen bond between Arg83 and cAMP has 99% occupancy in the first monomer
and 70% occupancy in the other and the hydrogen bonds from Ser84 are 100% and 96%
in the first monomer and 64% and 63% in the other. Studying the simulation of this
system, it is evident that the DNABD rotates during the simulation by a significant
amount for the monomer with lower hydrogen bond occupancy. This rotation allows
the binding site of cAMP to open up slightly, allowing these hydrogen bonds to break.
To quantify the extent of the DNABD rotation, the LBDs were aligned and the
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H-Bond Donor H-Bond Acceptor Occupancy / %
Residue Atom Hydrogen Residue Atom ff99SB-ILDN ff99SB ff12SB
Gly72A H N cAMPA O






2P 100 100 85
Ser84A H N cAMPA O
1P 100 100 82
Ser84A Hγ Oγ cAMPA O












 67 68 63
cAMPA H
10 N6 Thr128A O
1
γ 84 95 79
cAMPA H
11 N6 Ser129B Oγ 90 96 88
Table 5.3: Occupancy of the hydrogen bonds for three AMBER force fields; ff99SB-ILDN,
ff99SB and ff12SB. The occupancy values shown are the average values across the two chains.




Table 5.4: RMSDs between final structures of simulations using the force fields ff99SB-ILDN,
ff99SB and ff12SB. The structures were aligned using the backbone of the LBDs and RMSDs
calculated for the LBDs and the full protein.
RMSD calculated, using the Kabsch algorithm [232] in VMD [214], for the LBDs alone
and the full length protein using the final structures of each simulation. This is shown
in table 5.4. This shows that there are not many structural differences between the
backbones between the LBDs of each force field, however the LBD from the ff12SB
simulation shows greater deviation from the ff99SB-ILDN structure than the ff99SB
structure does. This is most likely due to the loosening of the LBD caused by the
rotation of the DNABD.
The extent of the rotation of the DNABD can be seen in table 5.4, as it increases
the RMSD of the full length CAP to 9.26 A˚ from the ff99SB-ILDN structure. It can
also be seen in figure 5.5. This figure shows an analysis to find the axis and extent
of rotation needed to rotate the DNABDs from the final structure of the ff99SB-ILDN
to the DNABDs from the final structure of the ff12SB simulation performed using the
hingefind plugin of VMD [214, 233]. The domains of the protein were determined by
finding rigid regions of the two structures that had an RMSD below the tolerance of
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Figure 5.5: Rotation of DNABD in simulation of holo2-CAP using the ff12SB force field,
shown relative to the final structure from the ff99SB-ILDN simulation. The axis of rotation
between a DNABD and the LBDs is shown as an arrow in the same colour as the DNABD.
4.5 A˚.
The most perturbed DNABD of the ff12SB structure has a rotation angle of 66.6◦,
while the less perturbed domain had a rotation angle of 27.5◦. With both DNABDs,
the axis of rotation is near the region between the DNABD and the LBD.
This large rotation of the DNABD is also accompanied by a rearrangement of
the cAMP binding site in the monomer which undergoes the DNABD rearrangement.
Figure 5.6 shows that the ligand binding site undergoes a structural rearrangement
just over 100 ns into the simulation for the ff12SB simulation of holo2-CAP. The other
two force fields used however, do not show a structural change in the binding site.
The experimental crystal structures of a number of variants of holo2-CAP do not
show the rotation of the DNABD seen in the ff12SB simulation. The simulations using
ff99SB and ff99SB-ILDN on the other hand do not exhibit structural rearrangements
to the extent seen in the ff12SB simulation. Furthermore, as seen in figure 5.1, the
structure of the binding site of holo2-CAP seen experimentally (4HZF) shows the hy-
drogen bonding network that is investigated in table 5.3. The ff99SB and ff99SB-ILDN
force fields represent this hydrogen bonding network better than the ff12SB force field.
This would perhaps suggest that ff99SB and ff99SB-ILDN are better force fields for
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Figure 5.6: RMSD of cAMP and the residues it forms hydrogen bonds with for a) ff99SB-
ILDN, b) ff99SB and c) ff12SB. The RMSDs were calculated with the residues in table 5.3,
with the black and red plots representing the two different monomers of CAP. The RMSDs
were determined using cpptraj, part of the AMBER tools package [228].
representing holo2-CAP than ff12SB. As mentioned earlier, ff99SB-ILDN was chosen
over ff99SB for the remaining simulations due to the small improvements to torsional
parameters that it included.
5.2.3 Normal Mode Analysis
Normal mode analyses were performed using the ff99SB-ILDN force field for a number
of variants of CAP. The variants investigated were WT, V132A, V132L, V140A, V140L
and H160L. They were chosen as these were identified by the elastic network model as
variants that could either affect the allostery in CAP (V132A, V132L and H160L) or
cause no change to the allostery in CAP (V140A and V140L). The latter two variants
were contained as negative controls.
The structure used to create the starting structures for the normal mode analyses
was the X-ray structure with a PDB ID number of 4HZF. The structure of holo2-
CAP was energy minimised in GROMACS using L-BFGS. One molecule of cAMP was
then stripped to create the structure of holo1-CAP, which was again energy minimised
using the L-BFGS method. The second cAMP molecule was then stripped before
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Figure 5.7: Overlaps of the first 25 normal modes from the three bound states of WT-CAP.
The overlaps of the normal modes from apo-CAP vs. holo1-CAP, holo1-CAP vs. holo2-CAP
and apo-CAP vs. holo2-CAP. The overlaps were calculated using only the Cα atoms for each
system. The first six normal modes are translational and rotational modes for each system.
minimisation, giving the energy minimised structure of WT apo-CAP.
The WT apo-CAP, holo1-CAP and holo2-CAP systems were each mutated to create
the corresponding systems for each of the variants, which were in turn energy minimised
using the L-BFGS method. All of the energy minimised structures of the CAP variants
were used for the normal mode analyses. All crystallographic water molecules were
retained for all of these NMAs.
From the NMAs, information regarding the frequency and directionality of the
global modes of motion can be obtained. Only the directionality of the motion is
investigated in this section. The frequency of the low frequency modes are investigated
in section 5.2.7 to estimate binding entropies.
Figure 5.7 shows the overlaps (see section 2.5.3) of the normal modes calculated
for the three bound states of WT-CAP. It is evident from this figure that the slow
modes for CAP as calculated by NMA only have subtle changes, with the majority of
the modes changing only slightly. The first five or so (none zero) low frequency modes
change the least between the three bound states, but the higher frequency modes have
a larger change upon binding.
One interesting observation in the overlap of the modes from apo-CAP and holo1-
CAP is that the line of greatest overlap does not perfectly follow the diagonal, instead
it appears that the overlap of the first 25 modes for holo1-CAP correspond to the first
22 or so normal modes for apo-CAP. This could imply that more low frequency modes
are activated for holo1-CAP. This could be equivalent to a few of the low frequency
modes in holo1-CAP disappearing in apo-CAP by being decomposed across a number
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of the low frequency modes in apo-CAP. This appears to happen to some extent for
mode numbers 12, 14, 19 and 25 of holo1-CAP as well as a few others to a lesser extent.
This activation of low frequency motions in the protein upon binding the first cAMP
is consistent with the observation by Kalodimos et. al [17] when studying the change
in dynamics upon binding cAMP to the truncated form of CAP (see section 1.5.5).
The picture upon binding the second cAMP is less clear, as the line of maximum
overlap between the modes of holo1-CAP and holo2-CAP appear to follow the diagonal
better, however the mode structure between these two bound states appears to deviate
more than between apo and holo1-CAP. It appears that a number of holo1-CAP modes
are decomposed over a number of holo2-CAP modes upon binding and a number of
holo2-CAP modes are composed of parts of a number of holo1-CAP modes. This cannot
be said to show agreement with what was observed by Kalodimos et. al [17].
Figure 5.8 shows the cross correlations (see section 2.5.2) between the residue motion
for apo-CAP, holo1-CAP and holo2-CAP. This shows the extent to which the motion
exhibited by a certain residue is similar to the motion exhibited by the other residues.
It is evident that the residues that have correlated motion with the opposite chain
tend to be either, near the interface between the two monomers, or near the cAMP
binding site. These residues also seem to correlate well with the motion of cAMP in
the same chain when it is present. The motion of the residues surrounding Thr128 and
Ser129 also seems to correlate well with the motion of cAMP in the second chain. The
proximity of these residues to the binding sites and the correlated motion across the
interface could contribute to the dynamic allostery observed in CAP.
When viewing the cross correlation as a function of residue space, as seen in figure
5.8, it is difficult to pick out subtle changes to the protein motion upon cAMP binding.
When looking at how the motion in CAP correlates to the motion of a single chosen
residue, it is possible to study this correlation in the real space. This is shown in figure
5.9, where the residue Thr128 is chosen. This residue is chosen as it is one of the residues
that forms a hydrogen bond with cAMP, and is on the dimer interface. This figure
suggests that upon binding one cAMP, the correlated motion across the dimer interface
seems to increase slightly, and binding the second cAMP causes another increase in
the correlated motion across the interface. The motion of cAMP also correlates well
with the motion of Thr128, even if cAMP binds to the opposite monomer. This hints
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Figure 5.8: The cross correlation of the motion between residues as shown in 2-Dimensional residue space for the three bound states of CAP. The
colour scale show the extent of cross correlation, with a cross correlation of 1 (red) indicating perfectly correlated motion and -1 (blue) showing
perfectly anticorrelated motion. The secondary structure of CAP is indicated along the residue axes, with purple rectangles indicating an alpha
helix and yellow rectangles and arrows indicating beta strands. The white triangles indicate the location of residues that form hydrogen bonds with


















Figure 5.9: The cross correlation of the motion between residue Thr128 and the rest of the protein plotted in real space. The top row shows the
correlation of the residues in the protein with Thr128 from the monomer which cAMP binds to first and the bottom row shows the correlation of
the other Thr128 with the other residues in the protein. For both rows, apo-CAP is on the left and holo2-CAP is on the right.
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Figure 5.10 shows the overlaps of the normal modes between WT-CAP and the
variants. This shows that the shape of the normal modes for the CAP variants are
not very different to those for WT-CAP. Implying that making these variations to the
secondary structure of CAP does not make large changes to the shapes of the normal
modes. This is especially true for the variants V132A, V132L and V140A and appears
to be the case for all three bound states of CAP. The variants V140L and H160L appear
to change the shape of the normal modes to a greater extent.
The lack of change in the shape of the normal modes for some variants compared
to WT-CAP would perhaps suggest that these vibrations are not the carriers of the
allosteric signal. However, these NMAs are all performed using the same crystal struc-
ture, whereas in reality, the protein would explore a number of local minima, not just
the one observed in the crystal structure.
What is quite surprising is that the negative control variant, V140L, appears to
change the shape of the modes more than V132L does. It is hard to explain the reason
for this, but could be due to the mutation in the V140L causing a larger perturbation
in local structure.
It is perhaps less surprising that H160L makes larger changes to the structure of the
normal modes, as this mutation is converting a large hydrophilic amino acid to a large
hydrophobic one. Therefore it is more likely to make larger changes to the interactions
within the local region of the protein.
However, as has already been discussed, the normal modes that were studied in this
section were all calculated from very similar static structures that are simple mutations
of the WT crystal structure. The method used does not allow the structure of variant
to equilibrate once the mutation is made. The NMA investigation in section 5.2.7
attempts to tackle this problem by performing NMAs on snapshots of long molecular
dynamics simulations of the CAP variants.
5.2.4 Molecular Dynamics Simulations of CAP Variants
A number of 300 ns MD simulations were performed on the three bound states of the
CAP variants; WT, V132A, V132L, V140A, V140L and H160L as described in 5.1.1
and using the AMBER 12 GPU code [130]. B-factors were calculated by looking at
the RMSF of the Cα atoms averaged over time. These B-factors are shown for the case
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apo-CAP holo1-CAP holo2-CAP
Figure 5.10: Overlaps of normal modes from WT-CAP vs. normal modes from the other
variants for apo, holo1 and holo2-CAP. The order of the variants from top to bottom is:
V132A, V132L, V140A, V140L and H160L.
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Figure 5.11: Comparison of experimental B-factors to the B-factors calculated from the MD
simulation (for chain A of WT holo2-CAP). The B-factors calculated by MD are scaled
by a factor of 13 for the plot for clarity. The secondary structural elements are displayed
below the plot, with α-helices displayed as purple rectangles and β sheets displayed as yellow
arrows. The positions of the residues that form hydrogen bonds with cAMP are indicated
with triangles (4).
of WT holo2-CAP in figure 5.11, with the experimental B-factors for comparison. The
calculations show a fairly good agreement with the experimental B-factors. Evidently,
the B-factors from the simulations have a much greater magnitude than those from
experiment, however this is to be expected as the experimental B-factors are from the
confined crystal structure where the molecule is not as free to move as it is in solution.
The effect of the increased motion when the protein is released from the crystal
confinement can be seen when observing how the RMSF varies as the simulation pro-
gresses (see figure 5.12). At the start of the simulations the RMSF values are at their
maximum, and as the simulation progresses, the RMSF values settle down and become
more consistent between 20 ns windows towards the end of the simulation.
It can also be observed that for WT holo2-CAP, one of the DNABDs undergoes
larger fluctuations that the other, especially at the start of the simulation. This eventu-
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Figure 5.12: The progression of the per-residue RMSF for every 20 ns window throughout
the simulation. The different chains are plotted separately and the windows are plotted on
three sub plots of five windows for clarity.
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holo2-CAP holo1-CAP
Figure 5.13: Final structure of holo2- and holo1-CAP after 300 ns of simulation for:  WT,
 V132A,  V132L,  V140A,  V140L and  H160L. The structures are RMS fit to the
corresponding final structure for WT-CAP, using the PyMOL [234] implementation of the
Kabsch Algorithm, using only the ligand binding domains for the fit.
ally diminishes; with the RMSFs of the two DNABDs becoming more similar towards
the end of the simulation. The differences between the RMSFs of the LBDs is much
more subtle, if at all. The differences between the DNABDs of each monomer is most
likely due to the crystal packing, leaving the two DNABDs in slightly different orien-
tations before the simulation is even started.
Throughout the simulation, there is very little change to the magnitude of the
fluctuations in the LBD. This is because the structure of the LBD does not change
much throughout the simulations. This can be seen to be the case when comparing the
final structures after 300 ns of simulation of the CAP variants studied. For holo2-CAP
and holo1-CAP, these are shown in figure 5.13, where it can be seen that there is very
little change to the structure of the LBD between each of the variants. The largest
change to the structure appears to be a rigid body rearrangement of the DNABDs
with respect to the LBDs. The changes in structure upon binding will be investigated
further, later in this section.
For apo-CAP there is also very little change to the structure of the LBD upon the
mutations being made. Also, for most of the systems the structural differences between
the DNABDs appear to be rigid body movements about the hinge region between
the LBD and the DNABD. Only WT undergoes a large structural rearrangement of
140 5.2. Results and Discussion
Figure 5.14: Final structure of apo-CAP after 300 ns of simulation for:  WT,  V132A, 
V132L,  V140A,  V140L and  H160L. The structures are RMS fit to the corresponding
final structure for WT-CAP, using the Kabsch algorithm with the backbone atoms of the
ligand binding domains for the fit [232]. This was performed in PyMOL [234].
one DNABD when compared to the other variants (and bound states of WT-CAP).
This structural rearrangement is discussed in greater detail later in this section. The
structure of the LBD, however, even in this WT system does not change much in
comparison to the other variants.
Table 5.6 shows the RMSDs of the LBDs for the final structures of the variants
against the final structure of WT-CAP as well as the RMSDs including the DNABD
in the calculation. This table confirms that there is very little structural change to the
LBDs when the mutations are made. This is the case for apo, holo1 and holo2-CAP,
as can be seen from the low RMSD values between the LBDs of the variant systems
and equivalent WT systems. This can especially be seen for holo1 and holo2-CAP,
where the RMSD between the LBDs does not exceed 1.53 A˚. For apo-CAP, the RMSD
between the variants and WT is slightly larger. This is most likely due to changes in the
shape of the large central alpha helices near the hinge joining the LBD to the DNABD.
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RMSD LBD / A˚ RMSD CAP / A˚
apo holo1 holo2 apo holo1 holo2
WT 0.0 0.0 0.0 0.0 0.0 0.0
V132A 2.31 1.53 1.28 12.24 3.58 2.65
V132L 1.76 1.17 1.21 12.35 2.28 4.03
V140A 1.82 0.98 0.96 11.24 2.46 3.69
V140L 1.96 0.95 1.35 12.68 3.77 2.36
H160L 2.16 0.92 0.94 11.83 1.86 3.51
Table 5.5: RMSDs between the variants and WT-CAP for the three bound states of CAP.
The RMSD alignment was performed on just the backbone atoms of the LBDs of CAP (up to
residue 138), using the PyMOL [234] implementation of the Kabsch algorithm [232]. RMSD
values are shown for the LBD alone and the full length CAP.
The differences between the RMSDs, however are still fairly small and definitely do
not support a structural change of this domain.
The RMSD between the variants and WT-CAP for holo1 and holo2-CAP, when
taking the entire CAP protein into consideration is still fairly small, not exceeding 4 A˚
by much in any instance. The RMSD for full length CAP is greater than the RMSD for
just the LBD in all instances. This is again consistent with the view that the change
in structure is a small rigid body movement of the DNABDs.
However, for apo-CAP, the RMSD between the variants and WT is much larger.
This is not due to large differences between the variant structures, but due to the large
rearrangement of the DNABD in WT-CAP. To tackle the problem that arises when
comparing these variant structures to WT apo-CAP and also to see how the structures
of each variant differs between their three bound states, comparison of the structures
of the three bound states for each variant was then performed separately.
Again, as can be seen in figure 5.15, there is very little structural change in the LBD
between the three bound states for each variant. This can be confirmed by observing the
low RMSD values for this domain in table 5.5. The only structural differences between
the three bound states are again only small rigid body rearrangements of the DNABD
for all variants except WT-CAP. For WT-CAP, only small differences are seen between
holo1 and holo2-CAP, however, apo-CAP exhibits a much larger rearrangement of one
of the DNABDs. This is exemplified in the RMSD of apo to holo2-CAP, which is 10.62
A˚ for full length WT-CAP.
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WT V132A V132L
V140A V140L H160L
Figure 5.15: Structural changes between apo, holo1 and holo2-CAP for each variant:  apo-
CAP,  holo1-CAP and  holo2-CAP. Structures were fit in PyMOL using the Kabsch
algorithm [232] to fit the LBDs.
RMSD LBD / A˚ RMSD CAP / A˚
apo holo1 apo holo1
WT 2.01 1.49 10.62 2.66
V132A 1.45 1.40 3.96 3.64
V132A 1.41 1.45 4.95 3.77
V132A 0.92 1.19 2.58 4.46
V132A 1.93 1.61 2.89 3.60
V132A 1.52 1.57 3.63 4.37
Table 5.6: RMSDs of apo and holo1 cap against holo2-CAP for all mutations of CAP. The
RMSD alignment was performed on the backbone atoms of the LBDs of CAP, and RMSD val-
ues determined for the LBD alone and the full length CAP. The calculations were performed
in PyMOL [234] using the Kabsch algorithm [232].
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Looking at the rotation and translation that is undergone by the DNABD, by fitting
the LBD of the protein to the same for holo2-CAP, the centre of mass of the DNABD
translates by 22.93 A˚ with the domain rotating 83.59◦ with respect to the LBD. The
hinge is effectively at the very top of the large central α helix. The location of this
rotation axis and the extent of the rotation is shown in figure 5.16.
When compared to the movement of the other DNABD, the centre of mass only
moves 5.31 A˚, corresponding to a rotation angle of only 5.52◦. However the rotation
hinge is much further away near the base of the long α helix in this case, as can be
seen in figure 5.16. These hinges and the extent of rotation were calculated by treating
both LBDs as one large rigid domain and each DNABD as separate rigid domains, and
then calculating the rotation relative to the final structure of WT holo2-CAP. These
domains were defined by finding rigid regions of the two structures that had an RMSD
below the tolerance of 4.5 A˚. The rotation axis was then calculated by finding the angle
difference between the LBDs of holo2-CAP and the DNABD investigated for apo and
holo2-CAP. This analysis was performed using the hingefind plugin of VMD [214,233].
The MD simulations were analysed further, using a number of different techniques.
Firstly, the role of residue Thr128 in the allosteric signalling was investigated (see
section 5.2.5). Then, PCA was performed on the entire simulation as well as smaller
windows of the simulation (see section 5.2.6). Free energy calculations were performed
using MM/PBSA [130, 180] and NMA for the conformational entropy to try to deter-
mine the free energy of binding for each binding event (see sections 5.2.7 and 5.2.8).
5.2.5 Investigating the Role of Thr128 in the Allosteric Sig-
nalling of CAP
While investigating the hydrogen bonds between Thr128 and cAMP, it became ap-
parent that the hydrogen bond occasionally got broken in holo2-CAP (see table 5.2).
Upon further investigation, it was apparent that there were two conformations that
each Thr128 residue could be found in, which can be described by the dihedral shown
in figure 5.17). This dihedral will be labelled χa for chain A and χb for chain B,
where chain A is the chain that binds cAMP first (in holo1-CAP). When the dihedral
is referred to for either chain, the notation χx will be used.
The most prominent dihedral angle that these atoms are found in for holo2-CAP
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Figure 5.16: Rotation axis (arrows) and the angle of rotation observed in the apo-CAP
DNABDs, when compared to the structure of holo2-CAP (translucent green structure). The
structure apo-CAP is split into three domains, one made of the LBDs (blue), and two com-
prising of each DNABD (grey and red). The arrows indicate the axis of rotation and the rods
indicate the extent of the rotation.
is around -60◦, but they can also be found occasionally with a dihedral around 60◦
in some of the simulations. The dihedral distributions for each conformation actually
average to -50.25◦ and 50.09◦, for WT holo2-CAP, but they will be referred to as -60
and 60 for clarity. In all of the available crystal structures of holo2-CAP in the PDB,
only the χx conformation is found. With the dihedral in Thr128 from each chain, being
able to have two different conformations, the system has four possible states.
Figure 5.18 shows these four states in their local environment within CAP. As
it can be seen, when χx = −60◦ and cAMP is present, Thr128 is able to form a
hydrogen bond with cAMP and it appears as if both chains are in this orientation,
the Cγ methyl groups of Thr128 may be oriented in a way where they form favourable
hydrophobic interactions with each other and the Val132 residue. However, in the
χx = 60
◦ orientation, the hydrogen bond to cAMP cannot be formed and it appears
as if fewer hydrophobic interactions will occur across the interface. When χx = 60
◦















Figure 5.17: The dihedral used to determine the conformation of Thr128, highlighted in red,
with the order used in the dihedral calculation indicated.
Figure 5.18: The two different conformations of Thr128 leads to four different states when
both chains are taken into account. Shown are images of each of these four states, firstly
from the side of the two α helices on the dimer interface, and secondly from the top, looking
down the length of the α helices.
for both chain A and B, the Thr128 sidechain can be rearranged in such a way that a
new hydrogen bond can form across the interface. This however occurs by breaking a
hydrogen bond internally in the monomer with residue Arg124.
Histograms of Thr128
To observe which orientation is most prominent for each Thr128 in each bound state,
histograms of χa and χb were plotted (see figure 5.19).
For WT holo2-CAP (figure 5.19 (a)), χx for both chains is almost exclusively -60
◦.
For the simulation of WT holo1-CAP, it is apparent that the χb = 60
◦ occurs more
frequently. However, χa remains in the -60
◦ orientation. As the cAMP is still bound
to chain A, but not chain B in this orientation, this implies that Thr128 for chain B is
more free to explore the other orientation. For apo-CAP, the cAMP from chain A is
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Figure 5.19: Histograms of the dihedral space for residue Thr128. The histograms for the
individual chains are shown separately. Variants shown are a) WT and b) V132A.
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Figure 5.19: Histograms of the dihedral space for residue Thr128. The histograms for the
individual chains are shown separately. Variants shown are c) V132L and d) V140A.
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Figure 5.19: Histograms of the dihedral space for residue Thr128. The histograms for the
individual chains are shown separately. Variants shown are e) V140L and f) H160L.
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removed, and in this simulation, both χx = −60◦ and χx = 60◦ are sampled for both
chains. This would imply that in the absence of cAMP, the Thr128 residue side chain
is more likely to rotate along the Cα-Cβ axis to form different interactions across the
dimer interface in these simulations of WT-CAP.
When observing the preferred values of χa and χb for the holo2 simulations of the
other variants (figure 5.19 (b-f)), it is evident that when both cAMP are present, the
strongly preferred orientation for Thr128 of both chains is when χx = −60◦. For holo1-
CAP, the Thr128 residue in chain A, the chain to which cAMP is bound, also appears
to be firmly held in the χx = −60◦ orientation. This would imply that when cAMP
is present, the hydrogen bonds between cAMP and Thr128 are strong enough to hold
Thr128 in the χx = −60◦ orientation.
Also, the population of Thr128 in chain B (the chain without cAMP) of holo1-CAP
in the χb = 60
◦ orientation increases for all variants when compared to holo2-CAP.
The distribution of χb = 60
◦ and χb = −60◦ is fairly even for all variants except
V140L, suggesting that for these variants, both configurations have similar energies.
For V140L (figure 5.19 (e)), it could either be the case that the χb = −60◦ configuration
is unfavourable, or the barrier between the two configurations is large enough that the
side chain cannot get out of the χb = 60
◦ orientation. As the system does not jump
between the two configurations except once into χb = 60
◦, the second case is the most
likely.
For apo-CAP, the variants V132A, V140A and V140L appear to sample both χx =
60◦ and χx = −60◦ in both chains. This again shows that the presence of cAMP
stabilises the χx = −60◦ orientation and implies that both orientations have not too
dissimilar energies when cAMP is absent. Only two variants; V132L and H160L appear
to not follow this rule, which is explored when the four different states are investigated.
Free Energy Surface of Four States of Thr128
Rather than just plotting a one dimensional histogram, it is also possible to investigate
which of the four states (in figure 5.18) are most favourable for each variant and bound
state by plotting a two dimensional histogram, with χa and χb as the axes. It is
also possible to plot the free energy surface of this dihedral space by performing a
Boltzmann inversion on the histogram. This plot is shown for WT apo-CAP in figure
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Figure 5.20: Histogram and free energy surface of the 2D dihedral space for Thr128 of both
chains. The histogram is shown on the xy plane and has the scale shown in the the colour bar.
The free energy surface is generated by performing a Boltzmann inversion on the histogram
and normalising so that the deepest well has an energy of 0 kJ mol−1.
5.20. The histogram is displayed as a flat contour plot on the base of the figure, and
the calculated free energy surface shown above it. This system, for example samples
all four possible states, with the most populated state being the χa = −60|χb = 60
state. This state therefore has the lowest energy on the energy surface. Figure 5.21
shows the histograms and energy surfaces for the 2 dimensional dihedral space for all
of the variants and cAMP binding states.
These free energy surfaces again confirm that in the presence of cAMP, the preferred
value of χx is -60
◦ for all variants. Thr128 is also again shown to be more flexible in
apo-CAP, with all four states on the dihedral being sampled for most variants. Only
mutations V132L and H160L do not sample all four states on the dihedral space of
apo-CAP. This may suggest a tightening in the region around this residue. These
variants are the only two identified by the ENM to push the protein towards positive
cooperativity of the variants studies. In the next chapter it is shown with ITC that
these two mutations do in fact push the system towards positive cooperativity. This
helps strengthen the argument that Thr128 is an important residue in the signalling
pathway for the cooperative binding of cAMP.
It is easy to see why making the V132L mutation may hinder the rotation of the
χx dihedral. Figure 5.22 shows that due to the location of the mutation being near the
location of residue Thr128, the added bulk of the leucine most likely hinders rotation
of the threonine compared to WT. Furthermore, mutating the valine to alanine as
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Figure 5.21: Histograms and free energy surfaces of the 2D dihedral space of Thr128 for all
variants; WT, V132A, V132L, V140A, V140L and H160L. The three bound states: apo-CAP,
holo1-CAP and holo2-CAP, were investigated for each variant.
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Figure 5.22: Mutating Val132 adjusts the hydrophobic interactions with Thr128. The figure
shows the Thr128 and Xaa132 residues for WT, V132A and V132L. As well as altering the
hydrophobic interactions V132L also gives residue 132 a lot more bulk, which could hinder
rotation of residue Thr128.
in V132A, creates more space for rotation of the threonine. The effect of the H160L
mutation is not as clear, as the site of the mutation is in the DNABD very distant from
Thr128.
ff12SB Investigations
To ensure that the effect seen here was not a force field dependent effect, 200 ns
simulations of WT-CAP were performed for the apo, holo1 and holo2 systems using
the newer AMBER ff12SB force field. These simulations found that for all three bound
states, the Thr128 residue was much less flexible, being constantly held with a dihedral
of -60◦, as can be seen in figure 5.23.
To investigate if this occurred because the energy barrier between χx = −60◦ and
χx = 60
◦ was larger, thus preventing the flip between the two dihedral angles, another
200 ns simulation of WT apo-CAP was performed, with a starting structure where
χx = 60
◦ for both chains. In the simulation, the dihedrals χa and χb, soon flipped and
stayed in the χx = −60◦ orientation, as can be seen in figure 5.24. This suggests that
it is not due to a large energy barrier that Thr128 stays in the -60◦ orientation, but
that the energy of the 60◦ orientation is unfavourable with this force field.
Plotting the force field dihedral terms for this force field, it is evident that their is
a large change in these terms, which destabilises the χx = 60
◦ orientation. The barrier
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Figure 5.23: Histograms of the dihedral angle of the sidechain of Thr128 using ff12SB. The
three bound states: apo, holo1 and holo2 are shown for WT-CAP.
Figure 5.24: The dihedral of Thr128 over time with χx = 60 as the starting structure.
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Figure 5.25: Dihedral functional forms for the N-Cα-Cβ-Oγ dihedral in Thr128 with ff99SB-
ILDN and ff12SB.
between the two energy wells, however, does not change much between the two force
fields. Of course, this is only part of the picture, as the 1-4 van der Waals and 1-4
electrostatic terms should also be taken into account, which could further destabilise
the χx = 60
◦ orientation or increase the barrier between the two orientations. It is
likely due to the 1-4 van der Waals and 1-4 electrostatic terms that the χx ≈ 180◦
orientation is not observed in any of the simulations.
Unfortunately, this shows that the changes to the Thr128 residue upon binding
of cAMP are not force field independent, and in fact the newest AMBER force field
does not display any changes in the residue upon binding. It was shown in section
5.2.2 however that the ff12SB force field may not correctly simulate WT-CAP. Which
could suggest that the signalling events, involving Thr128, seen in the ff99SB-ILDN
simulations could in fact be an important pathway for the allosteric signal regardless
of it not been seen in the ff12SB simulations.
5.2.6 Principal Component Analysis
The simulations were split into 20 ns windows, and PCA performed on each window to
see how the principal components evolve throughout the simulation. Figure 5.26 shows
the frequencies of the first 250 modes calculated using PCA on all of the 20 ns windows
of WT apo-CAP. As it can be seen from the figure, the normal mode frequencies can
change between windows. However, the lowest frequency normal modes tend to have
a wavenumber of less than 1 cm−1. This is on the timescale identified for hinge bend
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Figure 5.26: Frequency of the first 250 modes calculated using PCA on 20 ns windows
of WT apo-CAP. --- Window 1, --- Window 2, --- Window 3, --- Window 4, --- Window 5,
--- Window 6, --- Window 7, --- Window 8, --- Window 9, --- Window 10, --- Window 11,
--- Window 12, --- Window 13, --- Window 14, --- Window 15.
motions on domain interfaces [21]. The lowest frequency modes tend to be movement
of the DNABDs relative to the LBDs about the hinge region, so fits well within this
motion description.
The large differences between the frequencies of the normal modes for different
windows of the apo-CAP simulation, suggests that the different windows are sampling
different regions on the free energy surface. This would make sense due to the large
structural rearrangement of the DNABD in this simulation. This could also be hap-
pening in the simulations of the other systems, but to a lesser extent. There is also a
chance that diffusive motion is being sampled in all or some of the simulations, rather
than correctly sampling the shape of an energy well. These hypotheses are investigated
below, firstly by looking at how much the principal components resemble cosines; a trait
shared with the principal components of diffusive motion [175]. And secondly by cal-
culating the normalised overlaps between the covariance matrices of separate windows
in each trajectory.
The cosine content of each mode was determined using the GROMACS simulation
package, which uses equation 2.5.64 in section 2.5.6. These are shown for each window
of each variant of CAP in figure 5.27. It is evident that for most of the 20 ns windows,
the cosine content of the first PC is between 0.5 and 1, which would indicate that these
PCs have a motion that can predominantly be described as diffusive motion. This
means that for these windows, the protein moves fairly freely across the energy surface
and is not kept within one quasiharmonic region of the energy surface.
As an example of the cosine shape of the PCs, the projection of the first window
of the MD simulation of WT holo1-CAP on the first four eigenvectors for the window
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Figure 5.27: The cosine content for the first 8 Principal components calculated for each
of the 20 ns windows; Shown for all three bound states of the variants of CAP. A cosine
content around 1 for a PC indicates that it mainly samples diffusive motion. --- Window
1, --- Window 2, --- Window 3, --- Window 4, --- Window 5, --- Window 6, --- Window 7,
--- Window 8, --- Window 9, --- Window 10, --- Window 11, --- Window 12, --- Window 13,
--- Window 14, --- Window 15.
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Figure 5.28: Projections of the MD simulation onto the first four PCs for the first window
of the WT holo1-CAP simulation. This window has a fairly high cosine content for the first
PC (0.76), a low cosine content for PC 3 (2.5 × 10−3) and cosine contents of 0.43 and 0.32
for PCs 2 and 4 respectively.
apo-CAP holo1-CAP holo2-CAP
wt 0.212 0.223 0.249
v132a 0.214 0.236 0.234
v132l 0.225 0.228 0.239
v140a 0.246 0.264 0.263
v140l 0.247 0.233 0.246
h160l 0.247 0.255 0.270
Table 5.7: Average normalised overlaps between pairs of 20 ns windows of simulations for
each system.
is shown in figure 5.28. This window was chosen as it shows PCs with varying degrees
of cosine content, however most windows of all of the simulations could be shown to
demonstrate at least one mode with a high cosine content. The cosine content of the
first mode in this example is by no means the largest observed in any of the systems,
however the 1/2 period cosine shape of the mode can still clearly be seen.
Next, the normalised subspace overlap was determined between each 20 ns window
of a simulation using equation 2.5.62 in section 2.5.5 and plotted as a matrix map.
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Figure 5.29: The normalised overlaps between different windows of a simulation of a system
of CAP. Shown for the apo, holo1 and holo2 bound states of the WT, V132A, V132L, V140A,
V140L and H160L variants of CAP.
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This was performed for the simulations of the different bound states of the variants of
CAP as shown in figure 5.29. This figure shows a measure of the similarities between
the covariance matrices of two windows of the simulation, for every possible pair of
windows. Black signifies a normalised overlap of 1, where the two covariance matrices
are identical and white corresponding to a normalised overlap of 0 where the two
covariance matrices are orthogonal.
The normalised overlap is 1 along the diagonal as is to be expected; the normalised
overlap of a covariance matrix with itself is 1. The normalised overlaps between dif-
ferent windows of the simulations are much lower; typically between 0.2 and 0.3 for
all pairs of windows. This can clearly be seen by looking at the average normalised
overlaps between window pairs for each system in table 5.7.
The fact that the normalised overlaps is low between all of the windows of a sim-
ulation indicates that for the most part, the simulations are not in the same principal
component space in each 20 ns window. This again can indicate either that the win-
dows are sampling different regions of the energy surface or that they are not sampling
the bottom of an energy well; or both.
For these reasons highlighted above, using PCA on 20 ns windows of an MD sim-
ulation as a technique to estimate the entropy of the system would yield values that
one would have very little reason to have faith in. Therefore a different method was
attempted to try and determine the entropies of the systems studied. This analysis is
described in the following section.
5.2.7 Entropy of Binding from NMA Snapshots
This section looks at the techniques used to calculate the entropy of the cAMP binding
events using the 300 ns simulations of the different CAP variants. The conformational
entropy was determined by performing NMAs on snapshots of the simulation every 4
ns after a 100 ns equilibration time (totalling 50 snapshots).
For the NMAs, the snapshots used were stripped of all water molecules, reimaged
so the two monomers were not split across the PBC and energy minimised using the
L-BFGS method. For the energy minimisations that converged below the tolerance
of 0.001 kJ mol−1 nm−1, NMA was performed. Figure 5.30 shows the frequencies of
the first 200 vibrational normal modes for all of the snapshots for WT apo-CAP. The
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Figure 5.30: Frequencies of the first 200 normal modes of holo2-CAP; calculated by NMA on
50 snapshots from the MD simulation.
distribution of these frequency signatures has a much smaller variance than for PCA.
The frequencies calculated by NMA are also higher than those calculated by PCA.
This is caused by a few factors. Firstly, the NMAs performed do not contain solvent
molecules, which would have the effect of damping the normal modes in PCA. Secondly,
the simulations used in PCA allow the system to move between local minima, so the
resulting PCA gives a smoothing of the energy surface approximated as a harmonic well,
which can incorporate multiple minima. NMA on the other hand is always confined to
one local minimum. This effect is visualised in figure 5.31. Only if the simulation was
confined to one local energy minimum, would the frequencies seen by NMA and PCA
be very similar. The same protocol was also used to determine the entropy of cAMP
from 50 snapshots of a 200 ns simulation.
The entropic contribution of each normal mode was determined from the frequencies
collected from each snapshot of each system, using the classical method (see section
2.6.1). The average entropy for each mode in all of the systems was determined for each
mode. The entropies of the systems were then determined by summing the entropies
of up to the first 200 normal modes. Figure 5.32 shows plots of the average entropies
of the normal modes for each system and a cumulative sum, which increases as the
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NMA PCA 
Figure 5.31: Differences between NMA and PCA: NMA creates a harmonic approximation
of an energy minimum from the second derivative of that minimum. PCA samples the free
energy surface throughout an MD simulation, creating a quasiharmonic approximation of the
surface.
number of included modes increases.
These plots show a number of things. Firstly, the entropy of the systems is very
large compared to the differences in entropy between the systems. Secondly, as would
be expected the contribution to the entropy decreases as the mode number increases.
The error bars in the cumulative entropy (given as the standard error of the mean
calculated over the 50 4 ns snapshots) are displayed in inset plots of the systems, and




























































































































































Figure 5.32: On the left, the average cumulative entropy for the first 100 none zero modes of apo, holo1 and holo2-CAP for each of the variants.
The inset shows the size of the error bars, which are given as the standard error of the mean. The plots on the right show the average entropy of
the individual modes for each system. --- WT, --- V132A, --- V132L, --- V140A, --- V140L and --- H160L.
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Figure 5.33: The cumulative allosteric entropy for the first 200 (none zero) modes for each
variant: --- WT, --- V132A, --- V132L, --- V140A, --- V140L and --- H160L
The allosteric entropy for each variant was calculated with equation 2.6.71, using the
average entropies for each system. The allosteric entropy as a function of the number
of normal modes used in its calculation is shown for each variant in figure 5.33. This
figure shows that after 200 normal modes, the entropies have not yet converged, so to
get the absolute entropy, ideally more normal modes would be used in the calculation.
However, only the first 200 none zero normal modes were calculated when running the
NMAs (to obtain all of the normal modes would have been extremely time consuming
for the 50 calculations per system performed here). The entropies calculated using this







kJ mol−1 kJ mol−1 kJ mol−1 kJ mol−1
WT 1743.29(1.48) 1734.66(1.64) 1734.41(1.53) 8.38(2.69)
V132A 1730.17(1.16) 1732.06(1.36) 1731.56(1.51) -2.39(2.34)
V132L 1735.90(1.35) 1732.18(1.35) 1734.75(1.61) 6.29(2.50)
V140A 1735.29(1.53) 1734.85(1.74) 1735.21(1.61) 0.79(2.82)
V140L 1733.40(1.47) 1728.78(1.48) 1731.61(1.46) 7.45(2.55)
H160L 1737.14(1.46) 1735.01(1.33) 1738.99(1.75) 6.11(2.64)
Table 5.8: Entropies for the three bound states of the CAP variants calculated with NMA
on snapshots of the MD simulation. The allosteric entropy is also determined for each of the
variants.
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The trends seen in the conformational allosteric entropies calculated with this
method are very different to the trends seen using the elastic network model. Us-
ing NMA on the snapshots from the MD simulation, the entropies of V132L, V140L
and H160L are all similar to the WT value, the entropy of V140A is around 0 kJ mol−1
and the entropy of V132A around -2 kJ mol−1 when using the first 200 modes. The
exact values are given in table 5.8. With the ENM, the main component of the free
energy calculated is the conformational entropy, with an adjustment for the enthalpy.
That model predicted that both V140 mutations would not affect the allostery in CAP,
V132A would make cAMP more negatively cooperative and V132L and H160L would
push the system towards positive cooperativity.
What is seen with the NMAs could imply that the conformational entropy is not
the sole driving force behind the cooperativity in CAP, as is implied by the ENM. It
is likely that other factors will come into play such as enthalpy-entropy compensation.
The following section tries to investigate these other contributions to the allosteric free
energy using the MM/PBSA method. Also, in chapter 6 the entropies calculated with
this method are compared to the experimental entropies.
5.2.8 MM/PBSA
To try to determine the other contributions to the free energy of binding, the MM/PBSA
method was used. The method used in this thesis was initially checked by running the
calculations from a recent study of the stability of cyclic peptide (CP) nanotubes [235].
200 snapshots were used from a 10 ns simulation of the cyclo[(D-Ala-L-Ala)4] nanotube
was used in this check, to see if the values obtained were comparable to the original
study. Two different models for the nonpolar contribution to the free energy were
used. The first was the SASA model and the second was the model proposed by Tan
et al. [148], which models the repulsive contribution with the SASA and the attractive
contribution with an approximation of the van der Waals attractive forces. This non-
polar model will be termed the SASA/vdW model from this point for clarity. Both of
these models are described in more detail in section 2.1.12. Table 5.9 shows a quick
comparison of the values obtained with the methods used in this thesis to the values
obtained in the study.
There is strong agreement between the values calculated by the SASA model in
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Original study A B
∆GMM/PBSA ∆GMM/PBSA ∆GMM/PBSA
/ kcal mol-1 / kcal mol-1 / kcal mol-1
CP Unit AVG SD AVG SD AVG SD
CP1 -27.18 1.98 -24.77 4.70 -14.18 2.90
CP2 -54.63 2.79 -50.33 6.07 -31.25 3.80
CP3 -55.80 2.57 -52.19 4.84 -32.10 3.31
CP4 -55.85 2.77 -52.82 4.90 -32.67 3.06
CP5 -55.57 2.60 -52.74 4.84 -32.59 2.95
CP6 -55.57 2.66 -52.44 5.20 -31.86 3.47
CP7 -54.03 3.01 -50.99 5.62 -31.22 3.39
CP8 -26.48 2.30 -25.10 4.81 -14.33 2.49
Table 5.9: The MM/PBSA contribution to the free energy of assembly of CP nanotubes,
∆GMM/PBSA. Showing the values from the 2012 study by Subramanian et al. [235] and two
values calculated in this study by two different methods; A, the SASA model to calculate
the nonpolar contribution to the free energy and B, the SASA/vdW model [148].
this study and the values from the study by Subramanian et al. (r2 = 1.0 and p =
1.1× 10−9). This is the model that was used in the original study, which suggests that
the method used in this study correctly reproduces the method used in the original
study. The standard deviation in the values was larger for the calculations in this study
as less snapshots were used.
The magnitudes of the values for ∆G calculated using the SASA/vdW model for
the nonpolar contribution are smaller than the values calculated for the SASA model.
This does not mean that this model should be abandoned though, with no experimental
studies of the stability of the nanotube to compare the values to, it is not clear which
methodology models the nanotube better. Both models are therefore used for modelling
the nonpolar contributions of CAP-cAMP binding in this study.
The only differences between these calculations and the calculations for CAP-cAMP
binding are the frequency of the snapshots used and that the CAP-cAMP calculations
include an ionic strength of 300 mM to try to mimic the conditions for ITC.
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Investigating CAP-cAMP Binding
MM/PBSA was then used to investigate the binding of cAMP to CAP. Tables 5.10 and
5.11 break down the MM/PBSA energy contributions for both of the binding events
using the SASA and SASA/vdW models for the nonpolar contribution. Naturally the
only differences between the models are in the nonpolar contributions. The SASA
method only has one contribution, so in this case the ∆ESASA label is used, whereas
the SASA/vdW method has two contributions, so the ∆ESASA and ∆EDISP labels are


















Variant ∆Ebonded ∆EVDW ∆EEL ∆EPB ∆ESASA ∆GMM/PBSA










WT -3.45 (1.87) -70.63 (1.42) -100.79 (5.16) 94.57 (4.26) -4.84 (0.04) -85.15 (2.04)
V132A 5.08 (1.89) -32.09 (1.44) 87.45 (5.00) -88.72 (4.13) -0.19 (0.05) -28.47 (2.07)
V132L -0.01 (1.90) -53.40 (1.46) -36.75 (5.49) 40.87 (4.49) -2.93 (0.05) -52.21 (2.12)
V140A 7.07 (1.88) -47.65 (1.38) -14.37 (5.23) 17.95 (4.53) -1.29 (0.04) -38.30 (2.09)
V140L -9.16 (1.91) -49.43 (1.38) -52.91 (5.15) 48.85 (4.46) -3.01 (0.05) -65.65 (2.09)












WT -4.38 (1.87) -33.91 (1.40) -59.53 (4.93) 72.89 (4.09) -1.94 (0.04) -26.87 (2.02)
V132A -4.80 (1.87) -45.51 (1.44) -184.86 (5.47) 170.43 (4.46) -3.07 (0.05) -67.81 (2.17)
V132L -19.76 (1.89) -12.93 (1.49) -184.51 (5.38) 187.71 (4.41) -1.61 (0.05) -31.09 (2.05)
V140A -9.15 (1.89) -33.89 (1.36) -170.51 (5.30) 160.74 (4.77) -3.26 (0.05) -56.07 (2.07)
V140L -4.53 (1.88) -22.15 (1.37) -171.91 (5.27) 172.40 (4.23) -1.05 (0.05) -27.24 (2.05)
H160L 6.84 (1.89) -22.13 (1.38) 108.74 (5.18) -97.07 (4.51) -0.01 (0.04) -3.63 (2.09)
Table 5.10: Contributions to the free energy of both cAMP to CAP binding events. ∆Ebonded contains the energy contributions calculated using
differences in the bond length, bond angle and dihedral energy terms. ∆EVDW contains the energy contributions calculated using differences in the
vdW and 1-4 vdW energy terms. ∆EEL contains the energy contributions calculated using differences in the electrostatic and 1-4 electrostatic energy
terms. ∆GPB contains the polar energy contributions to the differences in solvation free energy calculated using the PB implicit solvent model. The
nonpolar contribution ∆GSASA to the free energy difference was calculated using the SASA model (see section sub:NP-implicit-theory). The sum of


















Variant ∆Ebonded ∆EVDW ∆EEL ∆EPB ∆EDISP ∆ESASA ∆GMM/PBSA










WT -3.45 (1.87) -70.63 (1.42) -100.79 (5.16) 94.57 (4.26) -47.28 (0.39) 83.84 (0.53) -43.74 (2.11)
V132A 5.08 (1.89) -32.09 (1.44) 87.45 (5.00) -88.72 (4.13) -10.94 (0.43) 19.89 (0.67) -19.32 (2.15)
V132L -0.01 (1.90) -53.40 (1.46) -36.75 (5.49) 40.87 (4.49) -32.89 (0.46) 61.48 (0.59) -20.69 (2.17)
V140A 7.07 (1.88) -47.65 (1.38) -14.37 (5.23) 17.95 (4.53) -23.93 (0.41) 40.25 (0.52) -20.68 (2.13)
V140L -9.16 (1.91) -49.43 (1.38) -52.91 (5.15) 48.85 (4.46) -31.03 (0.42) 58.17 (0.59) -35.52 (2.16)












WT -4.38 (1.87) -33.91 (1.40) -59.53 (4.93) 72.89 (4.09) -20.68 (0.39) 41.28 (0.50) -4.33 (2.06)
V132A -4.80 (1.87) -45.51 (1.44) -184.86 (5.47) 170.43 (4.46) -33.89 (0.41) 58.28 (0.58) -40.34 (2.22)
V132L -19.76 (1.89) -12.93 (1.49) -184.51 (5.38) 187.71 (4.41) -19.42 (0.44) 32.45 (0.59) -16.44 (2.09)
V140A -9.15 (1.89) -33.89 (1.36) -170.51 (5.30) 160.74 (4.77) -31.22 (0.38) 60.20 (0.53) -23.82 (2.13)
V140L -4.53 (1.88) -22.15 (1.37) -171.91 (5.27) 172.40 (4.23) -18.82 (0.41) 28.86 (0.55) -16.15 (2.12)
H160L 6.84 (1.89) -22.13 (1.38) 108.74 (5.18) -97.07 (4.51) -9.34 (0.37) 18.72 (0.47) 5.76 (2.16)
Table 5.11: Contributions to the free energy of both cAMP to CAP binding events. This table contains all the same energy contributions as table
5.10 except for the nonpolar contribution. In this table the nonpolar energy contribution has two contributions; a repulsive contribution, ∆GSASA
determined using the SASA model and an attractive contribution, ∆GDISP, an approximation of the vdW forces (see section 2.1.12). The values
shown do not include the vibrational entropy contribution to the free energy, which is discussed in section 5.2.7.
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Scrutinising the individual contributions to the free energy calculated by this method,
the efficacy of the method for free energy calculations of binding events can be deter-
mined. The magnitude of the changes to the energy of ∆Ebonded (the bond length,
angle and dihedral energies) is relatively small. This would be expected, as there no
are bonds made or broken in the binding event. The vdW energy, ∆EVDW, is nega-
tive for both binding events as one would expect, with new interactions being formed
between the protein and the ligand.
What is surprising is the magnitude and range of values seen for ∆EEL, the change
in electrostatic energy for the binding events. The hydrogen bonds formed between
the protein and the ligand would likely be the largest contribution to this electrostatic
energy for both of the binding events. For both binding events, a similar number of
hydrogen bonds would be made between the ligand and the protein. Making the lib-
eral estimate of eight new hydrogen bonds forming on each binding event, and another
liberal estimate of each of them contributing -20 kJ mol−1 to ∆EEL would place the
expected value of EEL around -160 kJ mol
−1. This value is only a very rough estimate,
as these new hydrogen bonds would not be the only changes to the electrostatic in-
teractions of the system upon binding. However, the value would be expected to be
not as dissimilar between different variants and between different binding events as is
seen. For example for H160L, the first binding event has a ∆EEL of -238 kJ mol
−1 and
the second binding event has a ∆EEL of 109 kJ mol
−1. The value for the first binding
event being favourable as would be expected and the value for the second binding event
being unexpectedly quite strongly unfavourable. This is the most extreme example,
but not the only example of unexpected values for ∆EEL.
These inconsistencies between the values of ∆EEL, strongly detract from the suit-
ability of using the MM/PBSA method for determining the free energy of protein-ligand
binding. This is even more true for determining allosteric energies, which requires cal-
culating the difference between two binding events, thus increasing any errors further.
A possible reason why such large fluctuations are seen in this electrostatic energy is
again that the MD simulations may not have converged. It is also quite likely that
with a protein as large as CAP, it is unlikely to ever converge to give reasonable results
using a method such as MM/PBSA.
Regardless of the mistrust of the MM/PBSA method, the remaining energy contri-
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Variant ∆∆Egas ∆∆Gsolv ∆∆GMM/PBSA ∆∆GTOT
/ kJ mol-1 / kJ mol-1 / kJ mol-1 / kJ mol-1
WT 77.06 (6.68) -19.87 (5.87) 57.19 (2.87) 48.81
V132A -295.60 (7.07) 256.21 (6.04) -39.38 (3.00) -36.99
V132L -127.04 (7.28) 148.21 (6.26) 21.16 (2.95) 14.87
V140A -158.59 (7.39) 140.98 (6.54) -17.61 (2.94) -18.40
V140L -87.09 (6.97) 124.43 (6.10) 37.34 (2.93) 29.89
H160L 394.80 (7.16) -339.66 (6.32) 55.14 (2.95) 49.03
Table 5.12: ∆∆GMM/PBSA values calculated using the SASA method for calculating the non-
polar contribution. The values shown do not include the vibrational entropy contribution to
the free energy, which is discussed in section 5.2.7.
Variant ∆∆Egas ∆∆Gsolv ∆∆GMM/PBSA ∆∆GTOT
/ kJ mol-1 / kJ mol-1 / kJ mol-1 / kJ mol-1
WT 77.06 (6.68) -38.74 (5.93) 38.32 (2.95) 29.94
V132A -295.60 (7.07) 274.53 (6.13) -21.06 (3.09) -18.67
V132L -127.04 (7.28) 131.34 (6.34) 4.30 (3.02) -1.99
V140A -158.59 (7.39) 155.62 (6.69) -2.97 (3.01) -3.76
V140L -87.09 (6.97) 105.39 (6.23) 18.30 (3.03) 10.85
H160L 394.80 (7.16) -361.31 (6.39) 33.49 (3.04) 27.38
Table 5.13: ∆∆GMM/PBSA values calculated using the SASA/vdW method for calculating
the non-polar contribution.
butions will be further analysed.
The PB solvation energy, ∆EPB, as would be expected has the opposite sign to
the electrostatic energy. Thus estimating the effect of the interactions being removed
between the ligand or protein and the solvent when the new interactions between ligand
and protein are made. However again, with some of the unexpected positive values of
∆EEL come unexpected negative values of ∆EPB.
The values calculated for ∆GMM/PBSA using the SASA/vdW model for the nonpo-
lar contribution to the solvation free energy seem slightly more reasonable than the
SASA model alone. This is more apparent when looking at the value of ∆∆GMM/PBSA
and combining these values with T∆∆Svib (determined by NMA in section 5.2.7). The
resulting value of ∆∆GTOT (as shown in table 5.13) seems closer to the experimental
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ITC values [59] than using just the SASA method for estimating the nonpolar contri-
bution for WT-CAP (shown in table 5.12). The ITC values are discussed in chapter
6. Both models correctly show the negative cooperativity for WT-CAP, however the
negative cooperativity is weaker and more reasonable using the SASA/vdW model for
the nonpolar contribution to the solvation part of ∆∆GTOT.
One thing that should be taken into account however is the margin of error of the
values calculated using MM/PBSA. The values in the above tables show the standard
error of the mean in parentheses. Each data point used to calculate the mean, however,
is not independent from the rest as they all come from the same simulation. This
means that the standard error of the mean underestimates the error by what could be
a large amount. This weakens the argument that these methods correctly predict the
negative allostery in WT-CAP. This is discussed further when the values of ∆∆GTOT
determined with MM/PBSA and NMA are compared to the ITC values for each of the
mutants in section 6.3.3.
5.2.9 Overall Discussion
In this chapter it was revealed that there was no significant change to the structure
of the LBDs after 300 ns of simulation for apo-CAP or holo1-CAP, for any of the
CAP variants, when compared to holo2-CAP. This further supports the hypothesis
that CAP undergoes allostery without conformational change. The fact that making
the mutations also does not change the LBD, further contributes to the hypothesis
that allostery can be manipulated without a conformational change.
The DNABD, on the other hand is seen to undergo a structural rearrangement for
one chain in the WT apo-CAP simulation. This rearrangement, although not occurring
to the same extent as that seen by Steitz and coworkers in the crystal structure of a
CAP variant [108], indicates the flexibility of the DNABD. As this rearrangement does
not occur to the same extent in any of the variants suggests an energy barrier to this
motion that is not crossed for these simulations.
A potential signalling pathway involving residue Thr128 was investigated, showing
a change in its preferred orientation and a decrease in flexibility in this region upon
cAMP binding. There was also shown to be less flexibility in the apo forms of the CAP
variants (V132L and H160L) that were predicted by the ENM to undergo positively
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cooperative binding of cAMP.
Additionally, free energy calculations for the allostery in CAP were performed.
These predicted weak negative cooperativity for WT-CAP as would be expected. How-
ever the margins of error on these calculations are large enough to throw doubt upon
the value calculated. The thermodynamics of binding cAMP to the CAP variants is
investigated further using ITC in the next chapter.
Chapter 6
Experimental
This chapter outlines the materials, methods and results for the experiments used
to study the structure and dynamics of these variants and how cooperative binding
of cAMP to CAP is affected by making these point mutations. The hypotheses and
observations made using the CG and atomistic methods in chapters 4 and 5 respectively
are investigated experimentally using X-ray crystallography and ITC. The experiments
for the Q108A variant (performed by David Burnell) are shown in detail and the
experiments for the remaining variants (performed by Phil Townsend) are provided
with less detail. Comparisons and differences between the experimental results and
the atomistic calculations are also investigated in this section.
6.1 Materials
Unless stated otherwise all chemicals were purchased from Sigma-Aldrich at highest
purity and Milli-Q R©water was used.
6.1.1 Pfu DNA Polymerase
Pfu (pyrococcus furiosus) DNA polymerase is a thermostable enzyme (Thermo Sci-
entific) used in a polymerase chain reaction (PCR) in the presence of Mg2+ (see sec-
tion 6.2.1). As well as DNA synthesis in the 5’-3’ direction, it also exhibits proof




6.1.2 BIOTAQTM Red DNA Polymerase
BIOTAQTM Red DNA polymerase (Bioline) is a mixture of the BIOTAQTM (Taq) DNA
polymerase and a red dye. Taq DNA polymerase is a thermal stable enzyme purified
from Thermus aquaticus [240]. The red dye allows direct loading onto an agarose gel
without the need for DNA loading buffer.
6.1.3 T4 DNA Ligase
T4 DNA ligase (Thermo Scientific) catalyses the fusion of two DNA strands either
in a cohesive ended or a blunt ended configuration. For example T4 DNA ligase can
catalyse the insertion of a target gene into a plasmid [241].
6.1.4 HindIII and BamHI Restriction Enzymes
Restriction enzymes cut DNA at specific sites defined by the base sequence. The
restriction site for BamHI (Thermo Scientific) is 5’-G|GATC-3’, leaving a GATC over-
hang on the DNA chain [242]. The restriction site for HindIII (Thermo Scientific) is
5’-A|AGCT.T-3’, leaving an AGCT overhang on the DNA.
6.1.5 Calf Intestinal Alkaline Phosphatase (CIAP)
Calf intestinal alkaline phosphatase (CIAP), purified from calf intestinal mucosa, (InvitrogenTM)
is a phosphomonoesterase that hydrolyses 5’-phosphate groups from DNA. It is used
to remove 5’-phosphate groups from a linearised plasmid before performing a T4 DNA
ligation reaction with an insert.
6.1.6 Plasmids
pCRTM-Blunt II-TOPO R© (Invitrogen) is a plasmid that allows the ligation of a blunt
ended PCR product into the vector that contains kanamycin resistance (see appendix
D.1) [243].
pQE30 (QIAGEN) is an IPTG (section 6.1.9) inducible expression vector that con-
fers ampicillin resistance. It introduces a histidine (H6) tag on the N-terminus of the
expressed protein (see appendix D.3).
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pREP4 (QIAGEN) is a plasmid (that is compatible with the pQE30 vector) which
contains the lacl q gene and confers ampicillin resistance (see appendix D.2).
6.1.7 E. coli Strains
Plasmids containing the target gene were transformed into chemically competent E.
coli strains DH5α (InvitrogenTM) and Mach1TM T1 (InvitrogenTM) when checking the
ligation efficiency by colony PCR and DNA sequencing.
For protein expression, the E. coli strain M182 ∆ CAP F− ∆(lacIPOZY )X74
galE15 galK16 rpsL thi+ lambda− [pREP4] [244,245] was used. This E. coli strain has
the WT-CAP gene removed to avoid the WT protein expressing at the same time as
the mutated protein.
6.1.8 Antibiotics
Two antibiotics were used as selection agents when growing E. coli colonies. These were
kanamycin (50 µg ml−1) and ampicillin (100 µg ml−1). The plasmids; pCRTM-Blunt
II-TOPO R© and pREP4 contain resistance to kanamycin, while pQE30 is resistant to
ampicillin.
6.1.9 Isopropyl β-D-thiogalactopyranoside (IPTG)
IPTG triggers transcription of the lac operon by binding to the lac repressor, releasing
it from the lac operon. If a foreign gene has been introduced into the lac operon (as is
the case in the pQE30 expression vector (section 6.1.6), it causes the transcription of
this gene to occur and hence expression of the target protein.
6.1.10 CAP buffers
Table 6.1 contains the buffers used with CAP during protein purification, mass spec-
trometry (MS) and ITC.
6.1.11 PACT premierTM HT-96
PACT premierTM HT-96 (Molecular Dimensions) is a crystallisation screen containing
96 × 1 ml solutions. The screen contains three separate screens; a 24 well pH/PEG
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Buffer Contents pH
Lysis Buffer 100 mM KH2PO4/K2HPO4, 200 mM
KCl, 2 mM 2-thioglycerol
7.8
Wash Buffer 100 mM KH2PO4/K2HPO4, 200 mM
KCl, 2 mM 2-thioglycerol, 15 mM imi-
dazole
7.8
Elution Buffer 100 mM KH2PO4/K2HPO4, 200 mM
KCl, 2 mM 2-thioglycerol, 300 mM im-
idazole
7.8
Storage Buffer 100 mM KH2PO4/K2HPO4, 200 mM
KCl, 2 mM 2-thioglycerol, 15% (v/v)
glycerol
7.8
ITC Buffer 100 mM KH2PO4/K2HPO4, 200 mM
KCl, 2 mM 2-thioglycerol
7.8
Mass Spec. Buffer 20 mM Tris-HCl, 100 mM NaCl 7.8
Table 6.1: Buffers used in the purification, ITC and MS of CAP.
screen, a 24 well cation/PEG screen and a 48 well anion/PEG screen [246]. The
composition of the solutions in the screen are given in appendix E.
6.2 Methods
6.2.1 Polymerase Chain Reaction (PCR)
PCR utilises DNA polymerase to amplify a specific target DNA sequence in vitro;
multiplying as little as a few molecules of the target DNA to as much as a microgram
[247].
In PCR, two short oligonucleotide primers (typically 20-30 base pairs long) bind the
target sequence of DNA to be amplified; one primer at the 5’ end of the target DNA
in the forward reading direction and the other at the 5’ end in the backward reading
direction [248]. Each PCR experiment consists of three steps; denaturation, annealing
and extension. This sequence of steps is repeated numerous times to generate enough
DNA for the purpose [249]. In a cycle of the PCR experiment the number of target
DNA copies would double if it were 100% efficient, however in reality the number of
DNA copies does not quite double. The new DNA copies can then be used as DNA
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Primer Direction Sequence Plasmid/Gene
F-CAP1−6 Forward atggtgcttggcaaaccg WT CAP
R-CAP205−212 Reverse ttattaacgagtggcgtaaacga WT CAP
F-CAPQ108A104−112 Forward cgccaattgattGCGgtaaacccggac Q108A CAP
R-CAPQ108A104−112 Reverse gtccgggtttacCGCaatcaattggcg Q108A CAP
M13 Reverse Reverse caggaaacagctatgac
pCR-Blunt
II-TOPO R©TM
Table 6.2: Primers used for the mutagenesis of Q108A CAP. Mutated bases are capitalised.
templates in the following cycles.
The primers used in PCR experiments determine the initiation site of the DNA
synthesis, but not where it terminates. After one cycle, this creates new single strands
of DNA extending beyond the end of the target sequence. After a small number of
cycles, strands of DNA that have been synthesised in the forward direction in one
step will be the templates for DNA synthesis in the backwards direction. The DNA
synthesised in this cycle will have a precisely defined length, containing only the target
sequence. After more cycles, the number of strands with this defined length will greatly
outnumber the strands of DNA with undefined lengths. PCRs take place in a thermal
block cycler, a device which automatically and accurately adjusts the temperature of
the PCR mixtures according to a program defined by the user.
6.2.2 Primer Design
Two complementary DNA oligomers (primers) consisting of 20-30 base pairs were de-
signed to contain the desired mutation. This length allows for sufficient specificity to
ensure that the sequence is not going to appear elsewhere in the DNA template, or in
any contaminant DNA. It is also a short enough length to ensure ease of binding to
the DNA template at the annealing temperature.
The sequence of the forward primer was designed to match the DNA template
for the nucleotides flanking the mutation site. However, the DNA base triplet at the
mutation site itself was changed to match the genetic code for the point mutant. The
sequence of the reverse primer was the reverse conjugate of the forward primer.
The primers were also designed to have a few G or C bases in the last five bases of

























Figure 6.1: Site specific mutagenesis using three separate PCRs; (a) and (b) synthesise
overlapping DNA fragments from the DNA template containing the desired mutation. (c)
then combines the DNA fragments, creating an copy of the DNA template sequence with the
desired mutation (d).
to the bonding between the A and T bases encourages specific binding of the primer.
WT primers flanking the CAP gene were also used in numerous PCR experiments. All
of the primers used for any type of PCR can be seen in table 6.2.
6.2.3 PCR Site Specific Mutagenesis
Complementary oligomers containing the desired mutation (section 6.2.2) were used
in two separate polymerase chain reactions, with primers flanking the CAP gene to
synthesise two overlapping fragments of DNA. These fragments were then used in a
third PCR (PCR3) where the DNA fragments annealed at their overlap to act as primer
for the 3’ extension of the opposite strand [250]. This process can be seen in figure 6.1.
The reaction mixtures for the first two PCRs (PCR1 and PCR2 in table 6.3) were set
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Component Volume / µl Volume / µl Volume / µl
(PCR1) (PCR2) (PCR3)
Pfu DNA Polymerase 10×
Buffer with MgSO4*
2.5 2.5 2.5
dNTPs 2.5 2.5 2.5
DNA chain (WT CAP) 0.5 0.5 -
Primer (F-CAPQ108A104−112) 1 - -
Primer (R-CAP205−212) 1 - 1
Primer (F-CAP1−6) - 1 1
Primer (R-CAPQ108A104−112) - 1 -
DNA chain (PCR1 output) - - 1
DNA chain (PCR2 output) - - 1
Pfu DNA Polymerase 0.5 0.5 0.5
H2O 17 17 15.5
Table 6.3: Polymerase Chain Reaction mixtures with a total volume of 25 µl used for site
specific mutagenesis
Cycle Step Temp / ◦C Time (PCR1/2) Time (PCR 3)
1 Initial denaturation 95 2 minutes 2 minutes
2 Denaturation 95 45 seconds 1 minute
3 Annealing 55 45 seconds 1 minute
4 Elongation 72 45 seconds 1 minute
5 Final Elongation 72 5 minutes 5 minutes
6 Storage 4 - -
Table 6.4: PCR cycles used for overlap extension PCRs. Steps 2, 3 and 4 were repeated in a
cycle 30 times.
up on ice and the reaction took place in a thermal block cycler with the cycle outlined
in table 6.4. The denaturation-annealing-elongation cycle was repeated 30 times.
Agarose gel electrophoresis (section 6.2.4) was used to distinguish the synthesised
DNA fragments from the WT gene. These fragments were then extracted (section 6.2.5
from the agarose and used in the next PCR. The reaction mixtures and the cycle used
for this reaction are (PCR3) in tables 6.3 and 6.4.
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6.2.4 Agarose Gel Electrophoresis
0.75 g of electrophoresis grade agarose gel powder was added to 50 ml TAE buffer
(40 mM Tris-acetate, 1 mM EDTA, pH 8.0) per each agarose gel required and mi-
crowaved until dissolved. 12.5 µl of 2.5× 10−2 M ethidium bromide per gel was added
before the gel set. DNA samples were mixed 4:1 with loading buffer (2% (w/v) orange
G and 20% (w/v) sucrose in TAE buffer) then loaded into a gel. A DNA marker ladder
was loaded alongside, for the purpose of estimating the length of the DNA chains. The
gels were run at a voltage between 100 V and 140 V. DNA was visualised using a UV
transilluminator.
6.2.5 DNA Extraction from Agarose Gels
To obtain pure target DNA, the DNA bands were cut from the agarose gel and dissolved
in 600 µl binding buffer (6 M sodium perchlorate, 10 mM EDTA, 50 mM Tris-HCl
pH 8.0) at 65 ◦C. 10 µl of 166 mg ml−1 silica suspension in water was added and the
mixture was held at room temperature for 30 minutes.
The suspension was centrifuged for 30 seconds and the supernatant discarded (All
centrifugation steps were run at 12000 g) The pellet was re-suspended in 200 µl binding
buffer and centrifuged again for 30 seconds. The supernatant was again discarded and
the pellet suspended in 750 µl wash buffer (400 mM NaCl, 20 mM Tris-HCl pH 7.5,
2 mM EDTA and 50% (v/v) ethanol) before being centrifuged again. The fluid was
discarded using a pump and the solid residue left to air dry at room temperature for
30 minutes.
The solid residue was then suspended in 15 µl H2O and incubated at 37
◦C for
15 minutes, before being centrifuged again for 2 minutes. As much of the supernatant
as possible was removed without disturbing the silica. This fluid, containing the DNA
was then stored at -20 ◦C until needed.
6.2.6 Zero Blunt R© TOPO R© PCR cloning reaction
This reaction is a cloning strategy for inserting blunt ended PCR products into a
plasmid vector. The ligation reaction was prepared on ice with 1 µl pCRTM-Blunt II-
TOPO R©, 3 µl PCR product, 1 µl 6× salt solution (200 mM NaCl, 10 mM MgCl2) and
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1 µl H2O. This was held at room temperature for 30 minutes before being transformed
into chemically competent E. coli (section 6.2.7). The E. coli was then left to grow
overnight on LB agar plates with the antibiotic Kanamycin (section 6.2.9).
In this reaction, the DNA is inserted into the pCRTM-Blunt II-TOPO R© plasmid in
either the forward or reverse direction, so the directionality of the insert for a num-
ber of colonies on the agar plate was checked by colony PCR (section 6.2.10) using
the M13 reverse primer (from the vector) and primers F-CAPQ108A104−112 and R-
CAPQ108A104−112 (from the insert).
6.2.7 Transformation into Chemically Competent E. coli
50 µl of chemically competent E. coli was thawed then immediately put on ice. 2 µl
of the ligation mixture was added and then it was kept on ice for 30 minutes. The
cells were then heat shocked at 42 ◦C for 45 seconds, then put on ice for two more
minutes. Next 950 µl of 37 ◦C Lysogeny broth (LB) (10 g dm−3 tryptone, 5 g dm−3
yeast extract and 5 g dm−3 NaCl) media was added and the bacteria was cultured at
37 ◦ C for 1-2 hours. The culture was then centrifuged and 850 µl of the fluid removed.
The bacteria were then re-suspended, spread on an LB agar plate (section 6.2.9) and
incubated overnight at 37 ◦C.
Once the mutant CAP gene was ligated into the pQE30 vector, 1 ml of super
optimal broth with catabolite repression (SOC) (20 g dm−3 tryptone, 5 g dm−3 yeast
extract, 0.5 g dm−3 NaCl, 0.186 g dm−3 KCl, 0.952 g dm−3 MgCl2 and 3.603 g dm−3
glucose) was used instead of LB and it was cultured at 32 ◦C for 1-2 hours. It was
then grown on LB agar plates overnight at 32 ◦C. The reason for this is highlighted in
section 6.3.2.
6.2.8 Media Preparation
All growth media was mixed according to manufacturer’s instructions, then autoclaved
at 121 ◦C for 15 minutes to sterilise. Any antibiotics were added at the time the media
was being used.
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6.2.9 LB Agar Plate Preparation
A stock solution of LB agar was made by autoclaving a mixture of 35 g LB agar
powder per litre of H2O at 121
◦C for 15 minutes. 25 ml of LB agar per plate was
then extracted from the stock in sterile conditions and selection agents were added to
prevent non-specific growth before being poured into a Petri dish. To melt the LB agar
stock for future uses it was micro waved.
6.2.10 Colony PCR
Approximately five cultures from an overnight agar plate were chosen to investigate
whether they contained the insert. A small sample of each colony from the plate was
added to separate copies of the PCR mixture from table 6.5. to check the directionality
of the insert from the Zero Blunt R© TOPO R© PCR cloning reaction, two PCR reactions
were run per colony.






BIOTAQ Red DNA polymerase 1
H2O 16.25
Table 6.5: Polymerase Chain Reaction mixtures with a total volume of 25 µl used for colony
PCR. *(200 mM Tris-HCl, 100 mM KCl, 100 mM (NH4)2SO4, 20 mM MgSO4, 1 mg ml
−1
nuclease-free BSA, 1% Triton R© X-100).
The PCR solutions were heated to 95 ◦C for 2 minutes for initial denaturation.
The PCR cycle of 30 seconds at 95 ◦C (denaturation), 30 seconds at 55 ◦C (primer
annealing) and 30 seconds at 72 ◦C (elongation) was repeated 30 times before a final
elongation step for 5 minutes at 72 ◦C. The reaction mixtures were then held at 4 ◦C
until required.
To check whether the mutated CAP gene was present in the PCR mixtures, (and
hence the E. coli colony) agarose electrophoresis was used (section 6.2.4).
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6.2.11 Plasmid DNA Purification
An 8 ml overnight LB culture of the E. coli shown to contain the plasmid by colony
PCR was centrifuged at 5000 g for 10 minutes. The supernatant was discarded and
the plasmid purified from the pellet using a commercial miniprep kit, following the
manufacturer’s instructions.
6.2.12 Restriction Digest
A restriction digest reaction, removing the inserted gene from the pCRTM-Blunt II-
TOPO R© vector (15 µl pCR-Blunt-CAP, 2 µl HindIII, 1 µl BamHI, 4 µl 10× BamHI
buffer(100 mM Tris-HCl, 50 mM MgCl2, 1 M KCl, 0.2% Triton X-100, 1 mg ml
−1
BCA, pH 8.0), 18 µl H2O) was set up on ice in parallel to a restriction digest incising
the pQE30 expression vector (10 µl pQE30, 2 µl HindIII, 1 µl BamHI, 1 µl CIAP, 4 µl
BamHI buffer, 22 µl H2O). The restriction digest reaction solutions were incubated at
37 ◦C for 2 hours. Agarose electrophoresis followed by extraction was then used to
separate out the CAP gene and the pQE30 vector.
6.2.13 DNA Ligation with T4 DNA Ligase
The mutant CAP insert and pQE30 vector were ligated using T4 DNA ligase, inserting
the CAP gene into the BamHI and HindIII sites of the pQE30 vector. A ligation
solution was made to a total volume of 10 µl. This mixture contained 1 µl of T4 DNA
ligase and 1 µl of 10× buffer (300 mM Tris-HCl pH 7.8, 100 mM MgCl2, 100 mM DTT
and 10 mM ATP). The rest of the solution was composed so that the mass ratio of the
insert to vector was approximately 3:1. The solution was made up to a final volume
of 10 µl with water. Where possible, the final concentration of the vector (measured
using a NanoDrop 2000) was no less than 10 ng ml−1.
The ligation mixture was then transformed into E. coli (section 6.2.7), and then
colony PCR with both kanamycin and ampicillin as selection agents (section 6.2.10)
followed by agarose gel electrophoresis (section 6.2.5) were used to determine whether
the ligation and transformation were successful.
Two successful cultures were then chosen to make 8 ml SOC overnight cultures with
both kanamycin and ampicillin as selection agents. The plasmid DNA was then purified
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using a miniprep kit (section 6.2.11), which was then sent off for DNA sequencing to
see if the sequence of the insert was correct and in the correct reading frame.
A plasmid with the correct insert was then transformed into the expression strain
of E. coli ; (M182 ∆ CAP [pREP4]) and plated on agar plates with kanamycin and
ampicillin. Colony PCR was then used to confirm successful transformation.
6.2.14 Protein Expression
A 100 ml overnight starter culture of Terrific Broth (TB) (21 g dm−3 tryptone, 24 g dm−3
yeast extract, 9.4 g dm−3 K2HPO4, 2.2 g dm−3 KH2PO4 and 8 ml dm−3 glycerol) was
grown at 32 ◦C with the antibiotics kanamycin and ampicillin.
10 ml of this starter culture was then added to each of six flasks containing 1 litre
of LB broth containing both kanamycin and ampicillin as selection agents. These were
then incubated in a shaker (180 rpm) at 37 ◦C until the optical density at a wavelength
of 600 nm (OD600) reached 0.6. Protein expression was induced by the addition of 1 ml
of 1 M IPTG to each flask. The cultures were incubated for a further two hours at
37 ◦C.
The bacteria was harvested by centrifugation (4500 g, 4 ◦C) for 15 minutes. Each
3 litres of LB culture made one E. coli pellet. Each pellet was re-suspended in 30 ml
bacterial wash buffer (50 mM Tris-HCl pH 8.5, 1 mM EDTA), then centrifuged (5500 g,
4 ◦C) for 20 minutes. The supernatant was then discarded and the pellet frozen at
-80 ◦C until needed.
6.2.15 Protein Purification
The frozen E. coli pellets were thawed out in a 37 ◦C water bath, then kept on ice. Lysis
of the E. coli cells was performed with a cOmplete, Mini, EDTA-free Protease Inhibitor
Cocktail Tablet (Roche Applied Science) dissolved in 2 ml lysis buffer (section 6.1.10).
More lysis buffer was then added to each pellet to make a total volume of 30 ml. The
pellets were then re-suspended and the cells disrupted by sonication for 150 seconds
before being centrifuged (50000 g, 4 ◦C) for 45 minutes.
The protein was then purified using nickel-chelated sepharose affinity. 5 µl samples
were collected of the supernatant and flow through for electrophoresis (section 6.2.17
and 6.2.18). Here the His-tagged target protein selectively bound to the nickel chelated
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sepharose in the column, while other proteins passed through the column. A number
of wash steps including one wash (wash 1) using elution buffer (section 6.1.10) and
at least two washes using wash buffer (wash 2+) were performed to remove unwanted
contaminant protein. The washes were monitored for protein content by adding a 20 µl
sample of the flow through to 1 ml Bradford reagent. 5 µl samples of the wash steps
were kept for analysis by electrophoresis.
The target protein was then eluted by the addition of 5 ml elution buffer. The effi-
cacy of the protein purification was checked using either SDS-PAGE gel electrophoresis
(section 6.2.17) or AmershamTM ECLTM gel electrophoresis (section 6.2.18).
A buffer exchange with storage buffer was performed using a ZebaTM Desalt Spin
Column (Thermo Scientific), following the manufacturer’s instructions. The protein
was then stored at -20 ◦C until needed.
To check that the correct protein had been expressed, MS was used. The MS was
performed by the MS service at Durham University using electrospray ionization (ESI)
to ionise the proteins. For crystallisation trials, the protein was purified further using
a Superdex 75 16/60 size exclusion column (GE Healthcare).
6.2.16 Protein Concentration Determination
The absorbance of the protein solution at a wavelength of 280 nm was measured with a
NanoDrop 2000 spectrophotometer with Nanodrop 2000 software version 1.4.2 (Thermo
Scientific), using the mean of five repeat measures. The protein concentration was
then determined using the Beer-Lambert Law and a molar extinction coefficient of
20,065 M−1 cm−1 at 280 nm [59].
6.2.17 SDS-PAGE Gel Electrophoresis
A pre-prepared SDS-PAGE gel was placed in a gel tank with 500 ml SDS buffer.
Samples collected from the protein purification were prepared by adding 10 µl H2O,
5 µl LDS and 1 µl DTT, and then boiled for 3-5 minutes to denature the protein.
Lanes of the gel were loaded with the prepared samples and the gel was run at 120 V.
Afterwards, the protein bands were stained using InstantBlueTM protein stain.
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6.2.18 AmershamTM ECLTM Gel Electrophoresis
AmershamTM ECLTM gels are pre-packed gels for performing polyacrylamide gel elec-
trophoresis (PAGE). Samples were prepared in the same manner as for SDS gels. The
AmershamTM ECLTM gel was placed in the gel box and a voltage of 180 V run across
it for 30 minutes. The lanes were then loaded with the prepared samples and the gel
run at 180 V. Afterwards, the protein bands were stained using InstantBlueTM protein
stain.
6.2.19 Degassing Samples
Samples for ITC were placed in small test tubes with a small magnetic stirrer into
a MicroCalTM ThermoVac machine. Samples were then degassed in the machine at
a temperature of 25 ◦C for approximately 10 minutes with the stirring mechanism
running.
6.2.20 Isothermal Titration Calorimetry (ITC)
The protein was dialysed into ITC buffer (see section 6.1.10) at 4 ◦C and the concen-
tration of protein in this solution then determined (section 6.2.16).
A stock of cyclic adenosine monophosphate (cAMP) in degassed ITC buffer (sec-
tion 6.2.19) was made to a concentration of 20 mM. A working solution of cAMP with
a concentration between 1 mM and 5 mM was then made by diluting the stock solution
in degassed ITC buffer. The concentration of cAMP used was altered depending on
the concentration of the protein available, and calculated using the Beer-Lambert Law
and a molar extinction coefficient of 14,650 M−1 cm−1 at 259 nm [59].
Both the protein and the cAMP solutions were de-gassed before being used for ITC.
The ITC machine was prepared by cleaning and loading the samples as described in
the manufacturer’s manual, loading the cAMP into the syringe and the protein into
the cell.
For the experiment a MicroCal iTC200 (with control software version 1.25.5) was
used to implement 40 consecutive injections of 1 µl of ligand into 202 µl protein. The
data for the first injection was discarded, as this was subjected to possible diffusion
between the syringe and the protein solution prior to data collection.
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Ligand binding for cAMP to CAP was described by a sequential three-site model;
with 2 major and 1 minor binding site [251]. The free ligand concentration of each
injection, [L], was calculated for each injection using the bisection method; allowing
the calculation of the fraction of protein in each bound state, Fi.














) , i = 0, 3 (6.2.2)
The binding constants, Ki, and binding enthalpies, ∆Hi, were determined by fitting
the calculated heat constant,









to the experimental value using the solver package on Microsoft R© Excel R©.
6.2.21 Protein Crystallisation
Two separate protein concentrations (7 mg ml−1 and 14 mg ml−1) were used for crys-
tallisation trials. Automated 96 well sitting drop vapour diffusion plates were prepared
using an Innovadyne Screenmaker 96+8TM for each protein concentration using a PACT
premierTM HT-96 screen (see section 6.1.11) [246].
Crystallisation screens were also set up in 24 well hanging drop vapour diffusion
plates. These screens were at pH 6.5 with 7-10% (w/v) polyethylene glycol 3350 and
15-20% (v/v) 2-methyl-2,4-pentanediol. These screens were used as it was under these
conditions that WT-CAP was known to crystallise [59]. All crystallisation trays were
left at room temperature for crystallisation to occur.
6.2.22 Crystal Structure Determination
Protein crystals were cryoprotected using a 1:1 mixture of mother liquor and 50% (v/v)
glycerol and flash cooled in liquid nitrogen. [252] The diffraction data was collected at
the Diamond Light Source and processed using Mosflm (version 7.0) [253] and Scala
(version 3.3) [254].
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The intensity of diffraction peaks decrease rapidly with resolution, so the signal to
noise ratio can be monitored as an indicator of data quality. The signal to noise ratio
for a resolution shell, 〈|I|/σ(I)〉, is determined by summing the intensities I over the








Another common indicator of data quality when merging N occurrences of reflection











where the summation is for all N repeat observations of a reflection h. I¯(h) is the aver-
aged intensity of each reflection. The merging of weak reflections in higher resolution
shells, causes a rapid increase in the Rmerge, due to an increase in relative error.
Both of the values of 〈|I|/σ(I)〉 and Rmerge were therefore used to help determine
which data set was used to build the structural model from.
The phase problem was solved and the initial structural model was built using
molecular replacement (as described in section sub:phase-problem) with Phaser (ver-
sion 2.1) using the WT-CAP structure(PDB 1G6N [107]).
Model building and refinement was then completed iteratively using Coot [219] and
Refmac (version 5.5) [197] in CCP4 (version 6.1) [254]. For the initial refinement,
10 steps of rigid body refinement was used. Restrained refinement was used for all
future steps, using bond length, bond angle and B-factor restraints as described in
section 3.1.7. Coot was then used after every 10 to 20 steps to manually refine the
structure.
During the automatic refinement, the quality of the model in comparison to the
diffraction data was quantified by the R-value (see equation 3.1.27). In the refinement,
95% of the data was used for the fitting of the model, so only this data was included
in calculation of the R-value. The free data was used to calculate Rfree, which helps
determine if the model was being over fit with too many parameters [200]. Other
measures used for the quality of the model were the root mean square values for bond
lengths, bond angles and chiral volumes.
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When the model was being built graphically using Coot , both the the combined
electron density map (2Fobs − Fcalc) exp(iφcalc) and the basic difference map (Fobs −
Fcalc) exp(iφcalc) were used. Both of these maps are introduced in section 3.1.7. The
combined electron density map was used for most of the visual modelling, with the
difference map clearly identifying where the model and the observed electron densities
differed. For the majority of the modelling a σ value of 1 was used for the electron
density maps, meaning that only the electron density that was one standard deviation
above the mean was visualised.
A number of other tools were used with Coot when building the model, including
“Real space refine zone”, a tool which automatically fit and refined a region of the
protein based on the electron density map, “Regularise zone”, a tool which optimises
the bond lengths and angles of a region of the protein, tools for changing residue
rotamers and a number of other tools for performing transformations. Coot was also
used to build the Q108A mutations into the model and mutate any residues where there
was no side chain electron density to alanine residues to improve the model. As well
as using the electron density maps, the quality of the model was monitored using the
Ramachandran plot to ensure the backbone dihedrals were within the allowed region,
a density fit plot, a geometry analysis plot and a rotamer likelihood analysis plot.
6.3 Results and Discussion
6.3.1 Mutagenesis
Three PCRs were run to include the desired mutation in the CAP gene (see section
6.2.3). The DNA chains synthesised by the first two PCRs were identified in and
extracted from the agarose gel (figure 6.2). After the second PCR, two bands appeared
in the agarose gel, although only one was expected. These were both removed from the
gel separately and analysed separately. Only one of these samples (the larger band)
was then taken further into the cloning process as the E. coli containing this insert
showed positive results in colony PCR, whereas the colony PCR for the other band
exhibited ambiguous results (figure 6.3).
Whenever the mutant CAP gene was ligated into one of the vectors used, colony
PCR was used to check whether it was successful. For the ligation into the pCRTM-
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Figure 6.2: (a) Agarose gel electrophoresis UV images of the first two PCRs: (1) 250 base
pair DNA ladder, (2) negative control, (3) positive control, (4) PCR2, PCR1 (table 6.3). (b)
UV image from the agarose gel electrophoresis of PCR3 solution: (1) positive control (2)
negative control and (3) PCR3 solution. In this case a split in the gel caused a bad image,
and hence the positive control is only visible as a spot. A DNA ladder was also accidentally
omitted from the gel.
Blunt II-TOPO R© plasmid, the directionality of the insert was also checked at the same
time by using the M13 reverse primer. Figure 6.3 shows the agarose gel for these PCRs.
Lanes 8 and 9 both appeared to show positive results, implying that for this colony
the insert got ligated into two plasmids which were both in opposite directions. The
E. coli colony used for this spot was then used to continue the cloning process. Row
B showed inconclusive results, so these were ignored.
Restriction digests of this plasmid were set up, and the mutant CAP gene was
separated out using agarose gel electrophoresis and ligated into pQE30. The insert was
checked, using colony PCR and DNA sequencing.
6.3.2 Protein Expression and Purification
A problem arose at this stage, as at some point during the cloning procedures, a
mutation occurred removing part of the promoter sequence from the pQE30 vector
preventing the mutated CAP gene from expressing (confirmed by DNA sequencing).
To try to prevent this occurring, SOC was used and cultures were grown at 32 ◦C
rather than using LB at 37 ◦C, which had previously been used for other E. coli
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Figure 6.3: Colony PCR of 5 colonies after the blunt CAP gene was ligated into pCRTM-
Blunt II-TOPO R©. The left hand row of lanes (row A) correspond to the colonies grown from
the large band from figure 6.2(b) and the right hand row (row B) to the colonies grown from
the small band. Lane pairs correspond to one PCR using the F-CAP1−6 primer and one PCR
using the R-CAP205−212 primer for each colony, both with the M13 reverse primer. Lane 1
contains the 250 base pair DNA ladder.
cultures. When SOC was used, the expression problems were solved, and Q108A CAP
was successfully purified (see figure 6.4). The concentration of protein obtained was
typically around 10 mg ml−1.
6.3.3 ITC
The binding model as described in section 6.2.20 was fitted to data from 8 ITC ex-
periments. An example fit can be seen in figure 6.5. The thermodynamic parameters
calculated in this manner are exhibited in table 6.6. The allostery coefficient for this
variant is determined to be Ka1
Ka2
= 1.8, which is similar to the value seen for WT-
CAP (1.6) and is within the error for the experimental technique (see table 6.7). This
confirms that as was predicted by the ENM, the variant Q108A does not affect the
allostery in CAP.
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Figure 6.4: Protein electrophoresis (using Amersham ECL gel) of protein purification solu-
tions (from left to right): (1) protein Ladder, (2) E. coli lysis solution, (3) flow through, (4)











1 22.0 9.18 -2.66 35.1
2 19.4 12.9 -8.30 44.1
3 10.6 9.32 -13.7 42.7
4 7.20 7.67 -2.66 35.1
5 19.0 11.1 -4.68 42.3
6 18.7 10.9 -8.16 43.5
7 25.3 9.22 -4.64 43.1
8 16.5 7.55 -12.1 2.96
Avg. 17.40 (2.1) 9.41 (0.5) -6.94 (1.47) 39.6 (2.00)
Table 6.6: Binding association constants and binding enthalpies for CAP Q108A as deter-
mined by ITC. The standard error of the mean for the average thermodynamic values are
given in parentheses adjacent to the mean.
A comparison of the thermodynamic parameters for this variant with the other
variants is discussed in the following subsection.























Figure 6.5: An experimental ITC curve shown as black squares with the corresponding mod-
elled curve for one of the runs for Q108A.
6.3.4 Comparison of ITC Results for all Variants
ITC was performed on the other variants by Phil Townsend, revealing the thermody-
namic properties of cAMP binding for these variants of CAP. These thermodynamic
parameters can be seen in table 6.7. This table shows that as was predicted by the
ENM, mutating residue V132 can manipulate the allosteric binding of cAMP. The
V132A mutation pushes the system further into negative cooperativity from the usual
weakly negatively cooperativity of WT-CAP (making ∆∆G larger) and the V132L mu-
tation makes the system a positively cooperative system (with ∆∆G < 0). The V132A
variant reduces the hydrophobic interactions between the two monomers as it has a
smaller hydrophobic group for the interaction to occur across the interface compared
to WT. The V132L has the opposite effect, increasing the hydrophobic interactions
between the two chains. This effect can be seen in figure 6.6. For V132L, this is the
equivalent of increasing kxx in the SCG models or increasing the relative spring con-



















Variant ∆H1 / ∆H2 / ∆∆H / −T∆S1 / −T∆S2 / −T∆∆S /
kJ mol-1 kJ mol-1 kJ mol-1 kJ mol-1 kJ mol-1 kJ mol-1
WT -8.97 (0.31) 34.3 (0.99) 43.3 (1.22) -19.9 (0.29) -62.1 (1.02) -42.2 (1.21)
V132A -11.1 (1.06) 2.88 (0.82) 16.7 (3.14) -16.3 (1.96) -29.3 (1.34) -13.0 (3.22)
V132L -7.80 (0.39) 25.4 (0.53) 33.2 (0.89) -22.8 (0.51) -57.4 (0.56) -34.6 (0.98)
V140A -20.3 (1.27) 52.6 (1.59) 72.8 (2.76) -6.08 (1.64) -84.4 (1.60) -78.3 (3.16)
V140L -9.26 (0.24) 30.0 (0.54) 39.3 (0.63) -20.7 (0.35) -58.9 (0.34) -38.2 (0.66)
H160L -12.0 (0.45) 40.3 (0.34) 52.3 (0.76) -16.6 (0.45) -68.2 (0.34) -51.6 (0.78)
Q108A -6.94 (1.47) 39.6 (2.00) 46.6 (2.46) -22.8 (1.57) -68.0 (2.10) -45.2 (2.51)
Variant Ka1 Ka2 Ka1/Ka2 ∆G1 ∆G2 ∆∆G
M−1 × 104 M−1 × 104 kJ mol−1 kJ mol−1 kJ mol−1
WT 12.2 (1.0) 7.5 (0.5) 1.6 (0.2) -28.9 (0.14) -27.7 (0.12) 1.15 (0.18)
V132A 14.1 (1.3) 3.1 (0.3) 4.8 (0.6) -29.1 (0.24) -25.4 (0.26) 3.76 (0.35)
V132L 24.6 (1.6) 42.5 (2.1) 0.58 (0.05) -30.6 (0.17) -32.0 (0.13) -1.39 (0.21)
V140A 10.6 (0.6) 19.6 (0.9) 0.59 (0.04) -28.3 (0.18) -30.3 (0.09) -1.96 (0.20)
V140L 20.7 (2.1) 13.5 (1.4) 1.6 (0.2) -30.0 (0.25) -28.9 (0.25) 1.07 (0.35)
H160L 10.2 (0.4) 7.7 (0.2) 1.3 (0.1) -28.5 (0.08) -27.8 (0.08) 0.71 (0.11)
Q108A 17.4 (2.1) 9.4 (0.5) 1.8 (0.2) -29.7 (0.36) -28.3 (0.13) 1.38 (0.38)
Table 6.7: Experimental thermodynamic parameters for WT CAP and its variants; obtained by ITC. Mean values are given for the first and second
cAMP binding events and the allosteric quantities, with the standard error of the mean provided in parentheses.
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WT V132A V132L
Figure 6.6: Hydrophobic interactions across the dimer interface for WT, V132A and V132L,
showing residue 132 as orange spheres.
Figure 6.7: Local structure of residue Cys179 in WT CAP compared to V132A.
The H160L mutation also reduces the negative cooperativity of the system when
compared to WT-CAP. It does not however, make CAP positively cooperative as is
the case for V132L. This is again in agreement with the predictions made by the ENM.
As for the V140 mutations, the ENM predicted that mutating this residue would
not affect the allostery of the system. For the V140L mutation, this is seen to be the
case. However, for the V140A mutation, the allostery of the system becomes positively
cooperative, contrary to the prediction made by the ENM. This change to the allostery
cannot be explained by a global change in structure as is discussed in section 6.3.7.
Nevertheless, there is a significant local conformational change in the crystal structure;
a rotation of the side chain of the nearby Cys179 residue. This local structural change,
shown in figure 6.7, allows the mutated V140A residue to form a new hydrophobic
interaction with residue Cys179. Including this mutation in the ENM by using the
spring constant kCys179/k = 4 for the springs connected to Cys179, the system was
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pushed towards positive cooperativity. This therefore qualitatively justifies the change
in allostery seen for the V140A variant.
The description of allostery in CAP is actually more complex than just looking at
the changes in conformational entropy, unlike what the ENM indicates. It appears in
table 6.7, that both the entropic and enthalpic contributions are equally important for
the allostery of the system and enthalpy-entropy compensation occurs to some extent.
For example, for all of the variants of CAP, the enthalpic contribution to the allosteric
free energy is always positive (which would indicate negative cooperativity). On the
other hand, the entropic contribution to the free energy (−T∆∆S) is always negative
(which treated alone would indicate positive cooperativity). This is contrary to what
was observed by Kalodimos et al. when they studied the truncated form of CAP [17].
They made the conclusion that allostery in the truncated form of CAP was dynamically
driven as only the entropic term led to the negative cooperativity of the system, the
opposite to the results in this section.
In this system, the enthalpy and entropy contributions to the allosteric free energy
are a similar magnitude, with opposite signs, leading to a weakly positive or weakly
negative allosteric free energy. The entropic contributions to the allosteric free energy
do not scale in the same way as the allosteric free energy calculated using the ENM
(which calculates the free energy as a crude enthalpic adjustment to the vibrational
entropy); mutations that are not supposed to make changes to the allostery in CAP
do make changes to the absolute values of the enthalpy and the entropy terms. It is
only when these contributions are combined that there is no change from the allosteric
free energy of WT-CAP. This and the differences observed between the full and trun-
cated forms of CAP imply that the story behind the allostery of full length CAP is
more complicated than being just entropically or enthalpically driven. Rather is the
consequence of enthalpy-entropy compensation.
Looking at the energy contributions separately, it is possible to compare these ITC
results to the entropies calculated from the atomistic simulations. This is performed
in the following subsection.
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Variant T∆∆SvibNMA T∆∆SITC







Table 6.8: Comparison of NMA entropies to ITC entropies. The vibrational entropies as
determined by NMA (T∆∆SvibNMA) are displayed with the entropies determined by ITC
(T∆∆SITC)
6.3.5 Comparison of ITC Results to Atomistic Simulations
In chapter 5 a couple of techniques, MM/PBSA and NMA were used to try calculate
the allosteric free energy for the variants of CAP.
NMA
Firstly, the contribution of the conformational entropy to the allosteric signalling in
CAP was calculated using NMA on snapshots of a long MD simulation. Table 6.8
shows how these simulation results compared to the ITC results. It is evident that
the entropies calculated by NMA have a lower magnitude when compared to the ITC
entropies. This can be explained, as the NMA calculations only return the conforma-
tional entropies, whereas the entropies determined using ITC contain all of the extra
entropic contributions such as the effects of the solvent. Additionally, only the first
200 modes were used for the calculation of the entropy by NMA, which was before the
entropy had converged.
There only appears to be any correlation between the ITC results and the NMA
results when ignoring the data point for the V140A variant. The best fit line for this
reduced data set 6.8 has a Pearson’s correlation coefficient of 0.857. The variant V140A,
however shows no agreement between the two methods; including this data point when
calculating the correlation (solid line) reduces the Pearson’s correlation coefficient to
0.149. This variant also did not behave as expected in the ITC when compared to the
ENM (see section 6.3.4). In that case, the difference was explained by a structural
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Figure 6.8: The C-Cα-Cβ-Sγ dihedral angle for Cys179 of WT, V132A and V132L.  WT,
 V140A,  V140L
change that had not been captured by the ENM.
To investigate if the reason that the MD shows different results to the ITC is because
it does not capture the structural change seen in the X-ray crystallography, the C179
residue was investigated further for the WT, V140A and V140L simulations.
To distinguish between the two different orientations of Cys179, the C-Cα-Cβ-Sγ
dihedral was investigated. For WT (4HZF) and V140L (4I02), this dihedral has a
value around -50 ◦. The PDB for V140A contains 6 monomers, of which only one has
a dihedral around -50 ◦with the other 5 chains having the Cys179 residue in a different
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orientation with dihedrals of around 165 ◦. This local structural difference between the
WT crystal structure and the V140A crystal structure can be seen in figure 6.7 and is
discussed earlier in section 6.3.4.
The distribution of this dihedral angle (χ) was then plotted for all three bound
states of WT, V132A and V132L CAP as shown in figure 6.8. This figure shows that
for all of the simulations, three different dihedral angle distributions are well sampled;
one centred at around 170 ◦, one centred at around 60 ◦ and one centred at around
310 ◦ (or -50 ◦). What is quite surprising is that for all of the simulations, the least
sampled dihedral angle in the simulations is the -50 ◦ dihedral; the dihedral observed
most in the X-ray structures.
The -50 ◦ dihedral of Cys179 gets sampled slightly more for V140L, but not signif-
icantly. Also, the V140A variant does appear to sample the χ = 160 ◦ orientation for
Cys179, however the differences between the dihedral distributions are almost negligi-
ble when compared to the large differences seen in the crystal structures. This therefore
does not confirm that the Cys179 residue samples the 160 ◦ dihedral significantly more
for the V140A mutation than the other variants. In fact, it appears as if none of the
variants sample the experimentally observed value for this dihedral angle to the extent
seen in the experimental data, which could suggest that this region of the protein is
not properly represented by the ff99SBildn force field.
The explanation as to why the entropy for the V140A variant is so different to the
others and the value determined by ITC is therefore still unknown.
MM/PBSA
MM/PBSA was used to try determine the other contributions to the allosteric free
energy, as was discussed in 5.2.8. Combining ∆∆GMM/PBSA (the contributions to the
allosteric free energy calculated using MM/PBSA) and T∆∆S (the vibrational entropy
determined with NMA) the resulting ∆∆GCOMP can be compared to the ITC values
for each of the CAP variants(∆∆GEXP). This is shown in table 6.9 using the energy
values determined with the SASA/vdW model for the nonpolar contribution to the
solvation energies in the MM/PBSA calculations.
This table shows that there is not any convincing agreement between the compu-
tational values of ∆∆G and the experimental values. For example, using computa-








Table 6.9: Comparison between computational and experimental ∆∆G values. The compu-
tational values (∆∆GCOMP) are determined using MM/PBSA and NMA, whilst the experi-
mental values (∆∆GEXP) are determined using ITC.
tional methods, V132A is predicted to exhibit strongly positive allostery, not negative
allostery as expected. As discussed in 5.2.8, the MM/PBSA contributions to the al-
losteric free energy carry large errors, hence the lack of agreement. A large contribution
to these errors can probably be attributed to the simulations not being properly con-
verged as is discussed in section 5.2.6. These simulations would not have been able to
explore as much of phase space as is necessary to get convincing results. As well as
this, the values calculated for the contributions to the vibrational entropy seemed a
little low. As discussed earlier in this section, this could be because not enough normal
modes are included in the calculation.
The lack of agreement with the computational values with experiment after 300 ns
of simulation makes one wonder how long a simulation would need to be run to achieve
proper convergence and whether force fields are accurate enough over such long time
scales, where errors could creep in. Also, even when there are fairly small errors in
calculating the free energy of one system, the percentage error is much larger when
looking at an energy difference and larger still when looking at the difference between
two energy differences as is the case when studying ∆∆G. These arguments all point
towards MM/PBSA perhaps not being an accurate enough method for investigating
cooperative binding.
6.3.6 Crystal Structure Determination of Q108A CAP
Two manual crystal screens using hanging drop crystal trays (described in section
6.2.21) exhibited no crystallisation in any of the wells. However, crystallisation did
6.3. Results and Discussion 201
Figure 6.9: Crystals of Q108A CAP grown in an PACT premierTM screen, with conditions:
(a) 0.2 M sodium bromide, 0.1 M Bis Tris Propane, 20% (w/v) PEG 3350 pH 6.5. (b) 0.2 M
sodium iodide, 0.1 M Bis Tris propane, 20% (w/v) PEG 3350 pH 8.5. (c) 0.2 M sodium
nitrate, 0.1 M Bis Tris propane, 20% (w/v) PEG 3350 pH 8.5. (d) 0.2 M potassium/sodium
tartrate, 0.1 M Bis Tris propane, 20% (w/v) PEG 3350 pH 8.5.
Resolution / A˚ Rmerge 〈I〉 σ(I) 〈|I|/σ(I)〉 Nmeas Nref
5.63 0.032 9578 633 30.1 7234 1337
3.98 0.049 12603 855 30.2 12395 2299
3.25 0.044 8424 618 25.9 14569 2974
2.81 0.055 3414 303 20.5 18119 3606
2.52 0.069 1840 211 15.7 20566 4120
2.30 0.090 1260 186 12.5 22812 4538
2.13 0.115 988 189 9.8 25141 4957
1.99 0.182 651 178 7.1 26974 5236
1.88 0.293 348 164 4.4 29109 5566
1.78 0.486 202 159 2.7 30611 5810
Table 6.10: Statistics from the resolution shells for the CAP Q108A variant diffraction pattern
output by Scala [254]. 〈I〉, σ(I), Rmerge and 〈|I|/σ(I)〉 are described in section 6.2.22, whilst
Nmeas and Nref are number of measurements and the number of independent reflections
respectively.
occur in a number of wells of the automated 96 well sitting drop screens. Figure 6.9
shows images of a number of crystals from the automated screen with the conditions
used to promote crystallisation.
A selection of these crystals (plus a few more) were taken to the Diamond Light
Source, where X-ray diffraction data was collected. MOSFLM was used to process the
diffraction patterns to a resolution of 1.78 A˚. The diffraction peaks were integrated and
analysed using Scala [254]. An analysis of the statistics of the data against resolution
can be seen in table 6.10.
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Parameter Value
Resolution / A˚ 1.78
Wavelength 0.9795
No. reflections 41452
Completeness / % 99.4
a / A˚ 46.0
b / A˚ 93.7
c / A˚ 104.0
α / ◦ 90.0
β / ◦ 90.0
γ / ◦ 90.0
No. protein atoms 3121
No. ligand atoms 66
No. water atoms 315




RMS bond length / A˚ 0.0159
RMS bond angle / ◦ 1.57
RMS chiral volume / A˚3 0.137
Average B-factor 29.3
Table 6.11: Crystallographic data collection and refinement statistics for the crystal structure
of CAP Q108A.
The value for Rmerge obtained for the highest resolution shell for CAP Q108A was
0.486 and 〈|I|/σ(I)〉 was 2.7. A value of Rmerge less than 0.5 and a value of 〈|I|/σ(I)〉
greater than 2 for the highest resolution shell are usually considered acceptable [255].
Therefore, they indicate that the data collected is of high enough quality to use to
solve the crystal structure.
The final crystal structure contained one CAP dimer in the asymmetric unit and
was in the P212121 space group, which is the same space group as the V132A, V132L
and V140L mutants [59]. Both of the chains were complete, contained no missing
loop residues, however at the termini, 5 residues from the N terminus and 4 residues
from the C terminus were unresolved from chain A. Chain B had 7 residues from the N
terminus and 3 residues from the C terminus unresolved. As well as the two monomers,
the unit cell also contained three cAMP molecules and 315 water molecules.
The parameters defining the unit cell and the refinement parameters for the crystal
structure (R-value,Rfree-value, RMS values and average B-factor) are shown in table
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Figure 6.10: The crystal structure of CAP Q108A. Residue 108 is coloured red to indicate
the position of the mutation.
Figure 6.11: A close-up view of the mutated residue, 108, in the crystal structure of the
Q108A variant of CAP. The 2Fobs − Fcalc electron density map shown here at a level of 1σ
indicates the presence of the mutation. Should the mutation be missing a large region of
electron density would be present corresponding to the glutamine residue in the WT.
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6.11.
The solved crystal structure can be seen in figure 6.10 and a close up of the mutated
residue with electron density can be seen in figure 6.11. There is very little global
structural change of CAP when mutating this residue, as is discussed more in 6.3.7.
6.3.7 Comparison of Crystal Structures for all Variants
The crystal structure for holo2-CAP was solved for WT, V132A, V132L, V140A, V140L
and H160L by Phil Townsend. The RMSD comparison between the WT CAP and the
variants were calculated for the full length protein and just the LBD using the Kabsch
algorithm [232]. These RMSD calculations were performed using PyMOL [234]. The
RMSD values and the number of atoms used in the calculations can be seen in table
6.12. This shows that the RMSD between WT and the variants is less than 2 A˚ for
all variants except V132L, which has an RMSD of 2.80 A˚. These values are low enough
to show that there no major changes to the global structure of CAP upon making the
mutations.
The RMSDs between the LBDs for the variants and WT-CAP are much lower than
for full length CAP; below 0.8 A˚ for all of the variants. This again shows that the
main differences between the structures of the CAP variants are small rotations in
the DNABD. The variant crystal structures are displayed in figure 6.12, showing how
similar the structures are and the small changes to the orientations of the DNABDs.
The next section relates these X-ray structures to the MD simulations and the NMA
first shown in chapter 5.
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PDB RMSDfull nfull RMSDLBD nLBD
/ A˚ / A˚
V132A (4I0A) 1.90 1575 0.53 1024
V132L (4I09) 2.80 1582 0.80 1030
V140A (4I02{A,E}) 1.54 1566 0.51 1025
V140A (4I02{B,C}) 1.49 1569 0.55 1028
V140A (4I02{D,F}) 1.40 1573 0.49 1028
V140L (4I01) 1.72 1581 0.55 1028
H160L (4I0B) 1.99 1570 0.53 1021
Q108A 1.90 1576 0.59 1028
Table 6.12: RMSDs of the X-ray structures of CAP variants from the aligned WT structure
using the backbone atoms for all overlapping residues in the calculation; performed using
PyMOL [234]. The number of overlapping atoms used in the calculation differs for each
variant and is displayed as nfull. The RMSDs of only the LBD is also included (RMSDLBD),
where the LBDs of the variant and the reference WT structure are aligned before the RMSD
calculated for the backbone atoms. nLBD shows the number of atoms used in the calculation.
PDB IDs of structures available on the PDB are provided in parentheses.
Figure 6.12: Overlay of the X-ray crystal structures of one monomer of the CAP variants.
The alignment is performed on the LBDs of both chains using PyMOL [234]. Chain A for
each variant is shown:  WT,  V132A,  V132L,  V140A,  V140L,  H160L and
 Q108A.
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6.3.8 Comparison of Protein Crystallography Results to Atom-
istic Simulations
The crystal structures of all of the variants studied in this thesis are all very similar,
and the main differences in structure are due to rotation of the DNABDs relative to
the LBDs. These differences are similar to the differences between the final structures
of the variants after 300 ns of MD simulation. This section investigates whether these
rotational differences observed between the different variant crystal structures can be
described by the motions observed by the atomistic techniques; NMA and PCA.
NMA
First NMA was investigated by looking at how similar the first six normal modes of
WT holo2-CAP are to the differences seen between the variant crystal structures. This
was done by calculating difference vectors between all nine PDBs to return a set of
36 vectors. These difference vectors were calculated by subtracting the coordinates
of one PDB from the coordinates of the other after all of the structures had been
aligned to the WT structure. The overlaps of these difference vectors with each of the
first 6 normal modes were then calculated (using Cα coordinates). The structure from
the NMA also had to be aligned with the WT crystal structure and the eigenvectors
transformed by the same amount before the overlaps were calculated. These alignments
and overlaps were performed using the author’s own code written in Python (given in
appendix C); the alignments performed using the Kabsch algorithm [232] and the
overlaps determined using the equations described in section 2.5.3.
The results of this analysis are shown in table 6.13. In this table the normal
modes that have a significant overlap with the difference vectors between two PDBs
are highlighted. The definition of a ’significant overlap’ in this study is considered to
be an overlap of 0.5 or above, a value where the motion described by the normal modes
will be similar to the difference vectors between the two PDBs.
This table shows that most of the PDBs tend to follow the 4th mode closest of all
the normal modes calculated. Figure 6.13 shows the vector of the 4th normal mode
and how it compares to the difference vector between the PDBs 4I09 (V132L) and
4I0B (H160L), which have a high overlap of 0.790. The figure shows vector arrows to
compare the direction of the motion for both vectors and a plot of the residue wise
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PDB Mode Number
s(u1−6,W)
PDB1 PDB2 1 2 3 4 5 6
A B 0.443 0.308 0.174 0.669 0.077 0.145 0.892
A C 0.552 0.015 0.228 0.705 0.060 0.109 0.932
A D 0.180 0.548 0.413 0.157 0.413 0.075 0.839
A E 0.195 0.475 0.417 0.211 0.405 0.121 0.813
A F 0.022 0.447 0.387 0.209 0.433 0.148 0.777
A G 0.480 0.219 0.101 0.585 0.106 0.350 0.874
A H 0.002 0.313 0.392 0.634 0.041 0.014 0.810
A I 0.430 0.272 0.112 0.694 0.108 0.155 0.888
B C 0.499 0.372 0.218 0.500 0.018 0.024 0.828
B D 0.250 0.103 0.415 0.658 0.205 0.169 0.865
B E 0.240 0.044 0.401 0.675 0.187 0.193 0.865
B F 0.339 0.011 0.359 0.649 0.185 0.199 0.860
B G 0.014 0.229 0.173 0.291 0.040 0.366 0.550
B H 0.269 0.003 0.132 0.791 0.072 0.079 0.853
B I 0.042 0.189 0.357 0.202 0.194 0.073 0.499
C D 0.393 0.235 0.384 0.676 0.134 0.129 0.921
C E 0.387 0.193 0.377 0.692 0.123 0.147 0.919
C F 0.453 0.167 0.347 0.672 0.123 0.151 0.918
C G 0.427 0.193 0.272 0.570 0.006 0.170 0.805
C H 0.387 0.136 0.024 0.790 0.062 0.071 0.895
C I 0.506 0.328 0.295 0.452 0.025 0.008 0.810
D E 0.054 0.528 0.054 0.280 0.131 0.252 0.666
D F 0.555 0.484 0.205 0.117 0.062 0.209 0.803
D G 0.244 0.194 0.348 0.544 0.190 0.313 0.805
D H 0.120 0.105 0.616 0.436 0.316 0.064 0.836
D I 0.239 0.128 0.360 0.676 0.176 0.177 0.850
E F 0.716 0.213 0.211 0.057 0.017 0.076 0.782
E G 0.233 0.133 0.335 0.564 0.172 0.334 0.802
E H 0.128 0.046 0.622 0.412 0.307 0.094 0.824
E I 0.229 0.070 0.347 0.693 0.158 0.200 0.850
F G 0.335 0.099 0.297 0.545 0.172 0.339 0.807
F H 0.012 0.011 0.601 0.431 0.317 0.109 0.812
F I 0.327 0.037 0.308 0.667 0.157 0.205 0.845
G H 0.280 0.072 0.192 0.745 0.088 0.195 0.849
G I 0.001 0.171 0.049 0.386 0.031 0.360 0.558
H I 0.257 0.022 0.164 0.790 0.089 0.084 0.856
Table 6.13: Overlap of (none zero) NMA modes to difference vectors between two PDBs.
PDBs used are: A: WT (4HZF), B: V132A (4I0A), C: V132L (4I09), D: V140A (4I02 chains
A and E), E: V140A (4I02 chains B and C), F: V140A (4I02 chains D and F), G: V140L
(4I01), H: H160L (4I0B), I: Q108A (unpublished). The difference vectors were calculated by
aligning all of the structures to the WT structure and subtracting PDB2 from PDB1. The
subspace overlap, s(u1−6,W), (see equation 2.5.61 in section 2.5.4), taking into account the
overlap between the first six normal modes, u1−6, and the PDB difference vector, W, is also
shown for each difference vector.
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cross correlation of these vectors in real space. The residue-wise cross correlation was
calculated with an adaptation of equation 2.5.58 using the individual PDB difference
vector between the two PDBs and looking at only the Cα atoms in the calculation.
These cross correlations are shown in figure 6.13 in real space, superimposed onto
the structure of PDB 4HZF. These show that for most regions of the protein, the
fourth normal mode from the NMA describes the differences between the two variant
structures very well, with only small regions where the two vectors do not correlate
well.
Table 6.13 also contains a column for the subspace overlap, s(u1−6,W), defined
by equation 2.5.61 in section 2.5.4. This value quantifies how much of the difference
between the two PDBs can be described by the six modes in the table. If all 3N − 6
normal modes of a protein with N atoms were used, the subspace overlap would have a
value of one as the normal modes form an orthogonal basis. Therefore, a good measure
of how much a reduced set of the normal modes contribute to the motion seen in a
reference vector is how close this subspace overlap is to a value of 1 for this reduced
set.
The value of the subspace overlap for the first six modes from NMA appears to be
over 0.8 for most of the difference vectors between the different PDBs, showing that
these six modes capture most of motion necessary for the structural changes between
each of the PDBs to occur. This implies that the structural differences seen between
the variants are again not large global changes and are instead more likely due to the
motion along the lowest energy motion getting frozen out at different points along the
mode during crystal packing.
PCA
The same analysis was performed on the first six modes calculated on the 200 ns WT
holo2-CAP MD simulation using PCA. In this case, the mode which best describes
the differences seen in the PDBs is the second mode, as can be seen in table 6.14.
However, the overlap of this mode with the PDB difference vectors is typically not as
great as was seen with the top mode calculated with NMA. Only 9 PDB difference
vectors having an overlap greater than 0.5 for mode 2 from PCA compared to the 22
difference vectors that have an overlap greater than 0.5 for mode 4 from NMA. This
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PDB Mode Number
s(u1−6,W)
PDB1 PDB2 1 2 3 4 5 6
A B 0.031 0.527 0.289 0.188 0.093 0.106 0.646
A C 0.022 0.562 0.195 0.203 0.075 0.208 0.667
A D 0.046 0.218 0.145 0.047 0.275 0.158 0.416
A E 0.052 0.210 0.101 0.095 0.257 0.176 0.404
A F 0.039 0.156 0.143 0.156 0.196 0.139 0.358
A G 0.034 0.451 0.258 0.318 0.150 0.150 0.646
A H 0.600 0.419 0.197 0.048 0.099 0.121 0.775
A I 0.018 0.532 0.236 0.195 0.097 0.129 0.635
B C 0.083 0.404 0.001 0.157 0.030 0.267 0.517
B D 0.001 0.301 0.140 0.191 0.103 0.193 0.441
B E 0.003 0.305 0.168 0.216 0.085 0.197 0.463
B F 0.005 0.334 0.144 0.241 0.038 0.165 0.468
B G 0.130 0.240 0.112 0.207 0.086 0.063 0.376
B H 0.343 0.579 0.058 0.082 0.003 0.138 0.694
B I 0.290 0.080 0.290 0.052 0.026 0.140 0.444
C D 0.033 0.391 0.097 0.201 0.061 0.252 0.521
C E 0.034 0.395 0.118 0.220 0.049 0.256 0.536
C F 0.028 0.413 0.102 0.236 0.015 0.231 0.539
C G 0.002 0.464 0.057 0.025 0.021 0.192 0.506
C H 0.291 0.600 0.045 0.119 0.004 0.202 0.708
C I 0.017 0.383 0.063 0.146 0.027 0.235 0.478
D E 0.021 0.091 0.278 0.271 0.152 0.072 0.433
D F 0.038 0.269 0.048 0.338 0.336 0.108 0.561
D G 0.055 0.204 0.096 0.274 0.071 0.217 0.426
D H 0.483 0.504 0.067 0.076 0.106 0.005 0.713
D I 0.044 0.304 0.098 0.196 0.099 0.208 0.442
E F 0.062 0.264 0.141 0.219 0.301 0.183 0.515
E G 0.057 0.209 0.125 0.297 0.053 0.221 0.450
E H 0.490 0.505 0.101 0.109 0.089 0.014 0.725
E I 0.046 0.308 0.126 0.220 0.081 0.212 0.461
F G 0.047 0.242 0.102 0.322 0.006 0.189 0.459
F H 0.512 0.471 0.081 0.147 0.043 0.016 0.717
F I 0.037 0.337 0.104 0.245 0.035 0.180 0.468
G H 0.401 0.534 0.025 0.154 0.024 0.165 0.706
G I 0.028 0.286 0.010 0.200 0.082 0.013 0.360
H I 0.367 0.569 0.028 0.084 0.003 0.146 0.698
Table 6.14: Overlap between PCA normal modes and the difference vectors between two
PDBs. PDBs used are: A: WT (4HZF), B: V132A (4I0A), C: V132L (4I09), D: V140A (4I02
chains A and E), E: V140A (4I02 chains B and C), F: V140A (4I02 chains D and F), G:
V140L (4I01), H: H160L (4I0B), Q108A (unpublished). The subspace overlap, s(u1−6,W),
between each individual difference vector, W, and the six PCA modes, u1−6, is also shown.
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is not surprising as the NMA was performed on one of the crystal structures, whereas
in the MD simulation the protein was free to explore a larger region of conformational
space. However, there is still significant overlap between the difference vector between
H160L and the other PDBs and the second mode.
Figure 6.13 shows the vector for the second principal component as arrows for
comparison with the PDB difference vector. The residue wise cross correlation between
these two vectors is also displayed, showing that again large regions of the protein
move in a similar manner to the difference seen between the X-ray structures. It
does highlight that there is less agreement with PCA to experiment than with NMA
however.
The subspace overlap between the H160L PDB and all of the other variants is
around 0.7 (see table 6.14), showing that the first six principal components are respon-
sible for most of the differences seen between these PDBs. The subspace overlap with
the principal components is also around 0.5 for the difference vectors between most of
the PDBs, which indicates that although the lowest modes from PCA do not capture
as much of the motion seen as NMA, they do still capture a large proportion of the
motion in the first six modes. Increasing the number of modes investigated would only
increase this subspace overlap.
Therefore both NMA and PCA are able to capture a large proportion of the motion
that would be required to cause the differences in structure seen in all of the variants of
CAP. However, it appears that the NMA method is able to capture the motion more
effectively.
6.3.9 Overall Discussion
In this chapter, the thermodynamic parameters of the cooperative binding of cAMP to
CAP were investigated using ITC. The variants, V132A, V132L and H160L, predicted
to affect allostery using the ENM in chapter 4 were shown by ITC to affect allostery
in the same way as predicted. Similarly, variants V140L and Q108A predicted by the
ENM to not affect allostery were also shown to not affect allostery by ITC. There was
some agreement between the entropies determined by atomistic NMA, although not
quite to the extent of the agreement seen between the ENM and ITC. There was less
agreement still between the thermodynamic parameters determined using MM/PBSA
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Figure 6.13: Comparison of difference vectors between PDBs 4I09 (V132L) and 4I0B (H160L)
to normal modes from NMA and PCA. a) The difference vectors between the two X-ray
crystal structures. b) and c) show the eigenvectors from a single normal mode as calculated
from each theoretical method above a plot of the residue wise cross correlation (see section
2.5.2) between this vector and the PDB difference vector in a); red corresponding to a cross
correlation of 1 and blue corresponding to a cross correlation of -1. b) shows the 4th none
zero normal mode calculated by NMA and c) shows the 2nd normal mode calculated by PCA.
All arrows are calculated to a length that would give the protein an RMSD of 2 A˚.
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on atomistic simulations and the experimental values. The errors using these particular
atomistic methods to calculate the allosteric free energy difference has the potential
of being significantly large, so if future study were to be performed on this system,
another more accurate method would be recommended. Repeating the chosen method
a large number of times would also be required to get statistically significant average
values.
The X-ray structure for the Q108A variant of holo2 CAP was solved. It was shown
that there were no major structural differences between this variant and any of the other
variants of holo2 CAP studied. Although this does not directly show allostery without
conformational change, combined with the ITC results it shows that the allostery in
CAP can be modified without changing the global structure of the protein.
The main structural differences that were observed between the holo2 CAP variants
were rearrangements of the DNABDs relative to the LBDs, again showing the flexibility
of the hinge region. These structural differences were shown to agree with the motions
seen in the principal components of atomistic MD simulations and NMAs; agreeing
more with the modes seen in NMA than PCA.
Chapter 7
Conclusions and Further Work
7.1 Conclusions
In this thesis, SCG models and the ENM were used to show that WT CAP is on a
region of the allosteric free energy landscape that is very sensitive to small changes
in the interactions within the protein’s LBD. An advantage of CAP being located
at this region of the free energy landscape is that changes in the environment that
make an unfavourable change to the cooperative binding of cAMP to CAP could be
counteracted by a mutation in CAP. Being at this location on the free energy landscape
allows CAP to adapt when there are changes to the environment. The SCG models
(and to a lesser extent the ENM) also showed that CAP was much less sensitive to
changes in the interactions within the protein’s DNABDs. This has the consequence
that changes to the homotropic allostery with the allosteric effector cAMP (which
binds to the LBDs) are unlikely to affect the DNA recognition helix, keeping these two
mechanisms separate.
The ENM was also used to identify individual residues, which when mutated were
likely to affect the allostery within CAP. Variants of CAP incorporating these point
mutations were investigated using atomistic computational methods and experimental
techniques. ITC for example showed a selection of the variants identified by the ENM
to alter the allostery within CAP, did in fact change the allostery as predicted. NMA
and MM/PBSA were used together to try determine the allosteric free energies for
these variants computationally. Although the computed entropies appeared to show a
fair agreement with the ITC values, the enthalpies showed less of an agreement and the
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errors with the values were argued to be too large for the trends seen to be statistically
significant.
Atomistic MD simulations were used to study some of the global and local motions
observed within the variants of CAP, with a potential pathway for the homotropic
allostery within CAP being identified through the Thr128 residues of each monomer.
The protein motion observed through MD simulations and NMA calculations was
also shown to agree with the ensemble of structures for the variants of CAP observed us-
ing X-ray crystallography. The inherent flexibility of the hinge region (residues 132-138)
was seen, with both simulation and crystallography. Indicating a range of orientations
of the DNABD relative to the LBD are possible.
Although the overall goal of showing that allostery within CAP occurs without a
significant conformational change could not be proved, this thesis did show that it
could be manipulated without a significant conformational change. It also showed that
both the enthalpy and entropy were important contributions to the cooperativity of
binding cAMP and the resulting allosteric free energy was a result of enthalpy-entropy
compensation. The following further work section outlines some additional work that
could be done that could help tackle some of the questions that are still open after this
thesis.
7.2 Further Work
In chapter 4, SCG models were used to study the allostery in CAP. It was mentioned
that it would be possible to use these models to study other allosteric homodimers by
adjusting the parameters of the model, and a larger range of proteins could be covered
by including the springs excluded in the current model.
The ENM, also discussed in chapter 4, allowed the addition of mutations to the
protein by adjusting spring constants. However with this model, all residues are treated
equally except the mutated residue. It would be interesting is to investigate an ENM
that has varying cut-offs for residues with different length side chains; longer side chains
naturally corresponding to larger cut-offs. Additionally, the spring constants could
be parametrised so they are different depending on the residues they connect. The
point mutations could then be made based on the residue parametrisations. Similar
ENMs with variable spring constants have previously been studied to look at motion
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in proteins [256,257], so there would be a good starting point for such a study.
As was discussed in chapter 5, the force field ff12SB is a new AMBER force field. It
was only used to study the WT variant of CAP. In the studies in this thesis, it did not
appear to simulate apo-CAP as would be expected. However, a more comprehensive
study of the force field compared to the other older AMBER force fields would be useful
for the entire scientific community.
The computational methods used in this thesis to determine the allosteric free en-
ergy, NMA and MM/PBSA, were found to not be of sufficient accuracy to determine
the small free energy difference involved in allostery. In a future study, other methods
such as thermodynamic integration could be used to determine the free energy of the
cAMP-CAP binding events. Such simulations could be run over a range of temper-
atures to determine entropic changes. Other alternatives could be steered molecular
dynamics or umbrella sampling. These methods are much more computationally ex-
pensive than the methods used in this study, and as a lot of repeats are needed for
statistically significant results, they were deemed too computationally expensive for
this study. However, with increasing GPU support for these types of calculations with
each AMBER release, running long studies on proteins of the size of CAP or larger,
using computationally expensive methods such as these is becoming increasingly pos-
sible.
Future experimental work could include continuing with the target of obtaining a
good quality crystal structure of apo-CAP. This could help answer a lot of the remain-
ing questions about whether the allostery in CAP occurs without a conformational
change.
Finally, in this thesis it was shown that it was possible to manipulate allostery in
a system that already exhibits negative allostery without a conformational change by
making point mutations in the protein. An interesting future study could be to see
if allostery can also be manipulated by binding another ligand to the protein rather
than making physical changes to the protein, or in other words another allosteric event.
Alternatively, a protein that does not normally exhibit cooperative binding could be
manipulated so that it does show this, either by making mutations or binding ligands
to distant sites on the protein.
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Configuration files and a sample script for performing MD in AMBER
A.1 Energy Minimisation
A.1.1 Minimising Solvent
CAP_2cAMP: initial minimisation solvent + ions
&cntrl
imin = 1, maxcyc = 10000,
ncyc = 5000, ntb = 1,
ntr = 1, cut = 10.0,
ntwx = 100
/








CAP_2cAMP: initial minimisation whole system
&cntrl
imin = 1, maxcyc = 50000,
ncyc = 25000, ntb = 1,



































Keep CAP fixed with weak restraints
10.0





CAP_2cAMP: 4000ps of production MD
&cntrl
imin = 0, irest = 1,
ntb = 2, pres0 = 1.0,
taup = 2.0, iwrap=1,
cut = 10.0, ntr = 0,
ntc = 2, ntf = 2,
temp0 = 300.0, ntx = 5,
ntt = 3, gamma_ln = 1.0,
ntp = 1, ig=-1,
nstlim = 2000000, dt = 0.002,
ntpr = 5000, ntwx = 5000,
ntwr = 10000, ioutfm=1
/







pmemd.cuda -O -i ../../wat_min1.in -o ${PROTEIN}_${VAR}_min1.out -p ${PROTEIN}_${VAR}.prmtop -c
${PROTEIN}_${VAR}.inpcrd -r ${PROTEIN}_${VAR}_min1.rst -ref ${PROTEIN}_${VAR}.inpcrd
#
pmemd.cuda -O -i ../../wat_min2.in -o ${PROTEIN}_${VAR}_min2.out -p ${PROTEIN}_${VAR}.prmtop -c
${PROTEIN}_${VAR}_min1.rst -r ${PROTEIN}_${VAR}_min2.rst
#
pmemd.cuda -O -i ../../heat_nc.in -o ${PROTEIN}_${VAR}_heat.out -p ${PROTEIN}_${VAR}.prmtop -c
${PROTEIN}_${VAR}_min2.rst -r ${PROTEIN}_${VAR}_heat.rst -ref ${PROTEIN}_${VAR}_min2.rst -x
${PROTEIN}_${VAR}_heat.nc
#
pmemd.cuda -O -i ../../density_nc.in -o ${PROTEIN}_${VAR}_density.out -p
${PROTEIN}_${VAR}.prmtop -c ${PROTEIN}_${VAR}_heat.rst -r ${PROTEIN}_${VAR}_density.rst -ref
${PROTEIN}_${VAR}_heat.rst -x ${PROTEIN}_${VAR}_density.nc
#
pmemd.cuda -O -i ../../md-prod_nc.in -o ${PROTEIN}_${VAR}_mdprod1.out -p






Configuration files for performing NMA in GROMACS.
B.1 Energy Minimisation
; STANDARD MD INPUT OPTIONS NMA MINIMISATION













; nblist update frequency
nstlist = 0
; ns algorithm (simple or grid)
ns-type = simple





; OPTIONS FOR ELECTROSTATICS AND VDW
; Method for doing electrostatics
coulombtype = Cut-Off
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rcoulomb-switch = 0
rcoulomb = 0
; Dielectric constant (DC) for cut-off or DC of reaction field
epsilon-r = 1





B.2 Normal Mode Analysis
; STANDARD MD INPUT OPTIONS NMA













; nblist update frequency
nstlist = 0
; ns algorithm (simple or grid)
ns-type = simple
; Periodic boundary conditions: xyz (default), no (vacuum)





; OPTIONS FOR ELECTROSTATICS AND VDW




; Dielectric constant (DC) for cut-off or DC of reaction field
epsilon-r = 1







A number of functions written in Python by the author; used to perform least-square fitting of coordinates (using the
Kabsch algorithm [232]) and overlap calculations are included below. The calculation performed in the program at the
end was used for determining the overlaps between PDB difference vectors and NMA and PCA modes as seen in section
6.3.8.
#!/usr/bin/python
import numpy as np, math
import string, os
# Residue weights for mass weighting
ResWeights=dict(zip(’ALA ARG ASN ASP CYS GLU GLN GLY HIE HIS ILE LEU LYS MET PHE \
PRO SER THR TRP TYR VAL’.split(),[71.078, 156.19, 114.10, 115.08, 103.14, 129.11,
128.13, 57.051, 137.14, 137.14, 113.16, 113.16, 128.17, 131.20, 147.17, 97.115, 87.077,
101.10,186.21,163.17,99.131]))
# # # # # # # # # # # # # # # # # # # # # # # # #
# Read options and arguments from command line #
# # # # # # # # # # # # # # # # # # # # # # # # #
from optparse import OptionParser
parser=OptionParser()
usage = "\
This program calculates the vectors between a series of PDB structures.\n\
It then compares these vectors to the eigenvectors from a Principal Component\n\
Analysis (PCA) or Normal Mode Analysis (NMA) (NMWIZ format) by calculating the\n\
overlap between these vectors.\n\n\
usage: %prog [option1] arg1 [option2] arg2 ... <PDB1> <PDB2>"
parser = OptionParser(usage)
parser.add_option("-n", "--nmwiz", action="store", metavar="FILE",
type="string", dest="nmwiz", help="NMWIZ file "
"containing coordinates and eigenvectors "
"to fit the PDBs to")
parser.add_option("-a", "--alignmask", action="store", metavar="MASK",
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type="string", dest="alignmask", help="Residue mask"
" to align structures. Format = :1-100 (for residues 1-100)")
parser.add_option("-e", "--vecmask",action="store", metavar="MASK",
type="string", dest="vecmask", help="Residue mask "
"to select the residues used in calculating"
"the overlap of the eigenvectors. Format = "
":1-100 (for residues 1 to 100)")
parser.add_option("-o", "--outtab",action="store", metavar="FILE",
default=’overlaps.tex’, type="string", dest="outtab",
help="Output file for table (in latex format)")
parser.add_option("-p", "--nmwout",action="store", metavar="FILE",
type="string", dest="nmwout", help="Output file "
"for nmwiz created from pdbs (uses nmwiz input"
" coordinates as output coordinates)")
parser.add_option("-x", "--vecstart",action="store", metavar="INDEX",
default=0, type="int", dest="vecstart",
help="First eigenvector to read from nmwiz file")
parser.add_option("-y", "--vecstop",action="store", metavar="INDEX",
default=6, type="int", dest="vecstop",
help="Last eigenvector to read from nmwiz file")
(options, pdbs) = parser.parse_args()
# Read nmwiz file into a Nx3 array (for coordinated)
def readnmwiz(infile):
print "Reading NMWIZ file: "+infile














coords=np.array([[float(coords1D[i]) for i in range(0,len(coords1D),3)],
[float(coords1D[i]) for i in range(1,len(coords1D),3)],





evecs.append([[float(lineData[i]) for i in range(3,len(lineData),3)],
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[float(lineData[i]) for i in range(4,len(lineData),3)],
[float(lineData[i]) for i in range(5,len(lineData),3)]])
evecs=np.array(evecs)
return coords,evecs,evecIndex,evecScale,[int(i) for i in resids],resnames,bfactors
# Extract data from a PDB file
def readpdb(inf,CA=False,opt2=’’):
print "Reading PDB: "+inf











for line in fileLines:
if line[0:6]==’ATOM ’:
if line[12:16].rstrip(’ ’).lstrip(’ ’)==’CA’:











for line in fileLines:
if line[0:6]==’ATOM ’:
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#~ element.append(line[76:78].lstrip(’ ’))
if altres:
print ’Alternate configurations found in PDB! Using first seen!’
return atomno,atomtype,resname,chid,residno,np.transpose(np.array(coords))
# Calculates the center of geometry of a coordinate set
def returnCOG(coords):
COG=[]
for dim in coords:
COG.append(np.mean(dim))
return np.array(COG)
#Calculates the center of mass of a coordinate set
def returnCOM(coords,masses):
COM=[]
for dim in coords:
COM.append(1/(np.sum(masses))*np.sum(masses*dim))
return np.array(COM)






for dim in range(len(coords)):
for x in range(len(coords[dim])):
coords[dim][x]=coords[dim][x]-center[dim]
return coords










# Calculates the (rotational) covariance matrix between matA and matB
def getCovariance(matA,matB):
return matA.dot(np.transpose(matB))
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# Corrects the rotation matrix if coords are not right-handed by




# Calculates the rotation matrix to rotate matB to align with matA











# Rotate a matrix by the rotation matrix: rotMat
def rotateMat(mat,rotMat):
return rotMat.dot(mat)
# Overall routine to run the RMS fit (rotating matB)
def RMSfit(matA,matB,retRMS=False):
E0 = np.sum( np.sum(matA * matA,axis=0),axis=0)\
+ np.sum( np.sum(matB * matB,axis=0),axis=0)
rotmat,s=calcRotMat(matA,matB,True)






#Center and Rotate matrix B to matrix A according to mask
def centerRMSfitmask(matA,matB,mask=[[0,401]],RM=False,masses=np.array([])):
matAmask=[[],[],[]]
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matBmask=[[],[],[]]
for mi in mask:
matAmask=[matAmask[c]+list(matA[c][mi[0]:mi[1]]) for c in range(len(matA))]




E0 = np.sum( np.sum(matAmask * matAmask,axis=0),axis=0)\
+ np.sum( np.sum(matBmask * matBmask,axis=0),axis=0)
#Return rotation matrix and s to calculate errors
rotmat,s=calcRotMat(matAmask,matBmask,getS=True)






# Calculates the overlap of two vectors given as np arrays (order doesn’t matter)
def Overlap(Vec1,Vec2):
return abs(np.dot(Vec1,Vec2))/math.sqrt(Vec1.dot(Vec1)*Vec2.dot(Vec2))
# Read the residue mask as given on the command line
def readResMask(mask):
return [int(i) for i in mask.lstrip(":").split("-")]
# Determine the starting and stop indices for the coordinates based on the residue mask
def translateMask(mask,resids):
maskbounds=readResMask(mask)
start = [i for i, x in enumerate(resids) if x == maskbounds[0]]
stop = [i for i, x in enumerate(resids) if x == maskbounds[1]]
if len(start)!=len(stop):
print "Invalid Alignment Mask failed for: "+pdbs[i]
return start,stop
# Make the masked coordinates
def makeMaskedCoords(coords,start,stop):
rco=coords[:,start[0]:stop[0]]
for i in range(1,len(start)):
rco=np.append(rco,coords[:,start[i]:stop[i]],axis=1)
return rco
# Make the masked coordinates in 1D
def makeMasked1d(data,start,stop):
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maskeddata=data[start[0]:stop[0]]
for i in range(1,len(start)):
maskeddata=np.append(maskeddata,data[start[i]:stop[i]])
return maskeddata
# Read all the PDBs and return useful information
# (residue numbers, residue names and coordinates)
def readAllPDBs(pdbs):
pdbresids,pdbresnames,pdbcoords=[],[],[]







# Check that there are no gaps in the PDB numbering
def checkPDBres(resids,chid):
ch=’-’






print ’Check resid: ’+str(resids[i])+’! It may be missing, so program may crash!’
rid+=1
# Make difference vectors between all PDB pairs
def makePDBmodes(vMPDBs,vMcoords):
vectors=[]
runcoords=[ rotateMat(x,calcRotMat(x,vMcoords)) for x in vMPDBs ]
for i in range(len(runcoords)):
for j in range(i+1,len(runcoords)):
vectors.append(runcoords[i]-runcoords[j])
return vectors
# Make a matrix of overlaps for all PDB difference vectors against the nmwiz vectors
def makeOverlapsMat(vMPDBs,nmwMaskedVecs,nmwMaskedCoords,retnmwdata=False):
Overlaps=[]
for i in range(len(vMPDBs)):
Overlaps.append([])
rm=calcRotMat(vMPDBs[i],nmwMaskedCoords)
nmwMV=[rotateMat(Vec,rm) for Vec in nmwMaskedVecs]
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# Write the latex overlaps table
def writeOverlapTable(outname,Overlaps,full=False):








"PDB1 & PDB2 & "




for i in loop1:
loop2=range(len(Overlaps[i]))





















Appendix C. Python Programming 257
# Write an nmwiz file (with minimum necessary information)
def Qwritenmwiz(outfilename,resids,resnames,coords,vectors):
string=’nmwiz_load ’+outfilename+’\n’




for i in range(len(vectors)):
string+=Qmakenmwizlinemode(vectors[i],str(i+1))
with open(outfilename,’w’) as f:
f.write(string)
# Write a line of nmwiz data
def makenmwizline1d(data,title):
string=title+’ ’
string+=’ ’.join([str(x) for x in list(data)])
string+=’\n’
return string
# Write the coordinate line for nmwiz file
def makenmwizlinecoord(data):
string=’coordinates ’
string+=’ ’.join(["%.4f" % i for i in data.flatten(’F’)])
string+=’\n’
return string
# Write a mode line for nmwiz file
def Qmakenmwizlinemode(data,modeno):
string=’mode ’+modeno+’ ’
string+=’ ’.join(["%.4f" % i for i in data.flatten(’F’)])
string+=’\n’
return string
# # # # # # # # # # # # # # # # # # # # # # #
# Begin Program script #




masses=np.array([ResWeights[item] for item in nmwresnames])
#read PDBs
pdbresids,pdbresnames,pdbcoords=readAllPDBs(pdbs)
# Centers nma/pca coordinates (nmwcoords) and all the PDB coordinates to the origin (masked)
# Then it Least square fits the PDB coordinates to the nmwcoords (masked)
# The masked difference vectors between the PDBs is determined (vMPDBs)
if options.alignmask and options.vecmask:




# Get evecs from nmwiz according to mask
nmwMaskedVecs=[makeMaskedCoords(x,vstart,vstop) for x in nmwevecs]
maskedMasses=makeMasked1d(masses,start,stop)

















print "At the moment align and vector masks needs to be assigned! EXITING"
quit()
# Get the overlaps between PDB difference vectors and nmwiz coordinates
Overlaps, NMWMV=makeOverlapsMat(vMPDBs,nmwMaskedVecs,nmwVMaskCoords,True)
writeOverlapTable(options.outtab,Overlaps,full=False)









D.1 pCRTM-Blunt II-TOPO R© map
Figure D.1: The map for plasmid pCRTM-Blunt II-TOPO R©
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D.2 pREP4 map
Figure D.2: The map for plasmid pREP4
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D.3 pQE30 map
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Tube No. Buffer/Salt Buffer/Salt pH Precipitant
A1 0.1 M SPG buffer None 4.0 25 % w/v PEG 1500
A2 0.1 M SPG buffer None 5.0 25 % w/v PEG 1500
A3 0.1 M SPG buffer None 6.0 25 % w/v PEG 1500
A4 0.1 M SPG buffer None 7.0 25 % w/v PEG 1500
A5 0.1 M SPG buffer None 8.0 25 % w/v PEG 1500
A6 0.1 M SPG buffer None 9.0 25 % w/v PEG 1500
A7 0.2 M sodium chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
A8 0.2 M ammonium chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
A9 0.2 M lithium chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
A10 0.2 M magnesium chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
A11 0.2 M calcium chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
A12 0.01 M zinc chloride 0.1 M sodium acetate 5.0 20 % w/v PEG 6000
B1 0.1 M MIB buffer None 4.0 25 % w/v PEG 1500
B2 0.1 M MIB buffer None 5.0 25 % w/v PEG 1500
B3 0.1 M MIB buffer None 6.0 25 % w/v PEG 1500
B4 0.1 M MIB buffer None 7.0 25 % w/v PEG 1500
B5 0.1 M MIB buffer None 8.0 25 % w/v PEG 1500
B6 0.1 M MIB buffer None 9.0 25 % w/v PEG 1500
B7 0.2 M sodium chloride 0.1 M MES 6.0 20 % w/v PEG 6000
B8 0.2 M ammonium chloride 0.1 M MES 6.0 20 % w/v PEG 6000
B9 0.2 M lithium chloride 0.1 M MES 6.0 20 % w/v PEG 6000
B10 0.2 M magnesium chloride 0.1 M MES 6.0 20 % w/v PEG 6000
B11 0.2 M calcium chloride 0.1 M MES 6.0 20 % w/v PEG 6000
B12 0.01 M zinc chloride 0.1 M MES 6.0 20 % w/v PEG 6000
C1 0.1 M PCTP buffer None 4.0 25 % w/v PEG 1500
C2 0.1 M PCTP buffer None 5.0 25 % w/v PEG 1500
C3 0.1 M PCTP buffer None 6.0 25 % w/v PEG 1500
C4 0.1 M PCTP buffer None 7.0 25 % w/v PEG 1500
C5 0.1 M PCTP buffer None 8.0 25 % w/v PEG 1500
C6 0.1 M PCTP buffer None 9.0 25 % w/v PEG 1500
C7 0.2 M sodium chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
C8 0.2 M ammonium chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
C9 0.2 M lithium chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
C10 0.2 M magnesium chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
C11 0.2 M calcium chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
C12 0.01 M zinc chloride 0.1 M HEPES 7.0 20 % w/v PEG 6000
D1 0.1 M MMT buffer None 4.0 25 % w/v PEG 1500
D2 0.1 M MMT buffer None 5.0 25 % w/v PEG 1500
D3 0.1 M MMT buffer None 6.0 25 % w/v PEG 1500
D4 0.1 M MMT buffer None 7.0 25 % w/v PEG 1500
D5 0.1 M MMT buffer None 8.0 25 % w/v PEG 1500
D6 0.1 M MMT buffer None 9.0 25 % w/v PEG 1500
D7 0.2 M sodium chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
D8 0.2 M ammonium chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
D9 0.2 M lithium chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
D10 0.2 M magnesium chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
D11 0.2 M calcium chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
D12 0.002 M zinc chloride 0.1 M Tris 8.0 20 % w/v PEG 6000
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Tube No. Buffer/Salt Buffer/Salt pH Precipitant
E1 0.2 M sodium fluoride None 20 % w/v PEG 3350
E2 0.2 M sodium bromide None 20 % w/v PEG 3350
E3 0.2 M sodium iodide None 20 % w/v PEG 3350
E4 0.2 M potassium thiocyanate None 20 % w/v PEG 3350
E5 0.2 M sodium nitrate None 20 % w/v PEG 3350
E6 0.2 M sodium formate None 20 % w/v PEG 3350
E7 0.2 M sodium acetate None 20 % w/v PEG 3350
E8 0.2 M sodium sulfate None 20 % w/v PEG 3350
E9 0.2 M potassium/sodium tartrate None 20 % w/v PEG 3350
E10 0.02 M sodium/potassium phosphate None 20 % w/v PEG 3350
E11 0.2 M sodium citrate None 20 % w/v PEG 3350
E12 0.2 M sodium malonate None 20 % w/v PEG 3350
F1 0.2 M sodium fluoride 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F2 0.2 M sodium bromide 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F3 0.2 M sodium iodide 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F4 0.2 M potassium thiocyanate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F5 0.2 M sodium nitrate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F6 0.2 M sodium formate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F7 0.2 M sodium acetate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F8 0.2 M sodium sulfate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F9 0.2 M potassium/sodium tartrate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F10 0.02 M sodium/potassium phosphate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F11 0.2 M sodium citrate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
F12 0.2 M sodium malonate 0.1 M Bis Tris propane 6.5 20 % w/v PEG 3350
G1 0.2 M sodium fluoride 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G2 0.2 M sodium bromide 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G3 0.2 M sodium iodide 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G4 0.2 M potassium thiocyanate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G5 0.2 M sodium nitrate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G6 0.2 M sodium formate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G7 0.2 M sodium acetate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G8 0.2 M sodium sulfate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G9 0.2 M potassium/sodium tartrate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G10 0.02 M sodium/potassium phosphate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G11 0.2 M sodium citrate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
G12 0.2 M sodium malonate 0.1 M Bis Tris propane 7.5 20 % w/v PEG 3350
H1 0.2 M sodium fluoride 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H2 0.2 M sodium bromide 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H3 0.2 M sodium iodide 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H4 0.2 M potassium thiocyanate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H5 0.2 M sodium nitrate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H6 0.2 M sodium formate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H7 0.2 M sodium acetate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H8 0.2 M sodium sulfate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H9 0.2 M potassium/sodium tartrate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H10 0.02 M sodium/potassium phosphate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H11 0.2 M sodium citrate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
H12 0.2 M sodium malonate 0.1 M Bis Tris propane 8.5 20 % w/v PEG 3350
Table E.1: Crystallisation conditions in the PACT premierTM HT-96 screen.
Abbreviations: HEPES; N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid,
MES; 2-(N-morpholino)ethanesulfonic acid, PEG; Polyethylene glycol, Tris; 2-Amino-2-
(hydroxymethyl)propane-1,3-diol, SPG buffer; Succinic Acid, Phosphate, Glycine, MIB
buffer; Malonic acid, Imidazole, Boric acid, PCTP buffer; Propionic acid, Cacodylate,
Bis-tris propane, MMT buffer; Malic acid, MES, Tris. [246]
